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Torpor is a hypothermic, hypometabolic state engaged when the availability of 
nutrients is insufficient to maintain homeostasis. It is observed in a wide range of 
animals, including the laboratory mouse, and if mimicked in humans, a synthetic 
torpor state could have useful clinical applications. The mechanisms that control 
torpor are not known. This thesis explores the neuroanatomical basis of torpor 
induction. The core method used a genetic approach that allowed targeted expression 
of transgenes in neurons that are active during torpor.  
First, two protocols for torpor induction in mice were validated, alongside the use of 
surface thermography as a proxy for internal body temperature. A method to detect 
torpor was developed using a moving window of the mean and standard deviation of 
mouse surface temperature across the 24-hour cycle. 
I then used the transgenic mouse model to express a fluorescent protein in neurons 
that were active during torpor. This identified that the dorsomedial hypothalamus 
(DMH) and the preoptic area of the hypothalamus (POA) increase activity during 
torpor.  
Next, a chemogenetically modified receptor was expressed in neurons that were active 
during torpor. Reactivation of those neurons generated a synthetic torpor state in the 
absence of any natural stimulus for torpor. Targeted reactivation of only the POA 
neurons that were active during torpor recapitulated this synthetic torpor, 
demonstrating that the POA contains neurons that are sufficient for torpor induction. 
A similar approach in the DMH demonstrated that neurons in this nucleus promote, 
prolong, and deepen torpor bouts in calorie restricted mice, but are neither necessary 
nor sufficient for torpor induction.  
In summary, these findings represent the first demonstration of a synthetic torpor in 
the mouse. They indicate that the POA is sufficient for torpor induction, and that the 
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Chapter 1 Introduction 
1.1  Clinical Background 
When demand for oxygen and nutrients outstrips supply, such as during ischemia, cell 
death occurs due to necrosis and apoptosis (M. Y. Wu et al. 2018). The extent of cell 
death depends on the severity and duration of the ischaemia as well as the nature of 
reperfusion (Eltzschig and Eckle 2011). When caused by occlusion of a cerebral or 
coronary artery, this imbalance manifests as stroke or myocardial infarction (MI), 
respectively: the two leading causes of morbidity and mortality globally (World Health 
Organization 2018). Cardiac arrest can be considered a global ischaemic insult, while 
critical illness requiring organ support also represents a state in which the demand for 
oxygen and nutrients is either unmet due to circulatory or respiratory failure, or else 
oxygen and nutrients cannot be utilized by cells due to bioenergetic failure (Aslami and 
Juffermans 2010).  
Traditionally, treatment has focused on redressing this imbalance by increasing supply. 
In the case of stroke or MI, increased supply is achieved by unblocking or bypassing the 
occluded artery. In the context of organ support on the intensive care the imbalance is 
corrected by fluid resuscitation, blood transfusion, parenteral nutrition, vasopressor or 
inotrope administration, and mechanical support of ventilation and even circulation. 
These approaches are far from perfect: there is a limited time-window during which 
returning blood flow is effective in stroke or MI (NICE 2019; 2015). Likewise, organ 
support in the intensive care frequently results in some degree of iatrogenic injury as 
efforts are made to increase oxygen and nutrient supply to normal or even ‘supra-




the significant injury that occurs following reperfusion (Eltzschig and Eckle 2011; 
Kalogeris et al. 2012). 
Thus, an approach that balances limited supply against demand by reducing metabolic 
rate would benefit a variety of pathological states. The ancient Greeks appreciated the 
potential for hypothermia as a therapeutic intervention: 
“Cold should be used … when there is, or is likely to be, 
haemorrhage”  
Hippocrates: Aphorisms (translated by W H S Jones, 1931) 
The concept gained serious consideration amongst ‘modern’ medical practitioners in 
the 1940s and 1950s when it was proposed to allow bloodless cardiac surgery 
(Bigelow, Lindsay, and Greenwood 1950) or to treat cancer (L. W. Smith and Fay 1939). 
These early studies report maintenance of core temperature in human patients at 32°C 
for up to four days, during which time cardiac, respiratory, gastrointestinal, and renal 
function was dramatically reduced and yet patients could be woken with no apparent 
ill consequences (Fay 1940). These first attempts to induce therapeutic hypothermia 
(or “artificial hibernation” as it was called then) identified that physical cooling 
techniques trigger profound autonomic responses such as vasoconstriction, 
tachycardia, and shivering. These reflex responses not only oppose the cooling effect 
but could prove harmful to the patient. A relative hiatus of several decades followed, 
with the application of hypothermia largely limited to cardiac surgery, where it 
continued to be achieved by physical cooling (easier when on cardiac bypass). Lack of 




and managing its complications (Karnatovskaia, Wartenberg, and Freeman 2014; 
Polderman 2009).  
There is now something of a resurgence of interest in cooling as a neuroprotective 
measure: therapeutic hypothermia is the only evidence-based treatment to reduce 
brain injury after cardiac-arrest (Hypothermia after cardiac Arrest Study Group, 2002); 
it permits periods of complete circulatory arrest during cardiac and vascular surgery; it 
improves outcomes in neonatal hypoxic encephalopathy (Azzopardi et al. 2009); and, 
there is evidence to suggest it may improve survival and neurological outcome in 
patients with persistently raised intracranial pressure severe traumatic brain injury 
(Polderman et al. 2002). This clinical data is supported by evidence from animal 
studies, which indicate that therapeutic hypothermia confers protection to rats 
following ischaemic stroke (van der Worp et al. 2010), following trauma to the brain or 
spinal cord (S. L. Smith and Hall 1996), and during sepsis (Chang et al. 2013), to dogs 
following cardiac arrest (Leonov et al. 1990), and to pigs following major haemorrhage 
(Z. Chen et al. 2005),. The protective mechanisms are incompletely understood 
(reviewed in (Polderman 2009)), but include: 
• Reduced metabolic rate 
• Reduced oxygen requirements 
• Reduced generation of reactive oxygen species 
• Preserved cellular ionic homeostasis leading to reduced apoptosis 
• Temperature-dependent inhibition of inflammatory cascades. 
While the results of further ongoing clinical trials of therapeutic hypothermia in stroke, 




the beneficial effects described above:  there have been equivocal or disappointing 
results in traumatic brain injury (Andrews et al. 2015), and there is some debate about 
the true usefulness of hypothermia following cardiac arrest (Nielsen et al. 2013). 
Failure to translate benefits from animal studies to adult clinical conditions may be due 
to side-effects arising from the counter-regulatory reflexes, which were identified back 
in the 1940s, and remain an issue today. These reflexes lead to: haemodynamic 
instability; shivering with increased oxygen consumption; cardiac arrhythmias; and 
electrolyte and glucose disturbances (Dundee et al. 1953; Sandestig, Romner, and 
Grände 2014).  
1.2  Torpor: the natural solution 
Torpor is the naturally occurring hypothermic, hypometabolic and hypoactive 
component of hibernation, which can be prolonged (in seasonal hibernators), or brief 
(in daily heterotherms such as the mouse). It serves as an adaptive response to relative 
energy deficit: a controlled reduction in metabolic demand in response to reduced 
availability of substrate. During torpor, body temperature typically runs a few degrees 
above ambient temperature, which in hibernating arctic ground squirrels results in 
core temperatures as low as -2.9°C (Barnes 1989). Metabolic rate falls to between 1 
and 5% of euthermic rates with similar reductions in heart and respiratory rates 
(Heldmaier, Ortmann, and Elvert 2004). Figure 1 shows a characteristic hypometabolic 
hypothermic torpor bout in a hibernating dormouse. There are obvious parallels 
between therapeutic hypothermia and natural torpor: both involve a drop in core body 
temperature, reduced metabolic rate, and protection against ischaemia-reperfusion 
injury (Bouma et al. 2012). Torpor necessitates inhibition of metabolism and 




adjustments to normal homeostatic mechanisms leading to suppressed 
cardiorespiratory, chemoreceptive, and nociceptive reflexes. Metabolic rate is actively 
suppressed beyond the passive effects secondary to reduced core temperature (Toien 
et al. 2011). Torpor therefore provides an intriguing model of a centrally orchestrated 
hypothermic and hypometabolic strategy for the protection of vital organs during 
periods of energy deficit. If such a centrally driven state could be mimicked in a clinical 
setting, it would avoid activating the deleterious reflexes seen when physical cooling 
techniques are applied, and may therefore represent an improved strategy for 
therapeutic hypothermia.   
Proposing to induce synthetic torpor in humans may seem science fiction, but there 
are several lines of argument that suggest it might not be so far-fetched. Firstly, 
torpor, hibernation, and estivation are remarkably conserved behaviours seen in all 
classes of vertebrate life, including the three oldest branches of mammals: 
monotremes, marsupials, and placentals including primates, as illustrated in figure 1 
(Carey, Andrews and Martin, 2003; Heldmaier, Ortmann and Elvert, 2004). Those 
mammals that engage torpor, do so through activation of ubiquitous genes, rather 
than a complement of genes that are unique to those torpid animals (Srere, Wang, and 
Martin 1992; Faherty et al. 2016; S. Zhao et al. 2010). Hence, this behaviour represents 
a fundamental physiological response that may have been relatively recently switched 
off in those animals that no longer naturally employ it. Secondly, even obligate 
homeotherms such as humans adjust core temperature across the circadian cycle. 
Core body and brain temperature peaks around 37°C three hours before sleep onset 






FIGURE 1-1 CHARACTERISTICS AND DISTRIBUTION OF TORPOR. 
Top panel shows the dramatic reduction in body temperature (Tb) and oxygen consumption 
(MR) typical of torpor in a torpid hamster. Bottom panel shows the widespread distribution of 
daily torpor (marked with triangles) and seasonal hibernation (marked with squares) in the 
mammalian class. One or both behaviours are seen in 11 of 20 extant orders of mammals. From 




In addition, the fever response is a controlled deviation from ‘normal’ 
thermoregulation. Hence, body temperature is adjustable even in animals that do not 
employ torpor. Lastly, there is a precedent for ‘hijacking’ pre-existing neural circuits to 
induce a physiological state that bears little resemblance to behaviour usually seen in 
that organism: general anaesthesia. No animal naturally enters a state of general 
anaesthesia and yet it is possible to induce it by targeted activation of specific neural 
circuits, which are probably normally involved in sleep induction (Y. Ma et al. 2019; Zhe 
Zhang et al. 2015; K. Sakurai et al. 2016; Jiang-Xie et al. 2019). 
1.2.1  Physiological characteristics of torpor  
This review will focus on the physiology of daily torpor in the mouse, primarily because 
this is the animal that will be studied experimentally. However, where relevant or 
where data in the mouse are lacking, other species including hamsters, squirrels, 
bears, and lemurs will be included. The latter group undergo prolonged seasonal 
hibernation, and an assumption is that the torpor during these hibernation periods is 
mechanistically equivalent to the brief torpor bouts seen in daily heterotherms such as 
the mouse. I note however, that this assumption has not been experimentally tested.  
Due to the large surface area to volume ratio of a mouse, maintenance of 
normothermia represents a significant energy cost. In mice housed at an ambient 
temperature of 22°C, over 30% of energy expenditure is directed towards 
thermogenesis (Abreu-Vieira et al. 2015). When mice are unable to access sufficient 
calories to maintain active physiology and normal body temperature, they will enter 
periods of torpor lasting several hours (Hudson and Scott 1979). Stimuli for torpor 
include acute fasting (Sunagawa and Takahashi 2016), a combination of fasting and 




food restriction (van der Vinne et al. 2018), or simply increasing the energy costs of 
foraging (Schubert et al. 2010). This latter observation supports the hypothesis that it 
is a relative imbalance of energy supply compared to the demands of maintaining 
‘normal’ physiological homeostasis rather than a response to cold and hunger per se, 
which triggers torpor. In summary: torpor is engaged in any situation where the 
available food is insufficient for metabolic demands.  
Female mice are more prone to torpor than males, and hence some studies present 
data from female mice only (for example, Swoap and Gutilla, 2009; Oelkrug, Heldmaier 
and Meyer, 2010; Kato et al., 2018) although males do enter torpor (Lo Martire et al. 
2018; Sunagawa and Takahashi 2016; Gavrilova et al. 1999; Solymár et al. 2015). 
Evidence from the pouched mouse, Saccostomus campestris, indicates that 
testosterone inhibits torpor (Mzilikazi and Lovegrove 2002). This might reflect the 
relatively lower energetic burden that normal activity and reproduction place on male 
compared to female mice, hence the need to conserve adipose tissue energy reserves 
may be greater for females. Alternatively, the relative female predisposition to torpor 
may be due to lower birth weight since low birth weight predicts higher torpor 
tendency irrespective of actual body weight at the time of fasting (Kato et al. 2018). 1 
1.2.2  Definition, timing, and duration of torpor 
The transition to torpor may not be all or nothing: fasted mice exhibit increased 
variability of both metabolic rate and body temperature, with graded reductions in 
core body temperature up to full torpor (Brown and Staples 2010). Despite the 
 
1 Following submission of this thesis, data emerged that indicate a role for oestrogen receptor 
expressing neurons in the preoptic area in torpor (Zhi Zhang et al. 2020), an observation that might 




magnitude of the final deviation from normal physiology, there is no consensus on the 
definition of torpor in mice. Examples include a core body temperature below 34°C 
proceeded by least fifteen minutes of consecutive decline (Willis 2007; Iliff and Swoap 
2012); body temperature below 31°C  for at least 30 minutes (Brown and Staples 
2010); body temperature below 32°C (Braulke and Heldmaier 2010)a metabolic rate 
25% below expected (Hudson and Scott 1979); the duration of a period of monotonic 
cooling resulting in a reduction in body temperature of at least 5°C followed by a 
period of monotonic increase up to at least 5°C above the nadir (Lo Martire et al. 
2018); or, deviation from a Bayesian estimate of individual basal metabolic rate or core 
temperature (Sunagawa and Takahashi 2016). These approaches vary in their 
complexity, as well as their ability to account for individual and / or circadian 
fluctuations in body temperature or metabolic rate.  
Although the trigger for torpor entry in mice usually originates from a fluctuating 
rather than predictable environmental stimulus, the timing of torpor entry is under 
circadian control. Torpor in mice generally occurs during the latter part of the lights off 
period (Brown and Staples 2010; Webb, Jagot, and Jakobson 1982). Timing of torpor 
entry is primarily under the control the circadian clock, but can be adjusted by the 
timing or expected timing of food (van der Vinne et al. 2018), or entrained to food in 
mice or hamsters lacking endogenous circadian clocks (van der Vinne et al. 2018; Paul, 
Kauffman, and Zucker 2004). Duration of torpor in mice is inversely proportional to the 
weight of the mouse (Hudson and Scott 1979), with some evidence that torpor is 
engaged when food restriction or fasting decreases body weight to approximately 20g 
(Solymár et al. 2015), although this experiment was performed only in male mice.  




aborted or shorter bouts (Hudson and Scott 1979; Webb, Jagot, and Jakobson 1982). 
Bouts may last 12 hours or more depending on the intervention used to induce torpor 
(Kato et al. 2018).  
1.2.3  Thermoregulation during torpor 
During torpor bouts, thermoregulation is not simply suspended: mice maintain active 
control of their temperature, usually tracking approximately two degrees above 
ambient temperature, but defending a minimum body temperature of 16 - 19°C 
(Hudson and Scott 1979). Further evidence for the continued - albeit adjusted - 
thermoregulatory control comes from the observation that the rate of decline in body 
temperature is lower in torpor than when hypothermia is induced pharmacologically 
or physically (M. A. Vicent, Borre, and Swoap 2017), that is to say, temperature 
decreases during entry into torpor are controlled. Indeed a very low ambient 
temperature may reduce the probability of torpor entry, again indicating ongoing 
albeit adjusted thermoregulation (Sunagawa and Takahashi 2016). Hypothermia in a 
torpid animal could be achieved through three distinct mechanisms: increased thermal 
conductance to the environment; reduced target temperature; or, reduced gain in the 
regulatory feedback system. Hibernating marmots appear to reduce both the gain and 
the target of the thermoregulatory system (Florant and Heller 1977), while daily torpor 
in mice may predominantly involve reduction in its gain (Sunagawa and Takahashi 
2016). Whether these observations reflect qualitative differences between the 
hypothermia seen during daily torpor and that during torpor in hibernation is not clear.   
1.2.4  Cardiovascular function during torpor 
The suppression of metabolism associated with torpor allows animals to tolerate 




perfusion. Heart rates of torpid mice typically reach a nadir of approximately 150 beats 
per minute (bpm) from resting rates of around 600 bpm (Swoap and Gutilla 2009). 
Hypothermia alone generates a degree of bradycardia, such as is seen clinically during 
therapeutic hypothermia (Stær-Jensen et al. 2014). However, heart rates are slower at 
any given core body temperature during entry into, compared to arousal from torpor 
(Swoap and Gutilla 2009). This indicates a dominance of the parasympathetic nervous 
system during entry, followed by sympathetic nervous system activation during 
arousal from torpor, at least in terms of the heart. For a given body temperature, 
pharmacologically-induced hypothermia generates a less profound bradycardia than 
that seen in torpor, which again supports the hypothesis that heart rate is actively 
suppressed during torpor entry (M. A. Vicent, Borre, and Swoap 2017).  
Given that heart rate in torpid mice drops by 75% from resting values, and mean 
arterial blood pressure is determined by cardiac output multiplied by total peripheral 
resistance, if all other parameters remained the same a 75% drop in mean arterial 
pressure would be predicted during torpor. However, systolic, diastolic, and mean 
arterial pressure drop by only 25-30% during torpor (Swoap and Gutilla 2009). 
Assuming pulse pressure as a proxy for stroke volume, cardiac output - which is 
calculated from stroke volume multiplied by heart rate - may be reduced by 
approximately 80%. The maintenance of blood pressure at values only 25-30% below 
those seen in euthermic mice is presumably achieved by increased total peripheral 
resistance.  
Hence, during torpor there appears to be simultaneous activation of the sympathetic 




latter driving bradycardia. Simultaneous activation of both the sympathetic and 
parasympathetic limbs of the autonomic nervous system has been proposed as a 
means to optimise cardiac function when pumping blood into a constricted vascular 
tree (Paton et al. 2005).  
1.2.5  Metabolic rate and respiratory function during torpor 
Respiratory function in torpid mice is less well studied, however, in the little pocket 
mouse Perognathus longimembris (a 7-11 gram rodent from the family Heteromyidae) 
daily torpor is associated with a reduction in respiratory minute volume to less than 
2% of basal levels (Withers 1977). Dormice (Glis glis) exhibit similar characteristics 
during torpor (Elvert and Heldmaier 2005). Both species increase the rate and decrease 
the depth of ventilation during entry and exit from torpor, a pattern that resembles 
panting. The purpose of this panting is unclear, but it may serve to increase heat loss 
during torpor entry, reduce the partial pressure of carbon dioxide in the blood prior to 
torpor, or expel accumulated carbon dioxide following torpor.  
The assessment of acid-base balance and partial pressures of O2 and CO2 in 
hypothermic hibernating animals is complex: the pH of pure water is dependent on 
temperature, as are the dissociation constants of biological buffers, and the partial 
pressure of a fixed amount of carbon dioxide (PCO2) in a solution decreases with 
decreasing temperature. One approach for assessing acid-base balance in hypothermic 
or hibernating animals is to take a sample of blood held in a sealed container, 
normalise the temperature and then measure the pH. This allows comparison with 




Blood taken from hibernating hamsters (Cricetus cricetus) and warmed to 37°C in a 
sealed syringe, tends to have a pH between 6.9 and 7.15 compared to euthermic pH of 
approximately 7.36, and an arterial PCO2 between 17 and 24 kilopascals (kPa) 
compared to euthermic values of approximately 6 kPa, indicating a respiratory 
acidosis. Alternatively, one can measure the dissociation ratio of imidazole groups on 
proteins (αim): acid conditions reduce the dissociation ratio (as does reduced 
temperature). Using this measure also indicates an acidic intracellular state during 
hibernation in blood, brain, and muscle of hibernating hamsters (Malan, Rodeau, and 
Daull 1985; Malan 1988). In contrast to the observation of a respiratory acidosis in 
hibernating hamsters, hibernating arctic ground squirrels appear to have reduced PCO2 
compared to euthermic ground squirrels and rats (Y. L. Ma et al. 2005). This difference 
may reflect differences in the body temperature of these hibernating species, with 
greater metabolic suppression in the colder artic ground squirrel leading to less CO2 
production, differences in the physiology of the species, or differences in the method 
for analysing the blood gases taken from hypothermic animals. The partial pressure of 
oxygen (PO2) in hibernating arctic ground squirrels is actually higher than in euthermic 
animals, reflecting presumably the reduced oxygen consumption, and only dips below 
normal euthermic values during arousal when metabolic activity is at a peak (Y. L. Ma 
et al. 2005). 
Oxygen consumption decreases to between 0.04 and 0.05ml O2.g-1.hr-1 in torpid 
pocket mice and dormice, which in the former is less than 1% of levels when housed at 
an ambient temperature of 10°C (Withers 1977; Elvert and Heldmaier 2005). Larger 
mammals such as the Alaskan black bear, whose basal metabolic rate is generally 




levels. Notably, the minimum oxygen consumption seen in hibernating bears is very 
similar to that seen in smaller mammals, reaching a nadir of 0.06 ml O2.g-1.hr-1 (Toien 
et al. 2011). The fact that large seasonal hibernators achieve similar metabolic 
suppression despite significantly higher body temperature during hibernation 
compared to small daily heterotherms, indicates that the reduction in metabolic rate is 
not simply a passive consequence of lowered body temperature, rather metabolism is 
actively suppressed. This hypothesis is further supported by several observations: 
reductions in heart rate, respiratory rate and oxygen consumption precede decreases 
in core temperature in all animals studied, and is largely independent of ambient 
temperature (Toien et al. 2011; Elvert and Heldmaier 2005; Withers 1977). Metabolic 
rate in torpid dunnarts is several times lower than that seen in a similar sized rat pup 
rendered hypothermic by exposure to a cold ambient temperature, with reversal of 
the normal relationship between body warming or cooling and metabolic rate during 
torpor (F. Geiser et al. 2014). Respiration in mitochondria taken from torpid mice is 
suppressed even when assessed at 37°C (Brown and Staples 2010). While metabolism 
is clearly suppressed during torpor, there is evidence that it increases immediately 
prior to torpor entry in the mouse (Lo Martire et al. 2018), the dormouse (Elvert and 
Heldmaier 2005),  and the Djungarian hamster (Heldmaier et al. 1999). The significance 
of this is not clear, but it may represent incomplete switching from euthermia to 
torpor with resultant episodes of shivering, or perhaps there is a need to clear 
metabolic substrates from the mitochondria prior to torpor in order to suppress 
metabolism and reduce free radical production during torpor.  
Remarkably, despite the dramatically reduced cardiac output and respiratory rate, 




hibernating arctic ground squirrels is no different from that seen in euthermic controls. 
This demonstrates the remarkable fine-tuning of metabolic supply and demand during 
torpor such that in the face of reduced supply there is no overall deficit.  
1.2.6  Renal function in torpor and hibernation 
Studies of renal function during torpor have understandably focused on larger 
seasonal hibernators rather than smaller daily heterotherms: the small size and shorter 
duration of torpor bouts in daily heterotherms makes investigation of their renal 
function much more challenging. It is not clear how comparable renal function in these 
different states may be: aside from the differences in torpor bout length and minimum 
core body temperature, for seasonal hibernators the approaching periods of torpor are 
predictable, whereas in daily heterotherms, the decision to initiate torpor occurs on a 
daily basis. The reduced time available for preparation may limit adaptations to the 
renal system in daily heterotherms compared to seasonal hibernators. Mice tend to 
drink most of their intake of water during the lights off period. Up to 25% of water 
intake occurs during the last four hours of lights off (Ho and Chin 1988), which 
coincides with the period during which torpor tends to occur. Water restriction 
protocols used in behavioural experiments typically limit water intake to 50% of the 
ad-libitum amount (Goltstein et al. 2018), and so the degree to which a 25% reduction 
in water intake - in the context of a mouse that is cold and metabolically inactive - 
represents a significant challenge to the renal system is debatable. Despite these 
caveats, it is likely that whatever happens to a seasonal hibernator happens in a daily 
heterotherm, albeit it to a lesser degree.  
Seasonal hibernators pass urine during the periodic arousals from torpor This urine is 




lower torpid temperatures (Pengelley and Fisher 1961; Moy 1971). Consistent with a 
picture of dramatically reduced or absent renal glomerular filtration during prolonged 
torpor serum creatinine rises in proportion to the time spent in torpor in dormice and 
ground squirrels (Zancanaro et al. 1999; Sandovici et al. 2004; Jani et al. 2013). In 
contrast to cold ischaemia, kidneys from torpid ground squirrels show no activation of 
caspase-3 nor apoptosis. During interbout arousals however, there is evidence of 
brush border injury and apoptosis but with preserved concentrating function. 
Tolerance to ex-vivo cold ischaemia is similar in kidneys taken from hibernating or 
summer ground squirrels (reviewed here (Jani et al. 2013)). It is generally assumed that 
due to the profound reduction in cardiac output during torpor, the kidneys are 
ischaemic, and that some intrinsic factor protects them from this ischaemia. However, 
it could be argued that there is a maintained tailoring of blood flow to metabolic 
activity such that no relative ischaemia occurs. The kidney is cold and inactive with 
reduced glomerular filtration, cellular protein turnover is presumably very low with 
low nitrogenous waste product formation, and therefore the blood flow required to 
maintain metabolic equilibrium and avoid ischaemia would be dramatically reduced 
compared to the euthermic kidney.  
1.2.7  Blood glucose and torpor 
There is a linear relationship between blood glucose and core body temperature in 
mice under conditions of thermoneutrality and ad-libitum food availability, as well as 
during fasting or calorie-restriction. In the period leading up to torpor entry, there 
appears to be a spike in activity, body temperature, and blood glucose level, which 
then all decrease with torpor entry. Hence, prior to the onset of torpor entry, glucose 




period of cooling that marks torpor initiation. Given this, it is unlikely that 
hypoglycaemia per se is the trigger for torpor induction. Arousal from torpor is 
associated with an increase in blood glucose prior to feeding, indicating hepatic 
gluconeogenesis during this stage.  (Lo Martire et al. 2018; Davis 1976).  
A similar picture is seen for plasma glucose measured in deer mice: levels are low prior 
to torpor, then drop further with torpor entrance. Tissue glycogen appears to be 
differentially handled depending on the tissue, at least in deer mice: liver glycogen 
mirrors plasma glucose; muscle appears to buffer glycogen, with the drop both 
delayed and attenuated as compared to liver. Glycogen stores in heart muscle show 
the opposite pattern: low immediately after feeding and increasing by three-fold 
around torpor. Presumably, the liver responds to the decreased plasma glucose by 
breaking down glycogen. On the other hand, the vital role of the heart dictates that it 
is somewhat spared from glycogenolysis, with circulating plasma glucose diverted to 
this organ from the liver. Ketones and free fatty acids rise with entry into torpor and 
remain elevated post arousal (Nestler 1991). Reduced environmental metabolic fuel 
availability is not absolutely necessary for torpor induction. Mice undergoing 
spontaneous torpor (Nestler 1991), Djungarian hamsters maintained under short 
photoperiod (Kirsch, Ouarour, and Pévet 1991), and hibernating marmots and ground 
squirrels (Davis 1976) are all able to enter torpor despite the continued presence of 
food. In deer mice undergoing spontaneous torpor levels of metabolic substrates are 
similar to those seen in calorie-restricted animals despite the availability of food 
(Nestler 1991). This phenomenon has been termed ‘voluntary starvation’ (Nestler 




stimulus for torpor entry, instead it demonstrates that low glucose can be induced by 
abstaining from food regardless of its actual availability.  
Molecules that interfere with glucose metabolism, such as 2-Deoxy-D-glucose (2DG), 
may induce torpor, or a torpor-like state, in hamsters. This is in contrast to agents that 
inhibit fatty acid oxidation (such as mercaptoacetate), where the effect is at best less 
robust, and may depend on the species studied (J. Dark, Miller, and Zucker 1994). 
Animals such as rats, which do not naturally enter torpor, can also be forced into a 
hypothermic state by administration of 2DG. This effect is seen both with 
intraperitoneal injection and intracerebral injection of 2DG (Shiraishi and Mager 1980). 
Interpretation of the IP effects of 2DG is complicated by the possibility of direct 
inhibition of peripheral heat production by 2DG. However, the central effects of 2DG 
are blocked by IP atropine, suggesting that they are dependent on vagus nerve 
efferents, although a competing central effect of atropine is possible. It is unclear 
whether the central response to 2DG is due to metabolic inhibition in a group of 
tonically active thermogenic neurons, or else due to activation of a group of neurons 
whose specific role is to sense reduced metabolic fuel availability and suppress 
thermogenesis in response. The latter scenario may be more likely: if the former were 
the case, one might not expect dependence on the vagus nerve, since one would 
anticipate that a tonic thermogenic signal would be mediated by sympathetic rather 
than vagal parasympathetic activation.  
1.2.8  Torpor, calorie restriction, and longevity 
There is an inverse relationship between average body temperature and longevity 
across a range of species including mice (Conti et al. 2006) and humans (G. S. Roth et 




primates (McDonald and Ramsey 2010). These observations are likely linked, since one 
of the effects of calorie restriction is to suppress body temperature, an observation 
that is seen in species that do not engage torpor, including humans (Soare et al. 2011). 
Calorie restriction, suppressed body temperature, and torpor represent linked 
conditions in which metabolism is suppressed and a transition is made from energy 
consuming processes that drive growth and reproduction towards those that promote 
cell survival and autophagy (C. W. Wu and Storey 2016), a process that is believed to 
clear cells of damaged proteins and prevent some of the changes associated with aging 
(Barbosa, Grosso, and Fader 2019). While calorie restriction increases life span in many 
species, the effect on longevity is dramatically increased in those species that respond 
by entering torpor (C. W. Wu and Storey 2016). Hence, the same cellular processes 
that promote longevity under calorie restriction may be engaged to an even greater 
extent in torpid animals.  
1.3  Physiology of mammalian thermoregulation  
Mammalian thermoregulation presumably evolved to enable control of the core 
temperature such that cellular and tissue function is optimised to the survival and 
reproductive benefit of the animal. The considerable energy cost of maintaining a core 
temperature several degrees above ambient implies homeothermy brings a significant 
survival advantage, allowing continued activity in the face of diurnal or seasonal 
reductions in the ambient temperature and hence allowing the occupation of a wider 
range of environmental niches (Abreu-Vieira et al. 2015). Despite this investment and 
its benefits, there are times when mammalian body temperature deviates from the 
normal range. This deviation can be physiological, such as during fever, sleep (Landolt 




temperature can be pathological due to poisoning, or environmental challenge. 
Internal sources of heat in mammals include those that generate heat as a by-product, 
for example basal metabolism with heat generated as a consequence of pumping ions 
across membranes, and heat generated by muscles during movement. Additional 
internal sources of heat include those for which heat production is the primary goal. 
Examples of this include shivering, and brown adipose thermogenesis where 
mitochondrial proton flux is uncoupled from adenosine triphosphate (ATP) production 
in brown adipose (reviewed in (Nicholls and Rial 1999)). In addition, mammals can take 
steps to reduce heat loss including piloerection and peripheral vasoconstriction. Heat 
defence responses include cutaneous vasodilation with visceral constriction and 
increased cardiac output to direct blood towards the skin surface, evaporative losses 
through sweating, panting, and grooming. Despite their mutually antagonistic effects, 
both the autonomic warm and cold defence responses are under the control of the 
sympathetic nervous system (Morrison 2016b). 
Early models of thermoregulation proposed a temperature target, or set-point, against 
which incoming signals of core and external temperature were compared, with a 
homeostatic response generated to drive the core temperature back towards the set-
point (Hammel and Pierce 1968). More recently, with advances in our understanding 
of the physiology of thermoregulation, a model of multiple independent mechanisms 
each with their own threshold has emerged (McAllen et al. 2010).  
1.3.1  Afferent thermoregulation signals 
Figure 1 shows a simplified schematic of the thermal defence circuit. Thermal signals 
encoding skin temperature arise from primary somatosensory neurons that express 




temperature into electrochemical signals for neuronal transmission. Once transduced, 
the signal is passed to second order somatosensory neurons in the dorsal horn 
(Lumpkin and Caterina 2007). Hot and cold information from the skin flows centrally in 
parallel streams, both relaying information from the dorsal horn via the parabrachial 
nucleus to the preoptic area of the hypothalamus (POA). Relatively little is known 
about the inputs from thermosensitive receptors in the viscera, although it is thought 
they enter the CNS via splanchnic and vagal afferents, and follow a similar path 
through the lateral parabrachial nucleus to the preoptic area (Morrison 2016b) 
The circuit controlling thermogenic responses to  changes in skin temperature was 
identified by combining the use of retrograde tracer (cholera toxin B-subunit (CTb)), 
anterograde tracer (Phaseolus vulgaris leucoagglutinin (PHA-L)),  and 
immunohistochemistry against the c-Fos protein (Nakamura and Morrison 2008), a 
surrogate for neuronal activation (Sagar et al. 1988). This anatomical analysis as well as 
in-vivo electrophysiological recordings indicate that the projection that travels via the 
external lateral and central parts of the lateral parabrachial nucleus (LPBel, LPBc, 
respectively) responds to skin cooling. Activation of this input to the preoptic area 
results in increased brown adipose tissue (BAT) thermogenesis, shivering, and 
increased metabolic and heart rate. The response is blocked by blockade of lateral 
parabrachial glutamate transmission, and does not require an intact spinothalamic 
tract. In contrast, skin warming induces c-Fos expression and increases firing in POA-
projecting neurons in the dorsal part of the lateral parabrachial nucleus (LPBd). 










FIGURE 1-2 SCHEMATIC OF THE THERMAL DEFENCE CIRCUIT 
Inputs include skin surface thermoreceptors, visceral thermoreceptors, intrinsic thermosensitive 
neurons in the POA, and circulating pyrogens. Warm-sensing neurons increase the inhibitory 
input from the VMPO and VLPO onto the DMH, which reduces a tonically active thermogenic 
signal from DMH to RPa. Cool-sensing neurons disinhibit this tonically active DMH to RPa 
projection, to increase heat production. Abbreviations: DRG, dorsal root ganglion; DH, dorsal 
horn; LPD, lateral parabrachial nucleus; MnPO, median preoptic area; VLPO, ventrolateral 
preoptic nucleus; VMPO, ventromedial preoptic nucleus; BDNF, brain-derived neurotrophic 
factor; PACAP, pituitary adenylate cyclase-activating polypeptide; DMH, dorsomedial 






nerve activity, and cutaneous vasodilatation, effects that are also dependent on 
glutamatergic transmission in the LPBd (Nakamura and Morrison 2010). Thermal- 
 
sensitive parabrachial neurons predominantly project to the median preoptic nucleus 
(MnPO) (Nakamura and Morrison 2008). 
1.3.2  Efferent thermoregulation signals 
As illustrated in figure 1, the POA can be viewed as sitting at the top of a 
thermoregulatory arc. It integrates information about both the internal and external 
temperature, and contributes to the autonomic response to thermal challenge by 
modulating BAT thermogenesis, shivering, and vasoconstriction (Morrison, Madden, 
and Tupone 2012; Morrison 2016a). Early experiments established that local heating of 
the POA induced vasodilatation, sweating, and panting responses akin to those seen 
when heating the entire animal, indicating the existence of intrinsically warm-sensing 
POA neurons in central thermoregulatory circuits (Clark, Magoun, and Ranson 1939b; 
Magoun et al. 1938; Nakayama, Eisenman, and Hardy 1961). Lesioning the POA 
disrupts thermoregulatory responses to thermal challenge (Clark, Magoun, and Ranson 
1939a). In the 1970s, electrophysiological recordings confirmed that the POA not only 
responds to local brain temperature changes, but also responds to increases or 
decreases in skin surface or spinal temperature (J. A. Boulant and Hardy 1974). More 
recently, the application of agonists or antagonists to cultured POA neurons that 
express calcium-sensitive fluorescent dyes established that central temperature-
sensing mechanisms are mediated by the transient receptor potential M2 channel 
(TRPM2). This channel, when exposed to increasing temperatures within the 




summary, the POA receives thermal information from the skin and viscera, as well as 
directly sensing the local brain temperature, it then uses this information to control 
down-stream thermoregulation as discussed below. 
Chemo- or optogenetic excitation of a warm-activated GABAergic projection from the 
ventral part of the lateral POA (vLPO) to the dorsomedial hypothalamic nucleus (DMH) 
suppresses thermogenesis and locomotion, while inhibiting the same projection 
induces the opposite effects. Data from in-vivo calcium imaging reveals the targets of 
this GABAergic projection are both glutamatergic and GABAergic neurons within the 
DMH, both of which increase their activity in response to low ambient temperature. 
Chemo- or optogenetic activation either the GABAergic or the glutamatergic DMH 
neurons increases core temperature and activity (Z. Zhao et al. 2017). There is 
presumably a second inhibitory neuron between the DMH GABAergic neuron 
identified by Zhao et al., and the BAT-activating sympathetic premotor neurons in the 
RPa. This could in principle lie within either the DMH or the RPa or in a relay elsewhere 
(Figure 1-2).  
Another GABAergic projection to the DMH arises from the ventromedial preoptic area 
(VMPO). These VMPO neurons express brain-derived neurotrophic fact (BDNF) and 
pituitary adenylate cyclase-activating polypeptide (PACAP). Again, in-vivo calcium 
imaging reveals that these VMPO neurons are activated by exposure to a warm 
environment. Opto-activation of the warm-sensing GABAergic BDNF and PACAP-
expressing cell bodies in the VMPO induces a drop in core body temperature, 
vasodilatation, and preference for a cooler environment. Optoactivation in the DMH of 




temperature but no vasodilation or cool ambient preference. This implies that the 
DMH is responsible for the inhibition of BAT thermogenesis, whereas VMPO 
projections elsewhere generate the vasodilation and behavioural preference (Tan et al. 
2016).  
The DMH then sends projections to the rostral raphe nucleus of the medulla that in 
turn project to, and activate, BAT via the spinal intermediolateral nucleus (DiMicco and 
Zaretsky 2007a; Cao, Fan, and Morrison 2004). This DMH-Raphe-BAT projection is 
involved in thermal defence and also in the thermogenic response to stress (Kataoka et 
al. 2014). This implies that either the DMH receives inputs from additional regions 
beyond the POA thermo-sensitive circuit that mediate the stress response, or else that 
the POA also responds to stress.   
Taken together this work establishes the principle that the POA sends a GABAergic 
projection to the DMH to inhibit thermogenesis. With increasing ambient or core 
temperature, these signals increase to inhibit thermogenesis. Likewise, when internal 
and/or ambient temperature drops, neurons in these GABAergic POA to DMH 
projections reduce their firing, which disinhibits the DMH leading to increased BAT 
thermogenesis. An additional principle that emerges is that the physiological effects of 
changes in temperature may be sensed at one level (e.g. the POA), with projections to 
several downstream sites evoking independent physiological responses. This pattern is 
seen in the projection from the VMPO to the DMH where activation of this pathway 
inhibits BAT thermogenesis but does not induce the additional vasodilation or cool 
environment preference seen when activating the VMPO itself (Tan et al. 2016). It 




neurons that perform the same function of increasing thermogenesis (Z. Zhao et al. 
2017), but a plausible explanation would be that it ensures tight or fail-safe control of 
this vital homeostatic process.  
1.3.3  Thermoregulation and fever 
In addition to a role in thermal homeostasis during normal physiology, the POA 
contributes to fever in the systemic inflammatory response via the action of 
prostaglandin E2 (PGE2) on prostaglandin EP3 receptors in the MnPO (Jack A. Boulant 
2000; Lazarus et al. 2007). Chemogenetic activation of TRPM2-expressing neurons in 
the POA induces hypothermia and limits fever. This effect is recapitulated by 
chemogenetic activation of glutamatergic POA neurons, at least some of which project 
to the paraventricular hypothalamus (PVH) (Song et al. 2016). This establishes that the 
POA is not simply involved in thermoregulation under normal physiological conditions, 
and that in addition to the GABAergic outputs to the DMH described above, there exist 
glutamatergic outputs to more caudal hypothalamic areas, such as the PVH, which also 
play a role in thermoregulation and fever. 
1.4  Thermoregulation, food intake and body weight 
There must be at least two processes that link food intake, thermoregulation, and 
maintenance of body weight. The first ensures that as changes in ambient temperature 
drive changes in energy expenditure, in order to maintain bodyweight a 
commensurate adjustment of food intake must occur. In this case, energy expenditure 
and food intake move together in parallel. Hence, cold exposure increases both BAT 
thermogenesis and food intake while warm exposure reduces both (Xiao et al. 2015; 
Ravussin et al. 2014; Kaiyala et al. 2012). The second process is driven by the need to 




move in opposite directions: calorie-restriction drives food intake and suppresses body 
temperature, whereas calorie excess increases body temperature suppresses food 
intake in humans (Soare et al. 2011), as well as rodents (Duffy et al. 1989; Rothwell and 
Stock 1997). The following section is not an exhaustive review of the regulation of 
appetite and food intake, but rather focuses on the mechanisms and anatomical 
regions in which the control of food intake interacts with thermoregulation and energy 
expenditure. For a recent review of the central control of appetite, see here 
(Andermann and Lowell 2017).  
Amongst several hypothalamic nuclei that contribute to control of food intake, the 
arcuate nucleus (ARC) is central and contains two distinct but intermingled populations 
of cells that perform opposing functions. One population responds to leptin, which is 
released from WAT to signal satiety and replete WAT stores. These neurons express 
the neuropeptide pro-opiomelanocortin (POMC), which is cleaved into α-melanocyte 
stimulating hormone (α-MSH), which in turn acts on melanocortin receptors (Cone 
2005; Dodd et al. 2015). The second population express neuropeptide Y and agouti-
related peptide (NPY and AgRP, respectively). This group is activated by ghrelin, a 
hormone secreted by the gastrointestinal tract during fasting that stimulates food 
intake (Müller et al. 2015; Hahn et al. 1998), and is inhibited by leptin. NPY/AgRP 
neurons, therefore, signal energy deficit and hunger. These two populations are 
mutually antagonistic: leptin depolarises ARC POMC neurons while hyperpolarising 
NPY/AgRP neurons, which reduces their inhibitory input onto the POMC population 
(Cowley et al. 2001; Myers and Cowley 2008). Meanwhile, AgRP is a potent antagonist 
at melanocortin receptors (reviewed here (Andermann and Lowell 2017)). Each 





FIGURE 1-3  SCHEMATIC OF THE CIRCUITS CONTROLLING FOOD INTAKE AND ENERGY EXPENDITURE 
Fasting stimulates the release of ghrelin from the gastrointestinal tract, which acts on arcuate 
NPY neurons. NPY-expressing neurons in the arcuate project to the PVH to stimulate food 
intake, and to the DMH to inhibit thermogenesis and reduce energy expenditure. Conversely, 
leptin, released from WAT in proportion to the amount of stored fat, acts on arcuate POMC 
neurons. Arcuate POMC neurons project to the PVH, where they inhibit food intake, and to the 
DMH, where they increase thermogenesis and energy expenditure. Orexin released from the 
lateral hypothalamus stimulates both food intake and thermogenesis. Sensory signals modulate 
the activity of arcuate NPY and POMC neurons in anticipation of food intake. At each level in the 





1.4.1  Leptin, pro-opiomelanocortin, and alpha-melanocyte stimulating 
hormone  
Leptin is a peptide hormone released by WAT in proportion to the size of the adipose 
tissue reserve, reflecting long-term food intake and energy stores (Frederich et al., 
1995). In addition to reflecting WAT stores, leptin release is suppressed during periods 
of fasting in mice (Swoap et al. 2006) and in humans (Bergendahl et al. 2000). Leptin 
receptors are widespread, but of particular relevance here, are found in the ARC, PVH, 
DMH, POA, and the nucleus of the solitary tract (NTS) (Yan Zhang et al. 2011; Myers 
and Cowley 2008). Leptin release is also inhibited by exposure to a short photoperiod 
in hamsters (Freeman et al. 2004), an observation that may account for the 
observation that humans eat more as winter approaches (de Castro 1991).  
1.4.2  Physiology of leptin 
As a signal of  replete WAT stores, leptin inhibits food intake and increases energy 
expenditure through BAT thermogenesis, growth, and reproductive behaviours 
(Schwartz et al. 1996; Frederich et al. 1995; Myers and Cowley 2008). Exogenously 
applied leptin blunts the neuroendocrine consequences of starvation (Ahima et al. 
1996) and suppresses food intake (Mistry, Swick, and Romsos 1997). Leptin deficient 
(ob/ob) mice are obese, due to both increased ad-libitum food intake (Welton, Martin, 
and Baumgardt 1973) and reduced basal metabolic rate, such that ob/ob mice pair-fed 
with lean littermates maintain a higher body mass with increased fat stores (Trayhurn 
and James 1978). In keeping with a role in linking energy balance and 
thermoregulation, leptin-deficient mice show defects in thermoregulation: 
hypothermic at sub-thermoneutral ambient temperatures and fatally incapable of 
defending body temperature with acute exposure to low ambient temperatures 




in leptin signalling, ob/ob mice show reduced BAT response to electrical or 
noradrenergic stimulation, indicating a role for peripheral leptin in priming BAT 
thermogenesis (Seydoux et al. 1982). Hence, the ob/ob mice are unable to recognise 
their ample fat stores and adapt as if in a starved state by suppressing thermogenesis 
and increasing food intake.  
1.4.3  Functional anatomy of leptin 
Leptin receptors are highly expressed in the ARC, which is a central hub in the 
processing of signals regarding the energy state of an animal (Cone 2005; Y. Chen et al. 
2015). Leptin’s actions here suppress food intake and, when combined with high 
circulating insulin, increase the sympathetically mediated browning of WAT (Dodd et 
al. 2015). Leptin’s effects in the ARC are mediated by a coordinated increase in the 
activity of pro-opiomelanocortin (POMC) neurons, and reduction in the activity of 
neurons that co-express neuropeptide Y (NPY) and agouti-related peptide (AgRP) 
(Myers and Cowley 2008; Cowley et al. 2001). POMC-expressing ARC neurons project 
to diverse brain regions including PVH, where they release α-melanocyte stimulating 
hormone (α-MSH), which acts on melanocortin receptors  (Cone 2005). In-vivo calcium 
imaging reveals that the ARC POMC neurons react to both the presence of food and 
also the sensory anticipation of food availability. This suggests that leptin responsive 
POMC neurons have a role in acute satiety and foraging, in addition to long-term 
energy balance (Y. Chen et al. 2015). Transgenic mice lacking the melanocortin 4 
receptor show a similar phenotype to ob/ob mice: obese with increased food intake 
and suppressed energy expenditure. Selective reintroduction of melanocortin 4 
receptors in the PVH normalises the excess food intake but not the suppressed energy 




In addition to running through circuits well-known for their role in modulating food 
intake, leptin receptors are also expressed in regions involved in thermoregulation: 
neurons that express leptin receptors are trans-synaptically labelled by pseudorabies 
virus injected into BAT. This delineates the presence of leptin receptors throughout the 
thermoregulatory circuit from BAT, up to the RPa, the DMH, and finally, the median 
POA (MnPO). Leptin receptor-expressing neurons in the DMH produce c-Fos in 
response to acute cold exposure (Yan Zhang et al. 2011). Chemogenetic activation of 
these DMH leptin receptor-expressing neurons stimulates BAT thermogenesis and 
locomotor activity without affecting food intake, resulting in decreased body weight 
(Rezai-Zadeh et al. 2014). Hence there is overlap between the circuits mediating the 
thermogenic effects of leptin and those mediating the thermogenic effect of acute cold 
exposure. Neurons in the POA that express leptin receptors also respond to exposure 
to a warm environment. Chemogenetic activation of these neurons inhibits feeding 
and reduces energy expenditure by inhibiting BAT thermogenesis (Yu et al. 2016). The 
simultaneous inhibition of feeding and thermogenesis is not usually a role attributed to 
leptin. Rather, leptin is usually associated with suppression of feeding and stimulation 
of thermogenesis (Myers and Cowley 2008). Hence one might anticipate that the effect 
of leptin on these neurons would be to inhibit their activity, the leptin receptor has 
been shown to be capable of inhibiting synaptic transmission (J. L. Thompson and 
Borgland 2013). These observations were dependent on ambient temperature, which 
suggests a role for POA leptin receptor-expressing neurons linking the necessary 
alterations of food intake that must accompany changes in the energy demands of 
thermogenesis. It would be interesting to establish the effects of leptin at its receptors 




In conclusion, the picture that emerges from the literature is that leptin tends to move 
energy expenditure and food intake in opposite directions: increased leptin drives 
weight loss by suppressing food intake and increasing energy expenditure. This 
suggests that its primary role is to control body mass and / or WAT stores. It may also 
contribute to suppressing both thermogenesis and food intake following exposure to a 
warm environment, although this is less well established.  
1.4.4  Neuropeptide Y and Agouti-related Peptide 
NPY is one of the most highly expressed neuropeptides found in the brain, where it is 
commonly co-expressed with AgRP. It is involved in energy homeostasis, circadian 
rhythms, the stress response, and cognition. NPY production is widespread, but of 
particularly relevance to energy homeostasis, it is  expressed in the ARC, the NTS, the 
DMH, and the PVH (Bi, Robinson, and Moran 2003; Elmquist, Elias, and Saper 1999; 
Chronwall et al. 1985). There are three main NPY receptors in humans and rodents: Y1, 
Y2, and Y5. Expression of these receptors is also widespread, but densities occur in 
areas related to homeostasis, thermoregulation, and energy expenditure including: 
PVH, ARC, lateral hypothalamus, NTS and DMH. As introduced above, NPY and AgRP 
respond to fasting or WAT store depletion by suppressing energy expenditure, and 
increasing food intake. Hence, NPY/AgRP have opposite and antagonistic functions to 
leptin (reviewed in Cone, 2005; Reichmann and Holzer, 2016). 
1.4.5  Physiology of NPY and AgRP 
Peripheral administration of ghrelin induces c-Fos expression in, and depolarises, ARC 
NPY/AgRP neurons (L. Wang, Saint-Pierre, and Taché 2002; Cowley et al. 2003; Y. Chen 
et al. 2015). These ARC NPY/AgRP neurons also express leptin receptors, the action of 




hyperpolarisation (Cowley et al. 2001). Hence, NPY and AgRP neurons are activated by 
low WAT energy stores and hunger. As with POMC neurons, NPY/AgRP neurons are 
modulated by the sensory anticipation of food, such that in food-restricted mice, 
presentation of sensory cues indicating food availability reduces firing (Y. Chen et al. 
2015). Adult ablation of NPY/AgRP neurons leads to mice with low body weight, 
reduced food intake, and increased BAT activity (Bewick et al. 2005; Gropp et al. 2005; 
Luquet 2005). Intra-cerebroventricular (ICV) administration of NPY acutely increases 
food intake and decreases BAT activity. ICV NPY also increases WAT lipoprotein lipase 
activity (indicating increased lipid deposition), an effect that persists in food-restricted 
rats, suggesting a direct effect rather than as a consequence of increased metabolic 
substrate availability (Billington et al. 1991). The effects of NPY on both BAT and WAT 
are mediated by sympathetic innervation, rather than via a circulating factor (Egawa, 
Yoshimatsu, and Bray 1991). NPY’s ability to drive lipoprotein lipase is an interesting 
observation since one might anticipate that NPY would liberate fat stores in an animal 
that is hungry. Instead, the activation of lipoprotein lipase suggests that the role of 
NPY is directed primarily towards replenishing fat stores rather than providing energy 
for immediate metabolism.  
1.4.6  Functional anatomy of NPY and AgRP 
Local injections of NPY into discrete hypothalamic nuclei has at times produced 
contradictory findings. Injection into the ARC induces hypothermia, as might be 
expected (Jolicoeur et al. 1995). NPY injection into the PVH may inhibit BAT 
sympathetic nerve activity (Egawa, Yoshimatsu, and Bray 1991), and yet it has also 
been shown to induce hyperthermia (Jolicoeur et al. 1995). Likewise, injection into the 




Yoshimatsu, and Bray 1991), but may also induce hypothermia (Jolicoeur et al. 1995). 
This bidirectional response might indicate that high doses of NPY activate 
autoreceptors in a negative feedback loop to block further NPY release. This may result 
in increased BAT thermogenesis. This hypothesis is supported by the observation that 
ICV injection of NPY at low doses induces hypothermia and at higher doses causes 
hyperthermia (Jolicoeur et al. 1995). Inhibition of NPY release by activation of 
presynaptic Y2 receptors has been observed in-vitro (King et al. 1999). This is an 
important consideration with implications for experiments that use opto- or 
chemogenetics to activate circuits in a potentially supra-physiological manner.  
ARC NPY /AgRP neurons project to the DMH and PVH, both of which also contain cell 
bodies that express NPY (Chronwall et al. 1985; Q. Wang et al. 1997; Tiesjema et al. 
2007; Chao et al. 2011). While both acute and chronic food restriction induce NPY 
mRNA expression in the ARC, only chronic food-restriction induces NPY mRNA in the 
DMH (Bi, Robinson, and Moran 2003).  Knock-down of DMH NPY expression increases 
WAT browning, lipolysis, and BAT UCP1. This increased BAT thermogenesis combined 
with observed increases in locomotor activity is not accompanied by increases in food 
intake, and therefore results in weight loss (Chao et al. 2011). The effect of NPY 
knockdown in the DMH mimics the effect of leptin in this nucleus, with a tendency to 
affect thermogenesis and energy expenditure more than food intake (Rezai-Zadeh et 
al. 2014). The DMH however, may be capable of increasing food intake via a 
cholinergic input to the ARC, which increases inhibitory tone on ARC POMC neurons 
(Jeong, Lee, and Jo 2017). It is tempting to speculate that this projection could form 
the basis for the link that drives increased food intake when the energetic costs of 




neurons that project to the PVH indicates that this circuit stimulates feeding via 
GABAergic input on PVH oxytocin neurons (Y. Chen et al. 2015; Atasoy et al. 2012).  
1.4.7  Food intake and thermoregulation: summary 
Figure 3 shows a schematic diagram of the circuits involved in control of food intake 
and energy expenditure. The ARC, DMH, and PVH form a circuit that integrates 
information about the past, the present, and the future energy state. These signals are 
generated by leptin, ghrelin, and sensory inputs, respectively. Leptin signals long-term 
energy balance as reflected by WAT stores. Ghrelin signals recent food intake and time 
since last meal. Sensory inputs signal the approaching likelihood of food. The system 
comprises parallel antagonistic and mutually inhibitory branches: elevated leptin 
indicates replete energy stores and releases the brakes on energy expenditure while 
inhibiting further food intake by activating  POMC neurons and inhibiting ARGP/NPY 
neurons; suppressed leptin and/or elevated ghrelin signals depletion of energy stores, 
driving food intake and suppression of energy expenditure through activation of 
NPY/AgRP and inhibition of POMC neurons. At each level neurons that are activated by 
ghrelin are generally inhibited by leptin and vice versa. A model that emerges from 
review of the literature is that the ARC to PVH projection responds rapidly to cues 
regarding acute energy requirements and food availability to drive changes in food 
intake. On the other hand, the ARC to DMH projection appears more concerned with 
adjusting energy expenditure so that WAT stores are maintained within a target range. 
Within this putative framework, the PVH might modulate feeding through the NTS, 
while the DMH would modulate energy expenditure via the RPa. The evidence for this 




1. NPY and POMC neurons projecting to the PVH are rapidly modulated even by 
the sensory suggestion of pending food (Y. Chen et al. 2015). Modulation of 
global energy expenditure on such a rapid timescale would be less useful than a 
system that follows long-term leptin signals.  
2. Selectively restoring POMC/α-MSH signalling in the PVH normalises the 
increased feeding in an obese mouse line but does not normalise the 
suppressed energy metabolism (Balthasar et al. 2005) 
3. Chemogenetic activation of leptin receptor-expressing neurons, or knock down 
of NPY neurons in the DMH modulates energy expenditure without affecting 
food intake (Rezai-Zadeh et al. 2014; Chao et al. 2011). 
4. While either acute or chronic food restriction induces NPY in the ARC, only 
chronic food restriction leading to depletion of WAT and reduced circulating 
leptin induces NPY in DMH (Bi, Robinson, and Moran 2003).  
This is a hypothetical distinction based on the broad consensus from the literature, and 
it is unlikely to completely account for how the circuit works: there will inevitably be 
exceptions to this concept, since hypothalamic circuits are characterised by 
redundancies and reciprocal interactions both within and between levels. 
1.5  Thermoregulation and sleep 
The section that follows focuses on the interaction between sleep, energy 
homeostasis, and thermoregulation. Sleep is a hypometabolic state in humans 
(Brebbia and Altshuler 1965; Ryan et al. 1989; Kennedy et al. 1982) and in rodents 
(Szymusiak and Satinoff 1981). Several theories regarding the purpose of sleep place 




described sleep as simply conserving global energy expenditure, such that the 
metabolic demands of maintaining activity during waking are partly balanced during 
the hypometabolic state of sleep (Ralph J Berger and Phillips 1995). The theory that 
sleep primarily represents a means to conserve energy would imply that most 
processes should be downregulated during sleep. There are in fact many processes 
that are upregulated during sleep (reviewed here (Schmidt et al. 2017)). This 
observation led to the proposal that rather than simply being a generalised 
hypometabolic state, sleep is a state in which energy is allocated to specific processes, 
with the partitioning of these activities to periods of sleep rather than wake providing 
an overall energy saving (Schmidt et al. 2017). In addition to these theories, which 
consider whole organism energy balance as the currency of sleep requirement, the 
energetic balances of the brain itself may play a role in the need for sleep. The synaptic 
homeostasis hypothesis (Tononi and Cirelli 2003) states that a primary role of sleep is 
to regulate the overall strength of synaptic connections, which grow during waking. 
The drive for this is both to maintain meaning in the connections within circuits, and 
also to reduce the overall metabolic demands of the brain (Tononi and Cirelli 2014). 
Whatever the precise role of sleep- and the theories described above are not mutually 
exclusive- sleep clearly represents an opportunity for reducing metabolic demand and 
/ or redirecting energy allocation, qualities it shares with torpor.   
1.5.1  Temperature changes during sleep 
In humans, intracranial temperature reaches a peak in the period one to two hours 
prior to the onset of darkness, and drops by approximately 1°C during sleep (Landolt et 
al. 1995). The cooling associated with sleep is an active process, in humans driven at 




et al. 2000). Similar alterations in core and brain temperature during sleep are seen in 
rodents (Zhe Zhang et al. 2015; Harding, Franks, and Wisden 2019).  
Non rapid-eye-movement (NREM) sleep is characterised by a controlled reduction in 
body temperature such that while core body temperature reduces, changes in ambient 
or hypothalamic temperature continue to induce thermoregulatory responses, 
including sweating (Geschickter, Andrews, and Bullard 1966), panting, and shivering 
(Parmeggiani and Rabini 1967). During NREM sleep, the temperature threshold for 
inducing metabolic heating is reduced, and the slope of the response also reduced 
compared to wake (Glotzbach and Heller 1976). In contrast, rapid-eye-movement 
(REM) sleep appears to involve total cessation of thermoregulation such that (in small 
animals at least) body temperature follows changes in ambient temperature, and does 
not respond to changes in local hypothalamic temperature (Heller and Glotzbach 1977; 
Walker et al. 1983; Glotzbach and Heller 1976). This abandonment of 
thermoregulation during REM may be a factor limiting the duration of REM epochs in 
sub-thermoneutral environments (Heller and Glotzbach 1977). REM sleep is also 
characterised by cerebral oxygen consumption similar to that seen during waking, 
which is in stark contrast with NREM sleep (Madsen et al. 1991).  
The interaction between sleep and body temperature is reciprocal: sleep is associated 
with a reduction in body temperature, and increased body or hypothalamus 
temperature or a warm ambient environment promotes sleep (McGinty and Szymusiak 
1990; Bunnell et al. 1988; Romeijn et al. 2012; Kräuchi et al. 1999; Lo Martire et al. 
2012). This relationship has led some to hypothesise that sleep is fundamentally a 




observation that vasodilation and a rapid rate of body cooling is associated with sleep 
onset appears somewhat at odds with the fact that prior to sleep humans and rodents 
seek out warmth (Harding et al. 2018). The reason behind this apparent paradox may 
lie in the observations that while increased temperature, be that core, brain, or 
ambient is associated with increased sleep, in particular NREM sleep, it is not the 
elevated temperature but rather the subsequent high rate of heat loss that seems to 
be most predictive of sleep initiation.  
In humans, increasing peripheral vasodilation associated with a falling core body 
temperature from its peak in the hours prior to sleep onset predicts latency to sleep 
(Kräuchi et al. 2000; 1999). Humans also tend to select a bed time that coincides with 
the maximum rate of circadian body temperature reduction (Campbell and Broughton 
1994). A similar observation has been made in mice: reactivating warm-sensing 
preoptic neurons induces a drop in core temperature and increased NREM sleep 
(Harding et al. 2018). Hence, seeking out a warm environment may place an individual 
in a setting that permits a high rate of heat loss, which aids sleep initiation. Of course, 
it may also be that the high rate of heat loss and relative unresponsiveness of the 
thermoregulatory system is in an undesirable but inevitable side-effect of the process 
of sleep induction. In this case seeking out warm environments would be a means to 
mitigate some of the heat loss that results from those side-effects. For example, if 
reduced sympathetic tone is required to allow the animal to enter a low vigilance 
state, then a corollary of that might be increased vasodilation and reduced BAT 




1.5.2  Functional anatomy linking sleep and thermoregulation: the 
preoptic hypothalamus  
In mapping the neuronal basis for the link between thermoregulation and sleep, the 
POA acts as a critical hub. In mice, recovery sleep following a period of deprivation is 
associated with a drop in core temperature of between 1.5 and 2°C, and increased 
delta power indicating NREM sleep. Chemogenetic reactivation of median and lateral 
POA neurons that are active during recovery sleep recapitulates both this increased 
NREM sleep and drop in core body temperature. Lateral POA (LPO) neurons are also 
the target of the α-2 agonist dexmedetomidine, which induces sedation that mimics 
recovery sleep (Zhe Zhang et al. 2015; Kroeger et al. 2018).  
The population of neurons in the region of the LPO and VLPO that are capable of 
inducing NREM and hypothermia express galanin: chemo- or optogenetic stimulation 
of GABA- and galanin-expressing neurons in the ventrolateral preoptic nucleus (VLPO) 
induces NREM and a drop in body temperature (Kroeger et al. 2018); knock-out of 
lateral preoptic (LPO) galanin neurons significantly attenuates the sedation and 
hypothermia associated with dexmedetomidine administration, and causes a rise in 
body temperature with somewhat disrupted sleep homeostasis (Y. Ma et al. 2019). 
These findings support the hypothesis that reduced sympathetic tone associated with 
activation of α-2 receptors disinhibits sleep- and hypothermia-promoting galanin 
neurons in the lateral and / or ventrolateral preoptic area. VLPO neurons that are 
active during sleep project monosynaptically to the tuberomammillary nucleus, which 
is known to modulate arousal (Sherin et al. 1996) In a related study, warm sensitive 
neurons in the region of the MnPO/MPO were reactivated using activity-dependent 




NREM sleep without a significant change in body temperature, reactivation of the 
glutamatergic/nitrergic subpopulation induced both, indicating that they may be part 
of the circuit that coordinates NREM sleep induction with body temperature reduction 
(Harding et al. 2018). In all these experiments, the drop in body temperature during 
chemogenetic-driven sleep was deeper than that seen in natural sleep (Kroeger et al. 
2018; Harding et al. 2018; Zhe Zhang et al. 2015). This observation may reflect the 
somewhat abnormal nature of the stimulation (Armbruster et al. 2007), or may reflect 
a role for these regions in torpor. 
1.5.3  Orexin, sleep, and thermoregulation 
Orexin A and B (also known as hypocretin 1 and 2) are closely related neuropeptides 
produced in the lateral hypothalamus (LH) with vital roles in maintaining wakefulness 
and stimulating food intake. Loss of orexin neurons is responsible for the clinical 
condition narcolepsy, characterised by uncontrollable sleepiness and cataplexy 
(Chemelli et al. 1999; T. Sakurai 2014). In contrast to, for example, ghrelin or 
neuropeptide Y described above, which stimulate food intake and suppress energy 
expenditure, orexin stimulates both (J. Wang, Osaka, and Inoue 2003; Inutsuka et al. 
2014). Orexin release from the lateral hypothalamus is inhibited by leptin (Goforth et 
al. 2014), stimulated by ghrelin, and also influenced by circulating glucose and 
triglycerides suggesting that the role of orexin is to arouse and motivate the animal to 
increase food intake (reviewed here (T. Sakurai 2014)).  
ICV injection of orexin stimulates food intake, an effect that can be reduced by 
blocking ARC Y1 receptors (Yamanaka et al. 2000). Local injection of orexin into the 
DMH, PVH, or LH also increases food intake, indicating that orexin acts at several sites 




increases body temperature, secondary to increased locomotor activity (Yoshimichi et 
al. 2001), direct sympathetic activation of BAT thermogenesis (J. Wang, Osaka, and 
Inoue 2003), and increased heart rate and blood pressure (Samson et al. 1999). The 
thermogenic effects of ICV orexin can be recapitulated by localised injection into the 
ARC, although lesioning the ARC did not entirely eradicate this response, indicating 
either residual ARC function or local diffusion and action at sites outside the ARC (J. 
Wang, Osaka, and Inoue 2003). Surprisingly, orexin knockout (orexin -/-) mice, which 
exhibit many of the features of human narcolepsy (Chemelli et al. 1999), have slightly 
elevated average body temperature, due to impaired heat loss during sleep (Mochizuki 
et al. 2006). A similar effect is seen in humans with narcolepsy: while average core 
temperature is depressed, body temperature during sleep is increased (Pollak and 
Wagner 1994). Disturbed heat loss during sleep may be either the cause or the effect 
of poor and fragmented sleep seen in orexin -/- mice and narcoleptic patients. 
Alternatively, due to the loss of normal wake-promoting orexin neurons, sleep in 
narcoleptic patients and orexin -/- mice may occur without engaging the POA neurons 
described above. Hence, in these individuals the normal mechanisms that 
simultaneously suppress temperature and induce sleep are not invoked. Whatever the 
details of this apparent paradox, orexin has complex effects on body temperature that 
depend on the sleep/wake cycle: during waking, it increases body temperature and 
during sleep it may facilitate heat loss.  
1.5.4  Sleep and adenosine 
The role of adenosine in sleep is complex and beyond the scope of this review, 
presented here is a summary of some key aspects, as they relate to torpor (a more 




adenosine receptors A1R, and A2R are widely expressed throughout the brain. The A1R 
is inhibitory and  generally considered to be neuroprotective through suppression of 
glutamate release and hyperpolarisation (reviewed here (Cunha 2005)), and by 
modulating cerebral blood flow and metabolic rate (Blood, Hunter, and Power 2003). 
In addition to their central effects, adenosine receptors in the cardiovascular system 
mediate negative inotropic, chronotropic, dromotropic, and anti-adrenergic effects via 
A1Rs, and vasodilatation via A2Rs (reviewed here (Shryock and Belardinelli 1997)). 
Central activation of A1Rs promotes sleep, hypothermia, sedation, and reduced 
locomotor activity (Anderson, Sheehan, and Strong 1994). 
Sleep deprivation increases the homeostatic drive for sleep, and is reflected in 
elevated time spent in NREM and by increased EEG delta power during subsequent 
recovery sleep (reviewed here (Borbély et al. 2016)). Expression of this rebound 
increase in NREM sleep is dependent on the presence of neuronal A1Rs, via an 
interaction with glia (Bjorness et al. 2009; 2016), although additional mechanisms may 
also be capable of providing this function, for example in whole-animal A1R knockouts 
(Stenberg et al. 2003). In this way, adenosine links the homeostatic drive for sleep with 
suppression of metabolic and cardiovascular systems, and induction of NREM sleep.  
1.5.5  Sleep and torpor 
Preserved thermoregulatory control despite altered body temperature is characteristic 
of both torpor and NREM sleep. Both also probably reduce overall energy expenditure. 
An obvious question is to ask what is the link between torpor and sleep, in particular 




Ground squirrels and pocket mice enter torpor through sleep and the drop in body 
temperature always begins during sleep (Walker et al. 1977; Heller and Glotzbach 
1977; R J Berger 1984). Electroencephalogram (EEG) recordings during torpor display 
the characteristics of NREM sleep provided brain temperature is above about 25°C. At 
brain temperatures below 25°C, EEG power is globally reduced but delta waves 
associated with NREM sleep are discernible. EEG power decreases (and with it the 
ability to discern sleep states) with brain temperatures below 20°C, and becomes 
isoelectric below about 10°C (Walker et al. 1981; Larkin and Heller 1996). Consistent 
with the observation that low brain temperatures are associated with the loss of 
NREM EEG pattern, there is evidence that prolonged torpor such as that seen in 
seasonal hibernators is associated with accumulation of sleep debt. During prolonged 
seasonal hibernation periods, arctic ground squirrels periodically arouse to euthermia 
through NREM sleep, the duration of which correlates with the minimum brain 
temperature reached during the preceding torpor (Trachsel, Edgar, and Heller 1991; 
Larkin and Heller 1996). These observations indicate that while torpor at intermediate 
core temperatures resembles NREM sleep, some of the vital functions of sleep are 
depressed during torpor at very low body temperature, and must be performed at or 
close to euthermia.  
1.6  Mechanisms of torpor 
1.6.1  The sympathetic nervous system and leptin in torpor 
As discussed above, torpor likely involves a coordinated activation of both the 
sympathetic and parasympathetic nervous systems, respectively generating 
vasoconstriction and bradycardia. Dopamine beta-hydroxylase (DBH) knock-out mice 




appear essentially normal. Norepinephrine can be at least partially restored by the 
administration of L-threo-3,4-dihydroxyphenyserine (DOPS)  (Thomas, Matsumoto, and 
Palmiter 1995; Thomas et al. 2002). DBH-/- mice fail to enter torpor after 12 hours of 
fasting at 20°C. This impairment can be reversed by the administration of DOPS. The 
normalisation of torpor seen with DOPS treatment is dependent on restoration of 
peripheral norepinephrine. In this series of experiments, selective activation of beta-3 
adrenoceptors in fasted DBH-/- mice resulted in a profound hypothermic state. 
Administration of beta-3 receptor antagonist (SR 59230A) to fasted DBH+/- mice 
altered the quality of torpor bouts by raising the minimum body temperature reached. 
Serum leptin is elevated in both the fed and fasting state in DBH-/- compared to 
DBH+/- mice. Fasting does not significantly reduce serum leptin in DBH-/- mice, but 
fasting in combination with administration of DOPS or a beta-3 agonist reduces serum 
leptin to levels comparable to fasted DBH+/- mice (Swoap et al. 2006).  
The model that emerges from this series of experiments is that activation of beta-3 
receptors on WAT suppresses leptin release, which serves as the signal for torpor 
induction. There are additional studies that support this model. Firstly, DBH -/- mice 
that also lack leptin signalling (by crossing with ob/ob mice to generate double-mutant 
mice) regain the ability to enter torpor, albeit unusually early and shallow bouts. The 
proposal is that in lacking leptin, these modifications bypass the need for sympathetic 
action on WAT. Once torpid, these double knock-out mice are unsurprisingly slow to 
rouse given they lack both leptin, which is BAT thermogenic, and norepinephrine, 
which acts on beta-3 receptors in BAT to stimulate thermogenesis (Swoap and 
Weinshenker 2008). Secondly, exogenous leptin reduces leptin mRNA expression in 




autoregulation of leptin is dependent on norepinephrine (or perhaps epinephrine) 
(Commins et al. 1999). Thirdly, torpor in short photoperiod-adjusted Djungarian 
hamsters can be blocked by chemical sympathectomy with 6-Hydroxydopamine 
(Braulke and Heldmaier 2010).  
Finally, knockout of the orphan receptor Gpr50 (Gpr50 -/-), which is structurally and 
functionally related to the melatonin receptor (Reppert et al. 1996) and is expressed in 
DMH and tanycytes lining the third ventricle, results in a similar phenotype to that 
seen in ob/ob mice: suppressed dark phase core body temperature and reduced 
threshold for torpor. Gpr50 expression is reduced in the DMH of ob/ob, and is 
normalised by leptin replacement. The body temperature of Gpr50 -/- mice does not 
increase in response to exogenous leptin administration, nor does exogenous leptin 
block torpor in these mice. Gpr50 -/- mice also have suppressed expression of 
thyrotropin-releasing hormone (TRH) in the PVH, which is further suppressed by 
fasting. Administration of a TRH analogue blocked torpor in Gpr50 -/- mice (Bechtold 
et al. 2012). This evidence suggests that leptin stimulates Gpr50 expression in the 
DMH, and that this in turn stimulates TRH release in the PVH. Activation of this 
pathway may provide a mechanism by which leptin reduces the propensity to torpor, 
and hence a drop in leptin may facilitate torpor. 
This is an appealing model, but there are some comments to be made: 
1. While the torpor bouts generated by administration of DOPS to fasted DBH-/- mice 
appeared similar to those seen in DBH+/- controls, administration of a beta-3 
agonist (CL 316243) produced a hypothermia so profound that the animals did not 




expected to assist recovery from torpor by stimulating BAT thermogenesis. It is not 
entirely clear, then, that this was the same as natural torpor.  
2. If activation of beta-3 receptors on WAT serves as the first step towards torpor 
induction, then administration of a beta-3 agonist to DBH+/- might be expected to 
increase the probability and or depth of torpor: this was not reported.  
3. Fasted DBH+/- mice given a selective beta-3 receptor antagonist appear to enter 
torpor normally, with a rate of decline in core body temperature that is 
comparable to controls. The difference between this and control torpor bouts 
appears to be that the beta-3 receptor antagonist caused the torpor bout to be 
terminated prematurely before core temperature reaches a ‘normal’ nadir. This 
does not fit with the model that beta-3 receptor suppression of WAT leptin release 
is the initiating trigger for torpor.  
4. If suppressed leptin is the signal for torpor induction, then one might expect to see 
the lowest level of serum leptin in the animals that show the most profound 
torpor. In fact, DBH -/- mice showed the most profound hypothermia on fasting 
despite having higher leptin levels than fasted DBH+/- littermates (see figure 4 in 
(Swoap et al. 2006)).  
5. Given that leptin acts on POMC/α-MSH neurons in the arcuate (see section 
1.3.4.1), blocking this pathway should mimic a drop in leptin and therefore be pro-
torpor. However Ay mice, which display ectopic AgRP production and through the 




melanocortin signalling, in fact show a reduced tendency to torpor (Gluck, 
Stephens, and Swoap 2006)2. 
6. Although there is a correlation between the ability to suppress leptin and the 
ability to enter torpor, a causal nature for this relationship has not been 
exhaustively demonstrated. An implication of this model is that exogenous leptin 
should prevent torpor, and that interfering with leptin signalling should induce 
torpor even in a fed state. These have been difficult to demonstrate, and will be 
discussed in more detail below. 
Mice lacking leptin, the ob/ob mice, are prone to deeper and longer torpor bouts than 
WT mice on fasting or food restriction, despite their large adipose tissue stores 
(Gavrilova et al. 1999; Himms-Hagen 1985). There are reports of spontaneous torpor in 
fed ob/ob mice (Webb, Jagot, and Jakobson 1982), although this has also been 
reported in WT mice (Iliff and Swoap 2012). However, it is obvious to point out that 
the ob/ob mouse is not permanently torpid, and neither are A-ZIP/F-1 mice, which 
have both dramatically reduced WAT and BAT and persistently low leptin levels. While 
A-ZIP/F-1 mice will readily enter torpor on fasting, exogenous leptin administration 
does not prevent fasting-induced torpor in these mice (Gavrilova et al. 1999). In 
contrast to this, leptin administration to ob/ob mice may block torpor entry (Gavrilova 
et al. 1999). Interpreting the effects of leptin administration to transgenic mice that 
have adapted to absent leptin signalling is challenging, especially given that the 
 
2 This observation might be explained by proposing that leptin signalling is upregulated in these mice 
due to the downstream block at the melanocortin 4 receptor. There is evidence that leptin acts via 
Gpr50 receptors to inhibit torpor (see discussion of the paper by Bechtold and colleagues above 
(Bechtold et al. 2012)). Since this pathway is intact in the Ay mouse, it provides a mechanism whereby 
blocking the POMC/ α-MSH – melanocortin receptor pathway could result in impaired rather than 




expression of torpor in these mice, even without the additional complexity of adding 
exogenous leptin, is not the same as torpor seen in WT mice.  
Investigation of the effect of leptin on torpor in wild type (WT) mice has also produced 
contradictory findings. One study reports no effect of leptin treatment on core 
temperature of  WT mice during a 24 hour fast (Gavrilova et al. 1999). In this study 
leptin administration to male WT mice fasted for 24 hours did not prevent the drop in 
core temperature seen in saline-treated mice. It is important that while in this study 
the core temperature of control WT mice during 24 hours of fasting did decrease, it 
remained above 30°C, and therefore above commonly accepted thresholds for torpor, 
and will be referred to as ‘fasting-induced hypothermia’ to differentiate it from full 
torpor (see section 1.2.1.1). This fasting-induced hypothermia persisted with leptin 
treatment. In the same study, fasting for 24 hours induced torpor in ob/ob mice, and 
not only was this torpor blocked by leptin, but the minimum core temperature of 
fasted ob/ob mice given leptin remained higher than the core temperature of WT mice 
given leptin. Hence while leptin prevented any core temperature response to fasting in 
ob/ob mice, fasting-induced hypothermia persisted in leptin-treated WT mice.  
Why leptin would abolish both torpor and fasting-induced hypothermia in ob/ob mice 
but not affect the latter in WT mice is unclear, but may be due to differences in the 
sensitivity of ob/ob mice to exogenous leptin. In another experiment, male WT mice 
fasted for 48 hours again showed fasting-induced hypometabolism but probably not 
torpor. In this study, leptin treatment did reduce fasting-induced hypometabolism 
(Ivanova et al. 2008). The reasons for these different results are not clear, but may 




did not affect fasting-induced hypometabolism, leptin was administered via 
continuous subcutaneous (SC) infusion whereas in the latter study, in which leptin did 
prevent fasting-induced hypometabolism, leptin was delivered in a single ICV injection. 
Whatever the reason for these differing results, neither have confirmed that leptin 
delivery to WT mice prevents full torpor bouts.  
Leptin treatment in fasted marsupial mammal (Sminthopsis macroura) reduces the 
duration and depth of daily torpor bouts (Fritz Geiser, Körtner, and Schmidt 1998), but 
again the effect of leptin in this species appears to be predominantly to impair the 
maintenance rather than the initiation of torpor. It seems that exogenous leptin might 
reduce the probability of torpor entry in Siberian hamsters although in those leptin-
treated hamsters that did enter torpor, the torpor bout depth, duration, and 
frequency remained comparable to torpor bouts in control hamsters. Comparing 
hamsters housed under identical conditions that did or did not enter torpor revealed 
no difference in endogenous serum leptin levels. Likewise the serum leptin levels were 
the same in individual animals on days in which the animal did or did not enter torpor. 
Finally, while animals that entered torpor tended to have low leptin, the lowest levels 
were recorded in hamsters that did not enter torpor (Freeman et al. 2004). 
In summary, the evidence for leptin’s role in torpor garnered from transgenic models 
varies depending on whether the model used is the primarily leptin-deficient ob/ob 
line, or the A-ZIP/F-1 line in which absent leptin is secondary to persistently deplete 
adipose tissue stores. While both models result in low leptin and increased propensity 
to torpor, only the ob/ob mice are sensitive to leptin replacement. That mice from 




mechanisms appear during development, or else a permissive rather than a sufficient 
role of low leptin in torpor. Attempts to establish the effects of leptin administration to 
WT mice have been hampered by the fact that the WT control mice were not entering 
full torpor in those studies. That said, converging evidence both from studies 
specifically examining leptin and torpor, as well as studies looking at the role of leptin 
under more ‘normal’ physiological settings, indicates that it is likely that high leptin 
would inhibit torpor and conversely low leptin likely forms at least part of the signal for 
torpor. Finally, evaluation of the studies to date raises the possibility that the beta-3 
adrenoceptor-driven suppression of leptin plays a greater role in maintaining than 
initiating torpor.  
1.6.2  NPY, ghrelin, and torpor 
Since ghrelin and NPY act as the counterbalance to leptin, signalling hunger and energy 
deficit (see section 1.3.4), it is reasonable to hypothesise an additional or parallel role 
in torpor. Ghrelin injection during a fast in a cool ambient temperature deepens and 
prolongs torpor bouts in mice, but does not induce torpor in the fed state. NPY -/- mice 
exhibit shallow and aborted torpor bouts, which are not rescued by peripheral ghrelin. 
This indicates that ghrelin exerts its effects on torpor via NPY neurons (Gluck, 
Stephens, and Swoap 2006).  
ICV injection of NPY in cold-acclimated Siberian hamsters (small, heterothermic 
mammals) reduces core body temperature and can increase the probability of torpor. 
This effect in hamsters is mediated by Y1 receptors (John Dark and Pelz 2008). ICV NPY 
may also inhibit food intake, in proportion to its effects on body temperature or torpor 
(Paul et al. 2005). This latter finding is surprising given NPY is usually considered 




which is to forage and increase food intake, is presumably switched to a signal to cease 
locomotor activity, and enter torpor, perhaps this observation reflects that transition.  
It is also relevant to note that hamsters undergo both fasting-induced torpor, which is 
triggered by energy deficit at any seasonal time, and short photoperiod-induced 
torpor, which is seasonal and does not necessarily involve an energy deficit. These 
distinct torpor phenotypes likely involve different regulatory mechanisms (Cubuk, 
Markowsky, and Herwig 2017), which might account for the observed effect of NPY on 
food intake in these animals.  
The arcuate is a key locus for NPY signalling, and selectively ablation of ARC neurons 
with monosodium glutamate (MSG), supports a role for this nucleus in torpor. For 
example, in contrast to controls, ARC-ablated mice do not enter torpor after 24 hours 
of fasting, although they do show a degree of fasting-induced hypothermia (Gluck, 
Stephens, and Swoap 2006). In Siberian hamsters, ARC ablation impairs short 
photoperiod-induced torpor, reducing the probability, and slightly reducing the depth 
and length of torpor bouts. However, torpor was still seen in these hamsters and there 
was no difference in ARC NPY immunoreactivity between ARC-ablated hamsters that 
did and those that did not enter torpor.  Likewise, ARC ablation reduced the 
probability of torpor in food restricted hamsters but had no effect on the quality or 
frequency of those torpor bouts in animals in which torpor was seen.  
Although NPY receptor antagonists have been shown to prevent NPY-induced torpor 
(or rather, NPY-induced torpor-like hypothermia) (John Dark and Pelz 2008), the same 
has not been demonstrated for natural torpor. This raises questions about whether the 




the starvation-induced drop in temperature that is seen in non-hibernators (Billington 
et al. 1991), although of course the two may lie on a continuum.  
In summary, there is evidence indicating roles for ghrelin and NPY within the ARC as 
signals for the conditions that are associated with torpor. There is also some evidence 
supporting direct roles in torpor, and a functioning ARC nucleus may be a requisite for 
the expression of torpor in mice. However, this necessity has not been demonstrated 
in hamsters, indicating either that alternative mechanisms exist capable of bypassing 
the ARC, or else suggesting that torpor in hamsters and mice is generated through 
distinct mechanisms. To date, there is no evidence that activity of ARC neurons is 
sufficient to induce a torpor bout.  
1.6.3  Adenosine, orexin, and torpor 
Adenosine, which was introduced in section 1.3.5.4, is a natural candidate to link many 
of the functions associated with torpor (Silvani et al. 2018). Central infusion of the A1R 
agonist N6-cyclohexyladenosine (CHA) into rats exposed to cold ambient temperature, 
generates a state that has many features of torpor, including vagally mediated skipped 
beats and bradycardia, inhibition of BAT and shivering thermogenesis, and decreased 
EEG power (Tupone, Madden, and Morrison 2013). Accumulation of adenosine during 
periods when demands for ATP outstrip supply, and the consequent engagement of a 
repertoire of responses that limit ATP consumption (reviewed here(Newby 1984)), 
make it an appealing candidate for signalling the drive for torpor.  
Prolonged subcutaneous infusion of aminophylline, a non-specific adenosine receptor 
antagonist, significantly impairs torpor in male mice, resulting in delayed, shallow, and 




Aminophylline infusion initiated during torpor brought about emergence (Iliff and 
Swoap 2012). In animals that enter torpor in response to seasonal cues, the response 
to adenosine is dependent on those cues. For example, central A1R blockade in Syrian 
hamsters causes arousal during the induction phase of seasonal torpor (Tamura et al. 
2005). In arctic ground squirrels, ICV infusion of CHA induces torpor or a similar state, 
in a manner that was modulated by the season, and was blocked by central A1R 
antagonists (Jinka, Tøien, and Drew 2011). Calorie restriction by alternate day feeding 
suppresses core temperature and respiratory rate in rats, and increases the sensitivity 
to IP CHA by increasing the expression of A1Rs in the hypothalamus (Jinka et al. 2010). 
Hence, modulation of the central sensitivity to adenosine provides a means for both 
hibernators and non-hibernators to adjust temperature responses to environmental 
cues.  
Despite the striking similarities between torpor and the physiological response to 
central A1R activation, there are some features that remain distinct. Changes in heart 
rate with torpor entry and arousal occur rapidly and display frequent skipped beats 
and asystoles, whereas those changes occur over several hours following CHA 
treatment and involve predominant extension of the inter-beat interval and rarely 
display asystoles. On the other hand, temperature changes are slower in natural torpor 
compared to CHA-driven hypothermia, with no evidence of shivering in the latter. 
Finally, c-Fos is induced in the liver and heart of mice treated with CHA, but is not in 
natural torpor, indicating calcium influx and potentially signalling cellular stress 
following CHA treatment (M. Vicent et al. 2017). And most importantly, fasting-




Orexin neurons may mediate some of the thermoregulatory adaptations seen 
following central adenosine administration, since orexin -/- mice are less sensitive to 
the effects of central CHA administration. However, these same mice also recover 
more slowly from the hypothermia induced by CHA, and are prone to deeper, longer, 
and more frequent torpor bouts than WT controls. In-vivo calcium imaging in this study 
indicated that orexin neurons are active immediately prior to and after fasting-induced 
torpor (Futatsuki et al. 2018). It is interesting to note that the orexin response to CHA 
appears to be bidirectional: orexin enhances CHA-induced hypothermia initiation and 
overcomes it during recovery. Likewise, the effect of orexin on body temperature 
appears to depend on the sleep/wake cycle: promoting thermogenesis during waking 
and heat loss during sleep (Mochizuki et al. 2006).  
In summary, adenosine represents a candidate signal for torpor initiation but, once 
again, must be designated as ‘contributing’ or ‘permissive’ and not a necessary and 
sufficient master switch. One might expect orexin to reduce the likelihood of torpor, 
and to assist in arousals, and while this role is supported by the observation of 
increased torpor depth and duration in orexin -/- mice, the role in WT mice or other 
species is not clear. There is currently no accepted explanation for the apparent 
bidirectional effects of orexin on body temperature and following CHA administration.  
1.6.4  Torpor and histamine 
Histaminergic neurons reside in the tuberomammillary nucleus (TMN) of the 
hypothalamus, and are involved in regulation of food intake, thermoregulation, 
locomotor activity, and promoting wakefulness (reviewed here (Haas, Sergeeva, and 
Selbach 2008)). Activation of H1 or H3 receptors in the POA induces hyperthermia in 




non-GABAergic neurons, while H3 receptors reduce the activity of GABAergic neurons 
(Lundius et al. 2010). It is somewhat surprising, then, that intra-hippocampal infusion 
of histamine delays arousal from torpor (Sallmen, Lozada, Beckman, et al., 2003). 
Several studies have investigated the modulation of histamine signalling during 
hibernation or torpor. The results appear to vary depending on the species, and the 
brain regions assessed. Histamine fibre density and tissue levels of histamine increase 
throughout the brain during seasonal hibernation in ground squirrels, with particularly 
striking elevation in the hippocampus and hypothalamus (Sallmen et al. 1999). 
Expression of histamine receptors 1 and 2 (the excitatory subtypes) is elevated in 
hippocampus of hibernating ground squirrels, whereas expression of the inhibitory H3 
subtype is reduced in the same region (Sallmen, Lozada, Anichtchik, Beckman, Leurs, et 
al. 2003). In contrast, H3 subtype expression is increased in the same species in the 
cortex, putamen, and caudate nucleus (Sallmen, Lozada, Anichtchik, Beckman, and 
Panula 2003). H3 receptor expression is also elevated in the ARC, DMH, 
suprachiasmatic nucleus (SCN) and TMN in Djungarian hamsters during daily torpor 
(Herwig et al. 2007). The unexpected observations that increased not decreased 
histamine transmission, accompanied by region-specific upregulation of inhibitory H3 
receptors, are associated with torpor indicate that the role of histamine signalling is 
more complex than simply increasing body temperature and arousal, nevertheless its 
precise role in torpor is not clear at this stage.  
1.6.5  Torpor and endogenous opioids 
The endogenous opioid system contributes to pain modulation, reward, the stress 
response, and several autonomic functions including digestion, arousal, and control of 




endorphin, enkephalins, and dynorphins, which act respectively but not exclusively at 
µ-, δ-, and κ- opioid receptors. Of note, β-endorphin is produced in POMC neurons, by 
an alternate cleaving of the precursor POMC (reviewed here (Benarroch 2012)). Early 
investigations into the thermoregulatory effects of intracerebral β-endorphin injection 
reported that the effects depended on both the location of the injection and the dose 
used. For example, injection into the POA, anterior hypothalamus (AH), periaqueductal 
grey (PAG), nucleus accumbens (NAcc), reliably produced an initial hypothermia, with 
core temperature dropping by approximately 1°C. This was generally followed by a 
period of hyperthermia, except when high doses were injected into the NA, where high 
doses appeared to produce a sustained hypothermia (Tseng et al. 1980). A similar 
effect is seen following administration of morphine to rats at increasing doses. These 
biphasic responses are probably the result of time- and dose- dependent activation of 
different opioid receptor classes. Studying the effects of various opioid receptor-
specific agonists and antagonists in rats and mice suggests that activation of κ- or δ-
opioid receptors results in hypothermia, whereas the µ-opioid receptor mediates 
hyperthermia (reviewed here (Rawls and Benamar 2011)). 
Some have argued for the existence of a ‘hibernation induction trigger’ (HIT) that 
circulates in blood of seasonal hibernators, and can be transfused from a hibernating 
individual into a non-hibernating individual with the effect of inducing hibernation 
(Dawe and Spurrier 1969), although this is somewhat controversial (L. C. H. Wang et al. 
1988). The apparent induction of hibernation via HIT transfusion is impaired by 
infusion of µ or κ agonists, whereas infusion of the δ agonist DADLE ([D-Ala, D-Leu]-
Enkephalin) appeared to mimic the effects of HIT infusion by inducing hibernation in 




generates a circulating δ-receptor agonist that is capable of triggering hibernation 
(Oeltgen et al. 1988).  
Less controversial observations of the role of the endogenous opioid system in torpor 
derive from experiments infusing agonists or antagonists either locally or ICV in 
hibernating hamsters. Arousal from the maintenance but not the induction phase of 
torpor can be triggered by ICV naloxonazine (a µ1 opioid receptor antagonist) in 
hibernating Syrian hamsters (Tamura et al. 2005). This maintained suppression of body 
temperature may depend on POMC neurons in the ARC that project to regions 
including DMH, AH, posterior hypothalamus (PH), and ventromedial hypothalamus 
(VMH) (Tamura et al. 2012).  
In summary, there is conflicting evidence from these experiments. In rats, and non-
torpid mice, the evidence suggests that δ-opioid receptor activation induces 
hypothermia whereas µ-opioid receptors induce hyperthermia. One might therefore 
expect δ-opioid receptor activation to be involved in inducing or maintaining torpor. 
Experiments using HIT infusion to induce torpor or a torpor-like state in ground 
squirrels support this model, with a role for δ-opioid receptor activation in torpor 
induction, while µ- and κ-opioid receptors appear to inhibit torpor entry. In contrast to 
this, and out of keeping with the findings in rats and non-torpid mice, in Syrian 
hamster undergoing seasonal hibernation, the evidence would suggest that POMC 
neurons in the ARC activate µ-opioid receptors in several hypothalamic areas to 
maintain low body temperature in seasonal hibernation. It is difficult to draw any 
synergy from these findings: it is possible that different opioid receptors are involved 




excessively long or deep torpor bouts. Alternatively, it is worth considering whether 
the doses of agonists and antagonists used resulted in non-specific activation of 
several opioid receptor subtypes. It would be interesting to test the effects of 
modulating endogenous opioid pathways in mice undergoing daily torpor, as the data 
above only describes effects on seasonal hibernators or euthermic mice and rats.  
1.6.6  Functional anatomy of torpor 
Examination of the expression of the c-fos gene, as a surrogate marker of neuronal 
activation, provides an alternative approach to the predominantly pharmacological 
analyses described above. In the 13-lined ground squirrel, a seasonal hibernator, in-
situ hybridisation (ISH) reveals distinct patterns of c-fos expression during different 
phases of the hibernation cycle (Bratincsák et al. 2007a). Entrance into torpor is 
associated with increased c-fos mRNA in the ventrolateral part of the MPA, whereas 
arousal from torpor is associated with increased expression in the ventromedial part of 
the MPA. In awake animals during interbout arousals, the ARC and dorsolateral 
hypothalamus were active. The SCN and reticular thalamus were active throughout all 
stages of torpor, areas involved in circadian rhythm generation and inhibition of motor 
activity, respectively. In torpid mice the combination of c-Fos immunohistochemistry 
and retrograde tracer expression identifies a group of neurons in the DMH that project 
to the RPa, which are specifically activated during torpor (Hitrec et al. 2019). It is 
anticipated that activating this pathway would inhibit thermogenesis by reducing the 
output from RPa to BAT, and indeed pharmacological inhibition of the rostral 
ventromedial medulla (a region that includes the RPa) induces a torpor-like state in the 




1.7  Discussion 
Determining the central mechanisms responsible for torpor induction has proved 
challenging. Several transmitter systems and their respective nuclei have been 
identified as potentially contributing, and yet none of these have been demonstrated 
as truly sufficient or necessary. This raises an important question to consider: is there a 
master switch for torpor, or is torpor the culmination of several processes that occur in 
parallel and together generate the phenotype that is torpor?  
If there is indeed a master switch, then it is reasonable to continue isolating 
transmitter systems and testing their necessity and sufficiency in torpor induction. If 
on the other hand there is none, and torpor represents several parallel and 
independent processes, then such an approach is unlikely to succeed. Instead, the aim 
should be to identify a network of circuits potentially distributed across a variety of 
regions and utilising a variety of transmitters.  
Several of the experiments described above employed the use of intracerebral drug or 
viral vector injections, hence it is worth noting that off-target drug action or virus 
expression might be a contributing factor to any physiology seen. Therefore, 
differentiating the contribution of adjacent brain regions such as the LPO versus the 
VLPO can be challenging. Also, it is not always possible to determine whether a paired 
physiological response such as NREM sleep induction and drop in core temperature is 
the result of a single group of neurons within the injection region that generates both 
behaviours, versus two intermingled but distinct populations contributing to each 
response independently. An additional complication is that many of the transmitters 




hibernation. Activating these pathways using exogenous drugs, opto- or chemogenetic 
techniques may generate an exaggerated modulation of body temperature that is not 
truly torpor.  
1.8  Aims and hypotheses of this PhD project 
The primary objective of this PhD project is to identify the neural circuit(s) involved in 
torpor induction in the mouse. This will provide a step towards exploring the possibility 
of inducing a torpor-like state in humans, which could be applied in clinical settings 
and for long-distance space travel. I hypothesise that the TRAP2 mouse (Guenthner et 
al. 2013; DeNardo et al. 2019; Allen et al. 2017) will allow specific targeting of neurons 
that are active during a torpor bout. This transgenic mouse provides permanent 
genetic access to transiently active populations of neurons, allowing selective 
expression of designer receptors exclusively activated by designer drugs (DREADDs) 
(Armbruster et al. 2007) in circuits that were active during a specific window of time, 
which is defined by the administration of 4-hydroxytamoxifen. The mechanisms of this 
transgenic system will be discussed in more detail in coming chapters. My a-priori 
hypothesis is that the circuit for torpor will be intermingled with the circuits 
responsible for thermoregulation, sleep, and energy balance within the hypothalamus.  
 
 
A brief outline of each subsequent chapter follows: 
Chapter 2: Torpor induction and detection. This chapter will introduce two different 




the use of infra-red surface thermography and implanted subcutaneous telemetric 
temperature probes for detecting torpor. I will also discuss methods for defining a 
torpor threshold. 
Chapter 3: Identifying neurons that are active during torpor. This chapter will present 
c-Fos immunohistochemistry data identifying core hypothalamic areas active during 
torpor. I will also present data from the TRAP2 mouse that further explores those 
regions active during torpor.  
Chapter 4: Generating synthetic torpor. This chapter will present data in which 
synthetic torpor is generated by brain-wide reactivation of torpor-active neurons.  
Chapter 5: The role of the dorsomedial hypothalamus in torpor. This chapter will 
present data, which demonstrates that torpor-active neurons in the DMH increase the 
probability and depth of torpor in calorie-restricted mice.  
Chapter 6: The preoptic area contains a torpor switch. This chapter will present data, 
which demonstrates that torpor-active neurons in the POA are sufficient for inducing a 
synthetic torpor in the absence of any natural stimulus for torpor entry.  
Chapter 7: Discussion. This chapter will summarise the findings, discuss their 






Chapter 2 Torpor induction and detection 
2.1  Introduction 
This chapter describes how torpor was induced and identified in adult laboratory mice. 
As introduced in Chapter 1, mice under laboratory conditions will enter torpor when 
driven into a sustained negative energy balance. These conditions include acute fasting 
(Sunagawa and Takahashi 2016), fasting combined with a drop in ambient temperature 
(Hitrec et al. 2019), food restriction over several days (van der Vinne et al. 2018), and 
increased energy costs of foraging (Schubert et al. 2010). Of these options, two were 
used in my studies: a drop in ambient temperature followed by withdrawal of food 
(Swoap and Gutilla 2009); and several days of calorie restriction (van der Vinne et al. 
2018). The latter approach was taken for two reasons. Firstly, by generating repeated 
torpor bouts at a predictable time on consecutive days, it was hoped that mice could 
be habituated to intraperitoneal (i.p.) injections so that the injection would not 
interfere with entry into torpor. This was necessary for future experiments. Secondly, 
food restriction over several days allows quantification of the tendency to enter 
torpor, since an increase in the likelihood of torpor manifests as torpor appearing on 
earlier days. Conversely, any intervention that reduces the propensity to torpor 
manifests as torpor appearing on later days after a greater degree of weight loss.   
As discussed in Chapter 1 (section 1.1.2), there is no widely accepted objective 
definition of torpor. Approaches to define torpor onset generally focus on the 
reduction in body temperature, since that is a major feature of torpor and also 
relatively easily measured. Examples include a core body temperature below 34°C 




2012); the duration of a period of monotonic cooling resulting in a reduction in body 
temperature of at least 5°C followed by a period of monotonic increase up to at least 
5°C above the nadir (Lo Martire et al. 2018); or deviation from a Bayesian estimate of 
individual core temperature (Sunagawa and Takahashi 2016) 
Commonly used methods for measuring animal temperature include rectal 
thermometer insertion; implantation of thermometric measurement systems 
(radiotransmitters, data loggers, or thermosensitive transponders); or infra-red 
thermography. Mice are not thermally homogenous, instead there are gradients of 
temperature from the outer surface to deep structures and from BAT to surrounding 
regions that are affected by both internal physiological factors and external 
environmental factors. Superimposed on these gradients is the diurnal fluctuation of 
body temperature, and the effects of food intake or starvation (Meyer, Ootsuka, and 
Romanovsky 2017; Billington et al. 1991). These factors combine to make the 
definition and measurement of normal body temperature in mice challenging to 
standardise. 
Rectal temperature, sampled with an inserted thermocouple, thermistor, or a 
resistance temperature detector, provides a cheap means to assess core temperature. 
However, it has the disadvantage of requiring frequent handling, which causes distress 
to the animal, and may affect the measurement (Clement, Mills, and Brockway 1989). 
Rectal measurement is also labour intensive, particularly when recordings are to be 
made over prolonged periods of time. Furthermore, differences in the depth of the 




Implanted devices provide prolonged recordings of temperature without the need for 
frequent handling. They can be inserted either subcutaneously or intraperitoneally, 
although values record at these two sites will differ (Meyer, Ootsuka, and Romanovsky 
2017). The disadvantages of these devices include cost and the need for surgical 
implantation, and in some cases the data can only be retrieved by manually scanning 
the vicinity of the animal or by removal of the device at the end of the experiment.  
Infra-red thermal imaging provides a means to non-invasively monitor surface 
temperature of mice. Thermal imaging is relatively cheap to perform, can span 
prolonged periods, and avoids disturbing mice either with surgical implantation or 
handling during the experimental period. However, surface temperature recordings do 
not directly equate to core temperature. They are affected by vasomotor tone, 
ambient temperature, the position of the animal relative to the camera, and the 
degree of fur covering the skin (Fiebig et al. 2018).  
Torpor research was a new line for the laboratory in which these studies were 
undertaken. It was therefore necessary to spend some time establishing protocols for 
inducing, detecting, and quantifying torpor bouts in mice. The aims of this chapter 
were: 
• to establish protocols for inducing torpor under laboratory conditions.  
• to validate the use of infra-red thermal imaging in mice under baseline and 
torpid conditions.  
• and to develop a criterion for identifying torpor based on infra-red thermal 




2.2  Methods 
All studies had the approval of the local University of Bristol Ethical Committee, and 
were carried out in accordance with the UK Animals (Scientific Procedures) Act under 
Professor Anthony Pickering’s project licence number 30/3362.  
The data presented in this chapter is derived from a variety of experimental cohorts. 
These include naive C57BL/6J obtained from Charles River (https://www.criver.com/); 
transgenic TRAP2 (Allen et al. 2017) mice that had undergone intracerebral vector 
injections to deliver Cre-dependent chemogenetic actuators; and double-transgenic 
mice carrying the TRAP2 gene and a Cre-dependent DREADD gene (Sciolino et al. 
2016). TRAP2 mice were obtained by donation from the Luo laboratory (Stanford 
University, USA) - but are now available from the Jackson lab 
(www.jax.org/strain/030323). The Cre-dependent DREADD mice were obtained from 
the Jackson lab (www.jax.org/strain/026943). These mice will be described in greater 
detail in subsequent chapters, but at the point that they were used in these studies, 
they had not undergone exposure to tamoxifen and therefore would not be expected 
to express the DREADD gene.  
All mice were females, at least 8 weeks of age, and weighed at least 20g on entry into 
experiments. Female mice were chosen on the basis of literature reports of their 
increased propensity to torpor (as discussed in Chapter 1 section 1.2.1) (Swoap and 
Gutilla 2009). Mice were maintained on a 12-hour reversed light/dark cycle with lights 
off at 08:30. Temperature and humidity were controlled (see below). For all 
experiments, lights off was assigned as zeitgeber time 0. At all times mice had free 




standard mouse chow (LabDiet, St. Louis, MO 63144, USA). They were housed in 
groups of up to four. Prior to torpor induction, mice were moved from their standard 
cages (Techniplast 1284L, https://www.tecniplast.it) to a custom built 32 x 42 x 56 cm 
cage, divided into four quadrants (16 x 21 x56 cm), into which each mouse was 
individually placed. This cage was designed to allow up to 4 animals to be monitored 
simultaneously using a single thermal imaging camera placed directly above (see 
Figure 1-1). The Perspex separating each quadrant was clear and had ventilation holes 
at 2cm from the floor height to allow interaction between mice in neighbouring 
quadrants. 
2.2.1  Baseline mouse surface temperature measurement 
Mouse surface temperature was recorded using a Flir C2 infra-red thermal imaging 
camera placed above the cage (www.flir.co.uk). This camera has a reported accuracy 
of ±2°C (this value refers to the standard deviation around the true temperature) and a 
sensitivity of <0.1°C at 25°. Hence, the camera was good at detecting changes in 
surface temperature but less good at reporting the absolute temperature. It has an 80 
x 60-pixel infra-red sensor and a 640 x 480-pixel standard digital camera (Figure 2-1). 
The camera has a sampling frame rate of approximately 1.8Hz. 
Mouse surface temperature was identified by extracting the maximum temperature 
value from regions of interest within each frame that correspond to each individual 
mouse’s compartment within the cage. Peak temperature data was extracted from the 
infra-red video using Flir ResearchIR software version 4.40.9 (www.flir.co.uk), and 
further filtered and analysed using Matlab 2019a (www.mathworks.com). The data 
processing stream was as follows: in order to limit noise and movement artefact, data 




resampled at 1 Hz, using the Matlab interpl function; finally, a moving average filter 
function was applied with a 360 data point window, using the Matlab smooth function. 
Mouse activity data was derived from the imaging video, extracted using Ethovision XT 
software (www.noldus.com).  
Baseline recordings of mouse surface temperature were taken for a period of three 
days at each of three ambient temperatures of 18°C, 21°C, and 30°. During this time, 
mice had free access to food and were therefore not expected to enter torpor 
(although there are rare reports of spontaneous torpor in fed mice (Hudson and Scott 
1979)). These measurements were then used to generate a mean and a standard 
deviation of the temperature across the diurnal cycle at each ambient temperature. 
Recordings were taken at each of these three ambient temperatures because these 
would be used in subsequent experiments, and mouse surface temperature varies with 
ambient temperature. This change in surface temperature with ambient temperature 
probably reflects changes in vasomotor tone as the animal modulates the exchange of 
heat with its surroundings (Fiebig et al. 2018).  
Ambient temperature was controlled using a portable air-conditioner/heater, which 
was adapted to duct the outflow into a cabinet containing the cages (an adapted 
Scantainer, www.scanbur.com).  Air was pumped into the top of the cabinet, returned 
from the bottom where it was mixed with fresh air, and drawn into the air conditioner. 
Temperature was servo-controlled via a temperature probe placed inside the cabinet. 
Relative humidity was controlled at 50% using an ultrasonic humidifier (PureMate PM 






FIGURE 2-1 SCHEMATIC OF THE EXPERIMENT SET-UP 
Up to four mice were housed in a purpose-built cage, viewed from above by an infra-red 
camera. Video was recorded and stored using a personal computer, and mice identified as the 
hottest region within each quadrant. Shown on the right is a still from the infra-red video 
showing two mice (top left and bottom right, bright yellow/white) that are normothermic and 





recorded every five minutes using a temperature data logger (LogTag uTRID-16, 
www.logtag-recorders.com), and humidity was checked daily (Figure 2-1). 
2.2.2  Temperature telemeter implantation 
Thermal imaging provides a measurement of the surface temperature of the animal. In 
order to validate this approach, a subset of animals was implanted with subcutaneous 
telemetric temperature probes (Anipill, Bodycap, www.animals-monitoring.com), and 
the correlation between this and infra-red surface temperature was assessed. The 
probe dimensions were 17.7mm long with a diameter of 8.9mm, weighing 1.7g. The 
probes are capable of sampling up to every minute, and have an accuracy of ±0.2°C as 
reported by the manufacturer (in this context, the accuracy refers to a guarantee that 
the measured value will be within 0.2°C of the actual temperature), and a sensitivity of 
<0.01°C. Due to their size, the probes were placed subcutaneously under the skin on 
the back of the mice. 
Mice were anaesthetised with i.p. injection of ketamine (70mg/kg, Vetalar, Pharmacia) 
and medetomidine (0.5mg/kg, Domitor, Pfizer). Depth of anaesthesia was assessed 
and monitored by loss of hindpaw withdrawal reflex and failure to respond to corneal 
brush. Additional i.p. injections of anaesthetic were administered as needed to 
maintain surgical depth of anaesthesia. Core temperature was maintained using a heat 
pad and monitored using a rectal temperature probe.  
Mice were placed prone, and ointment was applied to the eyes (Lacrilube, Allergan). A 
2 x 2cm region on the back midway between the shoulder blades and the tail was 
shaved, and cleaned with iodine solution. Sterile drapes were applied, and sterile 




throughout. A 1 cm midline incision was made in the centre of the prepared skin, and 
the anipill probe was inserted anteriorly towards the interscapular region.  
Following surgery, the wound was closed with non-absorbable suture and dressed with 
antibacterial wound powder. Anaesthesia was reversed with IP atipamezole (1mg/kg, 
Antisedan, Zoetis), and SC buprenorphine (0.1mg/kg, Vetergesic, Ceva Animal Health) 
was administered. Mice were recovered on a heat pad, then housed individually for 
three days following surgery and monitored daily until returned to baseline weight.  
2.2.3  Torpor induction protocol 1: Cold Fast 
Mice were acclimatised to a thermoneutral ambient temperature of 30°C (Abreu-Vieira 
et al. 2015) for a minimum of five days. Following acclimatisation, the ambient 
temperature was reduced to 18°C, at lights off. After 24 hours at this lower 
temperature, food was withdrawn at lights off, for a period of 16 hours. Figure 1-2 
shows a schematic of the ‘Cold Fast’ torpor induction protocol.  
2.2.4  Torpor induction protocol 2: Calorie Restriction 
Mice housed at standard animal house temperature (21-22°C) were given a single daily 
meal at lights off placed directly onto the floor of the custom-built cage for five 
consecutive days. The meal consisted of one pellet (2.2g) of feed (EUROdent Diet 22%, 
irradiated, 5LF5). This provides 8kcal per day, which is approximately 70% of the 
estimated unrestricted daily intake for a mouse of this size (Benevenga et al., 1995). 
Food restriction continued for up to seven days, with mice monitored daily for weight 
loss. Up to 20% weight loss was tolerated, although no mice crossed this threshold 





FIGURE 2-2 SCHEMATIC OF THE COLD-FAST TORPOR INDUCTION PROTOCOL 
Mice are housed at a thermoneutral ambient temperature of 30°C for a minimum of 5 days. At 
lights off on the 6th day, the ambient temperature is reduced to 18°C. 24 hours later, food is 















2.2.5  Statistical analyses 
Data are presented as mean ± standard deviation when normally distributed, 
otherwise it is presented as median [interquartile range]. Statistical analyses were 
carried out using GraphPad Prism version 6.07 (www.graphpad.com). ANOVA and t-
tests were used for normally distributed data, otherwise the Kruskal-Wallis test and 
Mann-Whitney U tests were used. For the purposes of generating a threshold for 
torpor, no statistical test was used on which to base a power calculation. Rather, in the 
absence of a widely accepted definition of torpor - based on surface temperature or 
otherwise - a pragmatic approach was taken. A threshold was chosen that captured 
the obvious reduction in body temperature seen in fasted or calorie restricted mice 
housed at a sub-thermoneutral ambient temperature, while not labelling any of the 
deviations of body temperature seen in mice that were fully fed at a sub-
thermoneutral temperature, or fasted at a thermoneutral temperature. For studies 
comparing subcutaneous and surface temperature measurements, Bland-Altman plots 
were generated. The number of mice used was limited by the availability of 
temperature implants and their battery life. However, the implants were programmed 
to record subcutaneous temperature every two minutes, and recordings were 
continued for a minimum of two days from two animals, giving a minimum total of  
5760 measurement pairs.  
2.3  Results 
2.3.1  Control of ambient temperature 
Reliable control of the ambient temperature was vital for these experiments for two 
reasons. Firstly, the ‘Cold Fast’ torpor induction protocol required manipulation of 




 Ambient 18°C Ambient 21°C Ambient 30°C 
Lights off surface 
temperature (°C) 
29.5 (±0.5) 31.7 (±0.6) 36.2 (0.4±) 
Lights on surface 
temperature 
29.3 (±0.6) 31.3(±0.6) 35.5 (0.5±) 
Welch-corrected t  t(739493) = 216.8, p 
<0.0001) 
t(1.811x106) = 525.2, 
p < 0.0001) 
t(1.79x106) = 1042, p 
<0.0001)  
 
TABLE 2-1. MEAN SURFACE TEMPERATURE AT DIFFERENT AMBIENT TEMPERATURES VARIES WITH LIGHTS OFF/ON 
Mouse surface temperature recorded for three consecutive days at 18°C (n = 3 female 





FIGURE 2-3 BASELINE 24-HOUR TEMPERATURE PROFILES AT DIFFERENT AMBIENT TEMPERATURES 
Mean mouse surface temperature at three different ambient temperatures as measured by 
infra-red thermal imaging camera. Mice were recorded for three consecutive days at an 
ambient temperature of 18°C (n = 3 female mice, blue line), 21°C (n = 7 female mice, red line), 
or 30°C (n = 7 female mice, green line). The mean and standard deviation of the surface 
temperature was then calculated across all days combined to give an estimate of normal values 







FIGURE 2-4 MOUSE SURFACE TEMPERATURE VARIABILITY 
Mice were recorded for three consecutive days at ambient temperatures of 30°C (top, n = 7 
female mice), 21°C (middle, n = 7 female mice), or 18°C (bottom, n = 3 female mice). Individual 
temperature profiles are compared to thresholds at 2, 3, or 4 standard deviations below the 




recording using infra-red thermal imaging is affected by ambient temperature, 
necessitating a stable environmental temperature throughout the course of each 
recording. Measuring the temperature within the cabinet every five minutes over 
three days at each target temperature indicated that at a target ambient temperature 
of 18°C, recorded mean within the cabinet was 17.8 ± 0.3°C. With the air conditioner 
off, relying therefore on the animal unit air conditioning systems, the mean 
temperature was 20.9 ± 0.4°C. Finally, at a thermoneutral target temperature of 30°C, 
the mean temperature achieved was 29.5 ± 1°C.  
2.3.2  Baseline surface infra-red thermal imaging recordings 
Baseline mouse surface temperature profiles were measured at different ambient 
temperatures using an infra-red thermal imaging camera. Mice were recorded for 
three consecutive days at ambient temperatures of 18°C (n = 3), 21°C (n = 7), and 30°C 
(n = 7). At each ambient temperature, the infra-red camera produced stable traces of 
surface temperature, with standard deviations ranging from 0.58°C at an ambient 
temperature of 18°C, to 0.67°C at an ambient temperature of 21°C (see Figure 2-3). As 
expected, and presumably reflecting changes in vasomotor tone, mouse surface 
temperature varied with ambient temperature (F(2,4406397) = 3.854x107, p <0.0001).  
At 18°C ambient, mean mouse surface temperature across the 24-hour cycle was 29.4 
± 0.6°C. At 21°C ambient, mean temperature was 31.5 ± 0.7°C. At 30°C ambient, mean 
temperature was 35.9 ± 0.6°C. Tukey’s multiple comparison test confirmed that the 
mean mouse surface temperatures differed significantly between all ambient 




Surface temperature varied between lights off and lights on, indicating that surface 
temperature undergoes regulated circadian fluctuation, as is reported from 
measurements of mouse core temperature (Harding, Franks, and Wisden 2019). At all 
ambient temperatures, mean mouse surface temperature was higher during the active 
lights off period than during lights on, and this effect was greater with increasing 
ambient temperatures. These diurnal differences were small but statistically significant 
(see Table 2-1).  
2.3.3  Torpor induction and detection 
In order to identify torpor bouts, and in the absence of a widely accepted objective 
definition of torpor, a threshold was generated from the baseline surface temperature 
profiles of fed mice in the absence of any stimulus for natural torpor. The timestamps 
on these prolonged baseline recordings were referenced relative to lights off to allow 
calculation of the mean and standard deviation of the mouse surface temperature at 
each ambient temperature for every second in the 24-hour period starting at lights off.  
Comparing individual mouse surface temperature traces against a threshold based on 
two, three, or four standard deviations from the mean, it is possible to determine how 
much variation in surface temperature could be expected under normal, non-torpid 
conditions. Mouse surface temperature transiently fluctuated below three standard 
deviations from the mean, occurring several times per day at each of the three 
ambient temperatures examined (see Figure 2-4). In contrast, fluctuations greater than 
four standard deviations from the mean were rare, and when they did occur, they 
were brief, lasting a matter of minutes (see Figure 2-4). Based on these observations, 
torpor was defined as a period of time lasting at least one hour during which the 




that zeitgeber time and that ambient temperature. This was a deliberately stringent 
criteria, the application of which could not be made in real-time but had to be applied 
to the thermal imaging data retrospectively. 
The ‘Cold Fast’ protocol  
A drop in ambient temperature from 30 to 18°C, followed 24 hours later by a fast for 
up to 16 hours resulted in torpor bouts, defined by the criteria above, in 83% of 29 
trials in 24 mice. An example torpor bout is shown in Figure 1-5A. The majority of the 
mice undergoing this protocol for torpor induction were used to measure c-fos 
induction and therefore were culled during the torpor bout, however five mice 
underwent prolonged recordings to gauge torpor duration under this protocol.  
Nadir surface temperature from mice allowed to complete the torpor bout was 24.7 ± 
1.4°C, compared to a mean nadir of 27.1 ±0.3 observed in mice held at the same 
ambient temperature with free access to food (Welch-corrected t(4.279) = 3.861, p 
<0.05). Note that the nadir temperature of fed mice (27.1 ±0.3°C) is 2.3°C lower than 
their mean temperature at the same ambient temperature. The nadir surface 
temperature in torpid mice at 18°C ambient is only 2.4°C lower than the nadir 
temperature in fed mice. The relatively small difference between nadir temperatures 
of torpid and active mice at 18°C is a consequence of picking out the single lowest 
temperature value recorded under each condition. There is a degree of variability in 
the surface temperature measurement. This is caused by factors such as movement 
artefact, where fed mice intermittently change orientation relative to the thermal 
camera results in very brief low surface temperature recordings. A distinction not 




that the nadir in torpid mice represents a prolonged period of reduced surface 
temperature, whereas the nadir in fed mice represents a brief dip within the general 
noise of the recording. Nevertheless, even with these caveats, nadir temperature in 
torpid mice was lower than the nadir in fed mice.  
Torpor onset occurred at median 8.17 ±1.67 hours from lights off and the start of the 
fast. The mean torpor bout duration was 2.57 ±1.42 hours. Activity of the mice, 
derived from the thermal imaging video, reduced to a minimum during torpor, and 
increased during arousal.   
The ‘Calorie Restriction’ protocol 
Five days of calorie restriction in which mice were given a single daily meal at lights off 
providing approximately 70% of the unrestricted daily calorie intake generated torpor 
bouts on at least one day in 97% of 45 trials in 30 mice. An example 5-day trial is 
shown in Figure 1-5B. Mean nadir surface temperature during torpor was 25.3± 1.3°C 
compared to a mean nadir of 30.0 ± 0.7°C in mice held at the same ambient 
temperature (21°C) with free access to food (t(11) = 9.40, p < 0.0001). Entry into torpor 
tended to occur in the second half of the lights off period, with the median time of 
entry into torpor occurring 9.76 [8.18 – 10.83] hours after lights off. Median torpor 
bout duration was 4.05 [IQR, 2.29 – 6.15] hours. Activity of the mice, derived from the 
thermal imaging video, reduced to a minimum during torpor, and increased during 
arousal.   
Under this calorie restriction protocol, torpor tended to emerge on day 3 [2-4]. The 




resulting in torpor on day 1 (95% CI 3.7 to 24.1%) and 71.1% of trials resulting in torpor 
on day 5 (95% CI 55.7 to 83.6%, see Figure 2-6A).  
The nadir temperature reached during torpor decreased with increasing days of calorie 
restriction from 27.3 ± 1.0°C on day one to 25. 4 ± 1.5°C on day five. One-way ANOVA 
revealed a main effect for day of calorie restriction (F(4,102) = 4.717, p <0.01), Fisher’s 
least significant differences multiple comparison test identified significant differences 
between nadir temperatures on days three, four, and five compared to day one (p < 
0.01, <0.001, and <0.01, respectively) and between day three, four, and five compared 
to day two (p , 0.05, <0.01, <0.05, respectively). This indicates that torpor depth 
increased with progressive days of calorie restriction. By day three a minimum surface 
temperature may have been reached, since nadir temperatures did not differ between 
days three, four, or five (see Figure 2-6B).  
Torpor duration increased from median 1.27 hours [1.09 – 1.65] on day one to 4.47 
hours [1.90 – 6.77] on day five. Kruskal-Wallis test confirmed a main effect for day of 
restriction on torpor bout duration (H(5) = 18.05, p < 0.01), with significantly longer 
bouts on days four and five compared to day one (Dunn’s multiple comparisons test, p 
< 0.01 and < 0.05, respectively, see Figure 2-6C). The increase in torpor duration was 
associated with torpor occurring increasingly early in the day relative to lights off, from 
a median 12.42 hours [11.21 – 15.13] from lights off on day one to median 9.11 hours 
[7.87 – 10.77] on day five. Kruskal-Wallis test confirmed a main effect for day of calorie 
restriction on time of torpor onset (H(5) = 20.20, p < 0.001), with Dunn’s test 




four, and five relative to day one (p < 0.05, 0.01, and 0.01, respectively) and between 
day four and day two (p < 0.05).  
An aggregate torpor depth score was calculated from the area under the torpor 
threshold curve on each day of calorie restriction. As expected, given the progressive 
increases in torpor bout duration and reduction in nadir temperature reached, torpor 
depth scores increased from median 6183 [2130 – 7350] s.°C on day one to 32550 
(10718 – 72823) on day 5. Kruskal-Wallis test confirmed a main effect for day of calorie 
restriction on torpor depth score (H(5) = 18.44, p < 0.01), with torpor depth score 
significantly greater on days four and five compared to day one (Dunn’s multiple 
comparisons test, p <0.01 and <0.05, respectively) and on day four compared to day 
two (Dunn’s multiple comparisons test, p < 0.05, see Figure 1-6D).  
Mice lost weight across the five days of calorie restriction from a mean of 24.1 ± 3g on 
day one to 20.5 ± 2.7g on day 5, a mean reduction of 15.0 ±2.5% (see Figure 2-7A & B). 
One-way repeated measures ANOVA found a main effect for day of calorie restriction 
on body weight (F(2.303, 101.3) = 696, p < 0.0001), and mean weights differed on 
every day-by-day comparison (Fisher’s least significant differences multiple 
comparisons, p < 0.0001 in all cases). Examination of the body weight at which torpor 
occurred confirms that the probability of torpor increases with reducing weight. Above 
23g, torpor occurred in 10 out of 75 instances (13.3%), whereas at body weights below 
23g, torpor occurred in 93 out of 150 instances (62%, χ2(1, 225) = 47.71, p < 0.0001). 
Likewise, at less than 3% body weight loss torpor occurred in 5 out of 34 instances 
(11.1%), whereas at greater than 3% body weight loss torpor occurred in 98 out of 180 






FIGURE 2-5 TORPOR INDUCTION PROTOCOLS 
Example traces of surface temperature (black/red) and activity (blue) during torpor as induced by two protocols. A, ‘Cold-Fast’ protocol: mice are acclimatised to a 
thermoneutral ambient temperature for five days, after which ambient temperature was reduced to 18°C. After 24 hours at this reduced ambient temperature mice 
are fasted for 16 hours from lights off (yellow bar). B, ‘Calorie-Restriction Protocol’. Mice, housed at an ambient temperature of 21°C, received a single restricted 
meal at lights off (green bars) for five consecutive days. Torpor (red lines) is defined as a period lasting at least one hour spent with a surface temperature at least 


































FIGURE 2-6 CHARACTERISTICS OF TORPOR INDUCED BY CALORIE RESTRICTION 
A, mice restricted to receiving a single daily meal at lights off that provides approximately 70% 
of ad-lib calorie intake tend to enter torpor by day 2 or 3 (error bars represent 95% confidence 
intervals). B, torpor bouts deepen over the first three days of calorie restriction with decreasing 
nadir temperature data shown is mean and standard deviation. C, Torpor duration increases 
with increasing days of calorie-restriction, data shown is median and interquartile range. D, the 
area below the threshold for torpor (torpor depth score) increases with increasing days of 
calorie restriction, data shown is median and interquartile range (IQR). E, Torpor occurred at 
increasingly early zeitgeber (ZG) time, relative to lights off. Tests performed are ANOVA or 
Kruskal-Wallis test. Multiple comparisons performed using Fisher least significant difference 
test, or Dunn’s test for ANOVA and Kruskal-Wallis tests, respectively. *, **, and *** indicate 
significant difference from values on day 1 at the 0.05 and 0.01, and 0.001 levels, respectively. 
#, #, and ### indicate significant difference from values on day 2 at the 0.05, 0.01, and 0.001 
levels. $$ and $$$ indicate main effect for day of calorie restriction at the 0.01 and 0.001 levels, 




         
 
            
 
FIGURE 2-7 WEIGHT CHANGES DURING CALORIE RESTRICTION COMPARED TO PROBABILITY OF TORPOR  
A, 5 days of calorie restriction resulted in weight loss. Error bars represent standard deviation. 
B, Data from A represented as % weight loss from day 1. C, irrespective of the day of calorie 
restriction, the percentage of mice entering torpor on a given day varies with weight measured 
at lights off on that day, error bars represent 95% confidence interval. D, irrespective of the day 
of calorie restriction, the percentage of mice entering torpor on a given day varies with the 
percentage weight loss measured at lights off on that day, error bars represent 95% confidence 
interval. ANOVA Test performed using Fisher least significant difference. #### indicates main 
effect for day of calorie restriction at the 0.0001 level.  **** indicates significant difference on 





2.3.4  Comparison of the torpor induction protocols 
Comparison was made between the duration and torpor depth scores of completed 
torpor bouts induced by the ‘Cold Fast’ protocol (n = 5 bouts), and the first bouts to 
appear in each run of five days’ calorie restriction (n = 38 bouts). Comparison of nadir 
surface temperature reached is confounded by the different ambient temperatures 
used in the two protocols. However, the torpor depth score calculates the area below 
the threshold for torpor, which has been calculated separately for each ambient 
temperature. This measure is therefore subject to less confounding by ambient 
temperature. Torpor depth scores resulting from the ‘Cold Fast’ protocol were no 
different to those induced by calorie restriction (17739 (8568 – 24173) versus 10797 
(6002 – 28547), respectively. Mann-Whitney U = 85, p = 0.79). 
Although torpor bouts tended to be longer under the ‘Calorie-Restriction’ protocol 
than the ‘Cold Fast’ protocol (2.68 hours [1.41 – 4.47] versus 1.90 hours [1.55 – 3.92], 
this difference did not reach significance (Mann-Whitney U = 87, p = 0.77).  
For comparison of the timing of torpor onset, all ‘Cold Fast’ protocol bouts were 
included. Torpor bouts under the ‘Cold Fast’ protocol occurred earlier in the day than 
the torpor bouts under the ‘Calorie Restriction’ protocol (median onset at 7.91 hours 
[6.38 – 9.58] versus 10.52 hours [9.58 – 11.35] after lights off, respectively, Mann-
Whitney U = 115, p < 0.001). 
2.3.5  Thermal camera validation 
Two naïve wild type mice underwent subcutaneous telemetric temperature probe 
implantation. These mice were then housed for two days at an ambient temperature 




simultaneously recording subcutaneous implant temperature and infra-red surface 
thermography. Finally, they were induced to enter torpor using the ‘Cold Fast’ 
protocol.  
When the mice were housed at 18°C ambient, the thermal imaging camera tended to 
record values 3.0°C lower than the implant, with 95% of the differences lying between 
-1.4 and -4.6°C (see Figure 1-8C). At 30°C ambient, the camera tended to record values 
1.2°C higher than the implant with 95% of the differences lying between 0.4 and 2.0°C 
(see Figure 1-8D). Importantly, at both 18 and 30°C ambient temperatures, the 
difference between the measurement devices remained was consistent across a range 
of mean values. This suggests that the risk of bias is low.   
There are several reasons why the implant recorded temperature differs from the 
thermal imaging measurement of surface temperature. Firstly, the degree of 
vasoconstriction versus vasodilatation (i.e. vasomotor tone) will affect the skin surface 
temperature as vasodilatation leads to greater flow of warm central blood out to the 
skin capillaries. Hence vasodilatation would be expected to result in better agreement 
between the implant and the camera. Secondly, the insulating effects of fur, which 
serve to increase the gradient between the internal and surface temperature of the 
mouse. Thirdly, movement artefact will affect thermal imaging but would not be 
expected to affect the implant measurements. Hence, if the mouse adopts an 
orientation in which the warmest part of its body surface is facing away from the 
camera, then the measured value would be expected to decrease. Finally, there are 
potential inherent inaccuracies in the devices’ abilities to measure absolute 




thermal camera has a reported accuracy of ±2°C. Both devices have reported thermal 
sensitivities of <0.1°C. 
It is apparent, therefore, that thermal imaging may have inherent inaccuracies when 
measuring the absolute temperature. However, the important question is whether 
thermal imaging is able to detect changes in surface temperature that reflect changes 
in core or subcutaneous temperature, albeit at differing absolute values. Hence, the 
two measurements need to correlate. When housed at 18°C, there was good 
correlation between the measurements made by the thermal imaging camera and 
those made by the implant (Pearson r = 0.59, p < 0.0001). The slope of the regression 
line was 0.57 ± 0.014 (see Figure 1-8A). Hence at 18°C ambient, for every 1°C change in 
measured implant temperature, there was on average a 0.6°C change in the measured 
thermal imaging surface temperature. When housed at 30°C, there was stronger 
correlation between the measurements made by the thermal imaging camera and 
those made by the implant (Pearson r = 0.83, p < 0.0001). The slope of the regression 
line was 0.93 ± 0.0097 (see Figure 1-8B). Hence at 30°C ambient, for every 1°C change 
in measured implant temperature, there was on average a 0.9°C change in the 
measured thermal imaging surface temperature. The difference in the slope seen at 18 
versus 30°C ambient likely reflects changes in vasomotor tone. At 30°C ambient, the 
mice are approximately thermoneutral and are likely to have low vasomotor tone, 
allowing the skin surface temperature to reflect subcutaneous (or core) temperature 
more accurately. On the other hand, at 18°C ambient, the mice will have higher 
vasomotor tone as they attempt to conserve heat, and this will dampen fluctuations in 






FIGURE 2-8 COMPARISON OF INFRA-RED THERMAL IMAGING AND IMPLANTED TEMPERATURE PROBE 
Two female mice were implanted with telemetric temperature probes subcutaneously on the 
back. The surface temperature was simultaneously recorded using an infra-red thermal imaging 
camera, while the ambient temperature was changed from 18°C (left column, two days of 
recording) to 30°C (right column, three days of recording). Top row, scatter plot showing 
camera temperature vs implant temperature. Thick black line indicates regression line, dashed 
black lines represent 95% prediction intervals. Bottom row, Bland Altman plots (Bland and 
Altman 1986) plotting the mean measurement between the camera and the implant against the 
difference between the camera and the implant, showing any systematic bias in the use of 
thermal imaging with changes in the estimated true animal temperature. Thick black line 
indicates the mean difference between the camera and the implant, dashed lines represent 






FIGURE 2-9 COMPARISON OF INFRA-RED THERMAL IMAGING VERSUS IMPLANTED PROBE DURING A TORPOR BOUT 
A, example torpor bout under the ‘Cold-Fast’ protocol, showing subcutaneously recorded body temperature using an implanted telemetric probe (blue line) versus 
surface temperature as recorded by infra-red thermal imaging camera (black line). Also shown, the ambient temperature as recorded by a thermometer data logger 
in the cabinet (green) and the estimation of ambient temperature taken as the average temperature across each frame of video taken from the infra-red camera 
(red line). B, scatterplot showing the correlation between camera measurement and implant measurement during the same 72 hours period as plotted in A, during 




The critical factor in establishing the validity of thermal imaging is whether it identifies 
torpor bouts when compared to subcutaneous implant measurements. Simultaneous 
surface thermography and implant subcutaneous temperature measurement revealed 
that the correlation between the implant and the thermal camera improved during 
periods when the mouse was cold, such as in torpor.  In a mouse entering torpor by 
the ‘Cold Fast’ protocol, the correlation between implant and camera improved during 
the torpor bout. Hence, when the implant temperature was below 32.0°C Pearson’s r 
was 0.93 (95% confidence interval 0.90 - 0.95) compared to 0.52 (95% confidence 
interval 0.49 – 0.55) in the same animal outside of torpor, see Figure 1-9B). In parallel 
to improved correlation between the thermal imaging and the implant measurements, 
there was also an improvement in the agreement. When the implant recorded 
temperatures greater than 32.0°C, the median difference between the implant and the 
thermal camera was -3.3°C [2.8 – 3.7]. At implant temperatures below 32°C, the mean 
difference between the implant and the thermal camera reduced to 2.9°C [2.6 – 3.2], 
Mann-Whitney U = 90262, p < 0.0001).  
2.4  Discussion 
This chapter presents two protocols for reliable torpor induction in laboratory mice, 
alongside data that supports the validity of using thermal imaging as a means to detect 
torpor bouts. Although these protocol for torpor induction were based on published 
methods (Swoap and Gutilla 2009; van der Vinne et al. 2018), they were new to the 
Pickering and Jones laboratories.  
Torpor occurred earlier relative to lights off under the ‘Cold-Fast’ protocol, which may 




temperature compared to simply calorie restriction at a warmer ambient temperature. 
Hence, mice in the ‘Cold Fast’ protocol may be enduring a greater energy deficit than 
those mice in the ‘Calorie Restriction’ protocol. The hypothesis that greater energy 
deficit results in torpor bouts that occur earlier in the day is supported by the 
observation that within the ‘Calorie Restriction’ protocol, torpor occurred at earlier 
zeitgeber times with progressive days of calorie restriction.  
Torpor bouts tended to be longer under the ‘Calorie-Restriction’ protocol. While this 
was not significant, the numbers of recordings of duration under the ‘Cold-Fast’ 
protocol was low. This observation is in contrast to previous reports that have 
indicated torpor bouts tend to be longer at lower ambient temperatures. One 
explanation for this discrepancy could lie in the fact that under the Home Office 
approved protocol food must be returned to the cage after 16 hours of fasting, which 
might have disturbed the mouse and prompted arousal during the ‘Cold Fast’ protocol. 
However, torpor induced by the ‘Cold Fast’ protocol occurred after 7.91 ±1.67 hours 
and lasted 2.57 ±1.42 hours, thus the majority of bouts would have spontaneously 
terminated before the food was returned. 
Under both induction protocols, torpor tended to occur towards the second half of the 
lights off period, which is in keeping with previous reports (Sunagawa and Takahashi 
2016; Hrvatin et al. 2020; Brown and Staples 2010). While this may simply reflect 
mounting energy deficit, it is interesting that this time coincides with the increasing 
occurrence of sleep as lights off progresses (Robinson-Junker, O’hara, and Gaskill 2018; 
Solarewicz et al. 2015) lending circumstantial support to the hypothesis that entry into 




1995). At the very least it supports the hypothesis that torpor entry is under some 
degree of circadian control (van der Vinne et al. 2018).  
The observation of higher skin surface temperature measured with thermal imaging 
compared to subcutaneous implant temperature at 30°C ambient is somewhat 
surprising. Assuming that the core of the mouse and/or the brown adipose tissue is the 
warmest region in the environment, there should be a gradient of heat from the core 
to the skin surface and from that to the air in the cage. It is conceivable that heat from 
the core is transmitted directly to the skin surface via dilated capillary beds when the 
mouse is housed at 30°C, but it seems unlikely that this would not eventually warm the 
subcutaneous tissue surrounding the implant to at least the same temperature as the 
skin. Alternatively, since the thermal imaging camera and software were set up to 
record the warmest region in the image, this might simply be a consistent bias 
secondary to consistently recording the upper distribution of a noisy signal. Finally, it is 
possible that a surface region of the mouse distant from the subcutaneous implant 
location has a higher temperature than the region surrounding the implant. For 
example, the eye or the capillary beds of the tail might have a higher than average 
temperature.  
Under fully fed conditions, as ambient temperature decreases from thermoneutrality, 
the camera reports increasingly low mouse surface temperature compared to an 
implanted probe. This likely reflects a genuine change in the surface temperature of 
the mouse compared to its subcutaneous temperature, since agreement between the 
thermal camera and a data logger thermometer was good (Figure 1-9A). It is likely that 




vasoconstriction at lower ambient temperatures (Meyer, Ootsuka, and Romanovsky 
2017). A corollary of this vasoconstriction is that the slope of the regression line for 
infra-red surface temperature compared to subcutaneous implant becomes 
increasingly flat. This has the effect of dampening the ability of the thermal camera to 
identify a change in mouse subcutaneous or core temperature at lower ambient 
temperatures.  
Despite these caveats, torpor could clearly be detected using the thermal camera even 
at lower ambient temperatures. In fact, during torpor there was a marked 
improvement in the correlation between thermal imaging measurements and implant 
measurements. This observation probably reflects the fact that as core temperature 
drops during torpor, the true subcutaneous and skin surface temperatures become 
more similar. Furthermore, as mice enter torpor, they become less active, which may 
reduce movement artefact secondary to changes in the orientation of the mouse 
relative to the camera. It may also hint that torpor involves skin capillary vasodilatation 
resulting in closer agreement between measures of subcutaneous and skin surface 
temperatures. Vasodilatation would enhance the rate of cooling as the mouse enters 
torpor, although currently the evidence suggests vasoconstriction rather than 
vasodilatation during torpor in mice (Swoap and Gutilla 2009) 
As discussed in Chapter 1, there is no widely accepted consensus on the definition of 
torpor by either core or surface temperature measurement. Defining torpor as a 
period of time lasting at least one hour during which surface temperature was at least 
four standard deviations below the mean for that time of day appears to provide an 




temperature across all times of day (Brown and Staples 2010; Braulke and Heldmaier 
2010), the approach taken here has the advantage of accounting for diurnal 
fluctuations in the surface temperature, and also accounting for diurnal fluctuations in 
the variability of surface temperature. Hence, at times of day when the standard 
deviation of surface temperature is greater, the threshold for torpor becomes stricter.  
Conclusion 
Torpor is reliably induced under laboratory conditions in female mice using either a 
drop in ambient temperature followed by a fast of up to 16 hours, or by five 
consecutive days of calorie-restriction. Infra-red thermal imaging provides a reliable 
means to identify torpor bouts in mice. The use of a threshold that includes both 
temperature and duration permits objective identification of torpor as well as 










































Chapter 3 Identifying neurons that are active during 
torpor 
3.1  Introduction 
The purpose of the experiments presented in this chapter was to identify nuclei within 
the mouse hypothalamus that are preferentially active during a torpor bout. There are 
several approaches to identifying which brain regions are responsible for particular 
behaviours. Classically, one might lesion a brain region and observe the effects on the 
behaviour of interest. As discussed in Chapter 1, arcuate lesions induced by injection of 
monosodium glutamate (MSG) support the hypothesis that this hypothalamic nucleus 
may generate some of the signal for torpor entry in mice and hamsters (Pelz et al. 
2007; Gluck, Stephens, and Swoap 2006).  
An alternative means to identify the neural seat of a behaviour includes the use of 
functional magnetic resonance imaging to detect regional changes in blood flow 
associated with activation of local neurons during activity (Glover 2011). This approach 
has the advantage of allowing whole brain imaging but is limited by the need for the 
animal to be immobilised and therefore usually anaesthetised (Jonckers et al. 2015).  
The implantation of recording electrodes allows measurement of local potentials from 
which the activity of individual neuron or groups of neurons can be deduced (Obien et 
al. 2015). It is also possible, although technically challenging, to perform single cell in-
vivo recordings during a behaviour of interest (Taof et al. 2015). Recent advances in 




(Ali and Kwan 2019).  A drawback of these latter approaches is that they generally 
require an a-priori hypothesis regarding where to place the electrode or fibre optic 
system, although recent developments do allow increasingly large areas to be 
surveyed (Allen et al. 2019; Cramer et al. 2019). 
Immediate early genes (IEGs) provide another method to identify neurons that are 
active during a behaviour of interest. IEGs are expressed in a variety of tissues, often 
coding for transcription factors that regulate functions such as cell-cycle entry, and in 
neuronal tissue, synapse formation or strengthening (Gandolfi et al. 2017). These 
genes demonstrate limited transcription in non-firing neurons, but are rapidly 
expressed in stimulated neurons. Both the period of active transcription and the half-
lives of the resulting mRNAs are short, providing a cellular-level marker of neuronal 
activation with a temporal resolution that spans tens of minutes to hours (reviewed, 
Sheng and Greenberg 1990).  
C-fos is one such immediate early gene, which codes for a protein c-Fos that is itself a 
transcription factor. C-fos/c-Fos has become a commonly used marker of neuronal 
activity. Calcium influx following neuronal activation leads to rapid and transient 
expression of the c-fos gene via activation of several calcium-dependent processes. 
These include phosphorylation of cAMP response element binding protein (CREB) by 
calcium/calmodulin-dependent protein kinase (CaMKII)(Sheng, Thompson, and 
Greenberg 1991). Depending on the second messenger system activated, different 
calcium-responsive regions of the c-fos gene promoter are targeted to trigger 
transcription, these include the serum response element (SRE) and the calcium 




C-fos gene expression is probably dependent on more than simply the occurrence of 
depolarising action potentials. Given c-Fos is a transcription factor, adjusting gene 
expression on the basis of simple action potentials may not be meaningful or useful, 
but rather c-Fos might be generated in response to either a change in the frequency of 
action potential firing (Kovács 2008) or the coincident occurrence of several synaptic 
inputs (Luckman, Dyball, and Leng 1994). Transcription of c-fos mRNA peaks 
approximately 30 minutes after the simulating event, with c-Fos protein reaching 
maximal levels after 90 to 120 minutes (reviewed, Kovács, 2008), although the precise 
time-course does depend on the species studied, the brain region examined, and the 
means of stimulation (Barros et al., 2015). The half-life of c-fos mRNA is approximately 
10-15 minutes, while the half-life of the c-Fos protein is in the region of 1-2 hours 
(Ferrara et al. 2003; Kruijer et al. 1984).  
There are two histological methods for identifying c-fos gene expression. Firstly, one 
can perform immunohistochemistry (IHC) using antibodies against the c-Fos protein. 
Alternatively, mRNA can be identified by in-situ hybridisation (ISH) with a 
complementary RNA probe that is labelled with a fluorescent or radioactive marker 
(reviewed, Benson, 2020). Animals must be culled around the time of the peak signal 
and processed for histological analysis. This represents a limitation of simple 
histological examination of c-fos expression: the maximum time from the stimulus to 
culling the animal is limited to approximately two hours, and it is not straightforward 
to distinguish the pattern of labelling associated with different events within that time 
window. Dual-epoch mapping techniques take advantage of the different timescales of 
c-fos mRNA and c-Fos protein expression. Provided two stimuli are administered 




pattern of activity produced by the first stimulus, while labelling mRNA should identify 
the pattern of activity produced by the later second stimulus (He, Wang, and Hu 2019). 
Recently, techniques have appeared that take advantage of the c-fos promoter 
activation following neuronal activity. Transgenes placed under the control of the c-fos 
promoter allow selected expression only in active neuronal populations. If such a 
transgene codes for a fluorophore, the potential window between labelling a first 
stimulus and any subsequent stimulus is widened, and determined by the half-life of 
the fluorophore. Alternatively, if the transgene under c-fos gene promoter control 
codes for a recombinase enzyme, then recombinase-dependent genes can be 
permanently switched on in active neurons. (reviewed, He, Wang, & Hu, 2019).  
Simply placing a recombinase enzyme - such as Cre - under the control of the c-fos 
promoter creates a potential problem. While the c-fos gene may be temporarily 
switched on in cells throughout the brain, the recombination events that switch on the 
transgene of interest are permanent. Hence, over time, increasing numbers of neurons 
will express the transgene, potentially reaching a saturation point when all possible 
cells will express the transgene. At this point the utility of the signal is entirely 
compromised. Therefore, the expression of transgenes under the c-fos promoter is 
often gated by employing a second control system that determines whether the 
transgene of interest can be expressed. These second control systems include the 
TetTag system, where the full expression of the transgene of interest is gated by the 
presence or absence of doxycycline (Reijmers et al. 2007); and the tamoxifen 
dependent Cre-recombinase system (Cre-ERT) where expression is gated by the 




metabolite 4-Hydroxytamoxifen (4-OHT) (Feil et al., 1996). These systems allow 
temporal control over c-fos driven transgene expression, preventing the eventual 
widespread saturated expression over time.  
The TRAP2 mouse is an example of an activity-driven transgenic system that utilises 
the Cre-ERT system under the c-fos promoter (Guenthner et al. 2013; Allen et al. 
2017). ‘TRAP’ stands for targeted recombination in active populations. Cre-
recombinase is a bacteriophage-derived enzyme that cuts and recombines DNA at 
specific Lox binding sites. Depending on the orientation of those Lox sites, the 
interleaving DNA is either excised or its orientation reversed. In the Cre-ERT system, 
the Cre enzyme has been fused to a modified oestrogen receptor (ERT), which no 
longer binds native oestrogen but will bind the synthetic anti-oestrogen, tamoxifen, or 
its metabolite 4-OHT (Feil et al. 1996). In the absence of tamoxifen or 4-OHT, the Cre-
ERT fusion protein remains in the cytoplasm where it is held by its complex with heat-
shock protein 90 (Hsp90). On binding of 4-OHT to the modified oestrogen receptor 
portion, Hsp90 dissociates from the complex, freeing the Cre-ERT protein to enter the 
nucleus and recombine any genes that are flanked by Lox sites (‘floxed’ genes). To 
generate the TRAP2 mouse, the second generation Cre-ERT gene (2A-iCre-ERT2) was 
knocked into the c-fos locus, whilst preserving endogenous c-fos function (Allen et al. 
2017). TRAP2 allows permanent activation or deactivation of floxed genes (‘TRAPing’) 
in neurons that are active during a time window that is defined by the administration 
of 4-OHT (see Figure 3-1).  
By combining the TRAP2 system with floxed genes that code for opsins (Boyden et al. 





FIGURE 3-1 SCHEMATIC OF ‘TRAP’ SYSTEM 
‘TRAP’, targeted recombination in active population. The fusion protein Cre-ERT2 is expressed 
under the fos promoter leading to Cre-ERT2 production in active neurons. In the absence of 4-
OHT, the Cre-ERT2 fusion protein remains in the cytosol bound to Hsp90, and no recombination 
occurs. In the presence of 4-OHT, the Cre-ERT2 fusion protein dissociates from Hsp90, allowing 
Cre-ERT2 to enter the nucleus and exert recombination, either excising a Floxed stop codon, or 
reversing a gene’s orientation (as shown here) to allow transcription. Once recombination 





those circuits that were active during the period of time surrounding administration of 
tamoxifen or 4-OHT. This transformative development allows targeting of neuronal 
populations that are active during specific behaviours of interest, temporally defined 
by the timing of 4-OHT administration. It is then possible to directly assess the function 
of these neurons by selectively reactivating them, and observing the behavioural or 
physiological response.  
While c-fos provides a powerful tool for both identifying and manipulating neurons 
involved in specific behaviours, particularly when combined with recent molecular 
genetic techniques, there are some caveats that warrant consideration. Firstly, 
compared to electrophysiological or calcium imaging approaches, the temporal 
resolution is low. Activity separated by a matter of minutes to perhaps hours will not 
be distinguishable. Secondly, neurons whose basal activity level is suppressed during a 
particular behaviour will not generate a c-fos signature. Finally, some neurons exhibit 
constitutive c-fos expression while others do not appear ever to express c-fos. Hence 
there is an imperfect correlation between neural activation and c-fos gene expression 
(reviewed, Kovács, 2008). 
At the time of initiating these studies a single paper had been published that 
investigated c-fos gene expression during torpor (Bratincsák et al. 2007a). Using ISH 
against c-fos mRNA in the ground squirrel, the authors identified the ventrolateral part 
of the medial preoptic area as an area that increases c-fos mRNA expression during 
entry into torpor. A second paper was published whilst this study was being 
completed, also introduced in Chapter 1 section 1.6.6 (Hitrec et al. 2019). This study 




torpid mice compared to controls and also projecting to the raphe pallidus, thus 
positioned to inhibit thermogenesis for torpor induction.  
The aims of this chapter were: 
• to identify key hypothalamic nuclei that show increased c-fos gene expression 
during torpor in the mouse. 
• and to validate the use of the TRAP2 mouse as a means to target neurons that 
are active during torpor induction.  
3.2  Methods 
3.2.1  Mice 
Female C57BL/6J mice were obtained from Charles River (https://www.criver.com/). 
Two female heterozygous TRAP2 mice were obtained directly from the Liqun Luo 
laboratory in Stanford University, California. The strain is now available via Jackson 
laboratory (www.jax.org/strain/030323). This line was bred to generate a homozygous 
maintenance colony. Homozygous Ai14 mice were obtained from our in-house colony, 
having been originally purchased from Jackson laboratories 
(www.jax.org/strain/007908). The Ai14 mouse carries a floxed gene encoding a red 
fluorophore (tdTomato) knocked into the Gt(ROSA)26Sor locus, which requires the 
action of Cre to remove a stop codon and allow indefinite tdTomato expression. 
Breeding pairs were established using one homozygous TRAP2 mouse and one 
homozygous Ai14 mouse to generate ‘TRAP x Tomato’ double-heterozygous offspring.  
The resultant double-transgenic ‘TRAP x Tomato’ mice permanently produce red 
fluorescent tdTomato protein in neurons that were active during a time period defined 




Mice were at least 8 weeks of age and weighed at least 20g on entry into experiments. 
They were maintained on a 12-hour reversed light/dark cycle. Mice had free access to 
water and free access to standard mouse chow (LabDiet, St. Louis, MO 63144, USA) 
except during fasting or calorie restriction. They were housed in groups of up to four. 
All studies had the approval of the local University of Bristol Ethical Committee and 
were carried out in accordance with the UK Animals (Scientific Procedures) Act, under 
Professor Anthony Pickering’s project licence number 30/3362. 
3.2.2  Experiment protocols 
Two complementary approaches were taken. The first employed 
immunohistochemistry against c-Fos in mice culled during torpor. The second 
approach used the TRAP2 mouse to genetically mark active neurons around the time 
of torpor entry. Both these approaches aimed to identify regions of the mouse brain 
that are preferentially active during torpor. In order to maintain statistical power, and 
based on the evidence discussed in Chapter 1 regarding brain regions likely to 
contribute to torpor, six hypothalamic areas were pre-selected for analysis in 
experiment 3.1. These were the arcuate nucleus (Arc), the medial preoptic area (MPA) 
the dorsomedial hypothalamus (DMH), the anterior hypothalamus (AH), the posterior 
hypothalamus (PH), and the paraventricular hypothalamus (PVH).  
Experiment 3.1: Hypothalamic c-Fos labelling in torpor 
Female C57BL/6J were induced into torpor using the ‘Cold Fast’ protocol (see Chapter 
2). Briefly, this involved housing at a thermoneutral ambient temperature of 30°C for a 




that commenced at lights off. Mice were monitored remotely via a thermal imaging 
camera placed above the cage (see Chapter 2).  
Two control groups were used experiment 3.1. The first group were fasted but not 
cold-exposed, underwent a 10 hour fast at a thermoneutral ambient temperature of 
30°C from lights off. These mice were not expected to enter torpor, since the energetic 
costs of maintaining a normal core temperature should be minimal. The second control 
group were cold-exposed but not fasted, exposed to the reduced ambient 
temperature of 18°C for 36 hours with free access to food.  
For c-fos staining, mice were culled 90 minutes hours after initiation of torpor or at the 
end of the control period by terminal anaesthesia with intraperitoneal pentobarbitone 
(175mg/kg, Euthatal). They were then trans-cardially perfused with 10ml heparinised 
0.9% saline (50 units/millilitre) followed by 20ml of 10% neutral buffered formalin. 
Brains were removed and stored in fixative solution for 24 hours at 4°C before being 
transferred to 20% sucrose in 0.1M phosphate buffer (PB), pH 7.4, and again stored at 
4°C.  
Experiment 3.2: TRAPing torpor-active neurons 
Female ‘TRAP x Tomato’ mice were entered into the ‘Calorie-Restriction’ protocol for 
torpor induction (see Chapter 2). Briefly, mice were housed at an ambient temperature 
of 21°C, and provided a single meal at lights off, which delivered approximately 70% of 
their unrestricted daily intake. The TRAP2 system is gated by the presence of 4-
hydroxytamoxifen, delivered by i.p. injection. This injection presented two potential 
issues. Firstly, it might prevent or delay the occurrence of torpor. Secondly, if the 




would also be TRAPed. In order to reduce the risks of these two occurrences, mice 
were habituated to daily vehicle injection seven hours after lights off (chen oil, four 
parts sunflower oil to one part castor oil, www.sigmaaldrich.com).  
At the time of designing and carrying out these experiments, relatively little was 
known about the time window for TRAPing. Maximal TRAPing was seen when the 4-
OHT and behaviour or stimulus of interest coincided (Guenthner et al. 2013). If the 
stimulus or behaviour occurred six hours before or six hours after the 4-OHT injection, 
then minimal TRAPing was observed. A pragmatic target of administering the 4-OHT 
within 3 hours prior to the torpor bout was chosen experiment 3.2. This was felt to be 
close enough to torpor onset for sufficient 4-OHT to be present, while early enough 
not to interfere with the expression of torpor. 
Once mice were reliably entering torpor, 4-OHT (50mg/kg) was added to the vehicle 
injection and administered as usual at 7 hours after lights off on the next day, in 
anticipation of a subsequent torpor bout. Control mice were selected as mice that had 
not entered torpor by day 2. These were given 4-OHT (50mg/kg, i.p.) on day 3 and only 
those that did not enter torpor following the injection were included as controls. 
Mice were culled by terminal anaesthesia (pentobarbitone (Euthatal) 175mg/kg,) a 
minimum of four weeks from the time of 4-OHT injection, to allow expression of the 
tdTomato. They were trans-cardially perfused with 10ml heparinised 0.9% saline (50 
units/millilitre) followed by 20ml of 10% neutral buffered formalin. Brains were 
removed and stored in fixative solution for 24 hours at 4°C before being transferred to 




TRAP x Tomato controls 
Spontaneous dissociation of HSP90 from the Cre-ERT2 fusion protein has been 
reported (Kristianto et al. 2017). The effect of this leak, in these experiments, would be 
tdTomato fluorophore expression in cells that were active during a period in which 4-
OHT was not present, i.e. during non-torpid periods. To assess for this, TRAP x Tomato 
mice that did not receive 4-OHT were included.  
Torpor definition 
Torpor was identified using thermal imaging cameras and defined as a period of time 
lasting at least one hour during which surface temperature remained at least four 
standard deviations below the mean for that zeitgeber time, as detailed in Chapter 2. 
This torpor definition requires retrospective analysis of the thermal imaging data. 
Therefore, in order to determine the timepoint at which mice should be culled for c-fos 
labelling in experiment 3.1, torpor was visually identified from the raw trace on the 
thermal imaging camera software. This was determined by observation of a persistent 
drop in surface temperature combined with cessation of locomotor activity. The 
temperature data was then retrospectively analysed to confirm that the threshold for 
torpor had been reached, and those failing to enter torpor by the time of culling were 
excluded from the analysis.  
3.2.3  Immunohistochemistry 
Brains were sectioned at 40μm thickness into a 1:3 series on a freezing microtome, 
transferred to 0.1M PB containing 1:1000 sodium azide, and stored for up to 2 weeks 
at 4°C, or else transferred to a cryoprotectant solution (2:3:5, glycerol: ethylene glycol: 






























FIGURE 3-2 C-FOS ANTIBODY VALIDATION 
SC52 anti-c-Fos primary antibody at 1:500 concentration (A) was compared to CST2250s at 1:500 (C), 1:2000 (D), and 1:6000 (E). Labelled nuclei are in the 
paraventricular thalamus, following exposure to a hypoglycaemia protocol (tissue courtesy of Dr. Anna Simpson). B shows a schematic representation of the section 
location. All scale bars represent 100µm. Abbreviations: 3V, third ventricle; PVT, paraventricular thalamus.   
A B 




gave a single section, 120µm from the midline, that contained part of each nucleus of 
interest. For identification of TRAPed neurons expressing tdTomato in experiment 3.2, 
40µm coronal sections were taken and mounted directly onto slides without 
immunohistochemistry. This was because the fluorescence signal from the tdTomato 
was sufficiently bright not to require amplification.  
For immunohistochemistry, sections were mounted onto glass slides (Superfrost Plus, 
ThermoFisher Scientific), and dried either overnight at 21°C or for 30 minutes at 30°C. 
Sections were then blocked by incubation with 5% normal donkey serum in 0.3% 
Triton-X and 0.1M PB (PBT) for 4 hours. Primary anti-c-Fos antibodies were obtained 
from Cell Signalling Technology (2250S, rabbit anti-c-Fos, 1:2000). Primary antibodies 
were diluted in 5% normal donkey serum in PBT and applied to sections for overnight 
incubation at room temperature. After incubation in the primary antibody, sections 
were washed once with a 0.15% Triton-X in PB for 15 minutes, then in PB for a further 
15 minutes. After washing, sections were incubated for 4 hours in donkey anti-rabbit 
IgG secondary antibody (Alexa-488, Life Sciences, 1:1000) in 5% normal donkey serum 
in PBT. Sections were again washed as above, then covered in FluorSave (Merck) and 
coverslips applied. 
C-Fos antibody validation 
The Cell Signalling Technology anti-c-Fos primary antibody (2250s) had not been 
validated in our laboratory, although the manufacturers report that it is cross-reactive 
with mouse c-Fos, and that it can be used in immunohistochemistry 
(www.cellsignal.com). It has been used in published articles (Cho et al. 2020). This 
antibody was therefore compared to another anti-c-Fos antibody that had been used 




1:500). A validation study was performed comparing the established SC52 antibody 
with the 2250s antibody at a range of concentrations in tissue samples from mice 
exposed to a hypoglycaemia protocol, which generated a well-characterised pattern of 
c-Fos expression in the paraventricular thalamus (tissue donated by Dr. A Simpson). 
All titres of the 2250s antibody resulted in nuclear staining in a pattern consistent with 
that seen with the SC52, and in keeping with expected pattern of c-fos expression 
triggered by the hypoglycaemia protocol (Simpson 2019 (PhD thesis)). A dilution of 
1:2000 for the 2250s antibody was selected from this preliminary study based 
qualitatively on the pattern of labelling (see Figure 3-2).  
Imaging 
For c-fos nuclei counting, sections were imaged using a Leica DMI6000 widefield 
microscope with a 0.75 numerical aperture, 20x objective, excitation filter 480/40nm, 
dichroic mirror 505nm, emission filter 527/30nm. Sagittal sections 120µm from the 
midline were imaged. Regions corresponding to the hypothalamic nuclei of interest 
were selected manually based on the Mouse Brain Atlas Images (Franklin and Paxinos 
2007) and were analysed using Image-J software (Schindelin et al. 2012). An 
automated image processing protocol was employed to count c-fos positive nuclei. 
This involved background subtraction with a rolling ball radius of 50 pixels. Labelled 
nuclei were identified by applying a threshold to the image that identified regions with 
brightness three standard deviations greater than the mean background. Overlapping 
regions were separated using the watershed method. Highlighted areas were then 






FIGURE 3-3 EXAMPLE OF TRAPED CELL AUTOMATED COUNTING IN PREOPTIC AREA FROM A MOUSE THAT ENTERED TORPOR 
Left panel shows tdTomato labelled neurons in a mouse that entered torpor following a 4-OHT injection. Section taken from approximately bregma +0.02mm. The 
grey box indicates the preoptic area region of interest, which was applied to all images from this study. Right panel shows the result of the automated processing: 




For counting TRAPed cells expressing tdTomato in experiment 3.2, a different 
approach was taken. 40µm thick coronal sections were imaged using the same Leica 
DMI6000 widefield microscope and 0.75 numerical aperture, 20-times magnification 
objective, excitation filter 546/10nm, dichroic mirror 560nm, emission filter 580/40nm.  
Masks for regions of interest were taken from the Mouse Brain Atlas (Franklin and 
Paxinos 2007). These masks were then digitally applied to each of the widefield images 
so that exactly the same size and shape area of interest was used for cell counting 
across animals. The DMH, PH, and Arc were defined by their atlas boundaries. The 
preoptic area mask was defined dorsally by the anterior commissure, ventrally by the 
ventral surface of the brain, and laterally by the lateral extent of the ventrolateral 
preoptic nucleus (see Figure 3-3). Hence, the preoptic area as defined here included 
the medial and lateral parts of the medial preoptic nucleus, the ventromedial and 
ventrolateral preoptic nuclei, the medial and lateral preoptic areas, and parts of the 
strio-hypothalamic, the septo-hypothalamic, the median preoptic, and the 
periventricular nuclei. Because TRAPed cells express tdTomato in a somato-dendritic 
distribution (compared to nuclear c-Fos labelling), the automated cell counting 
procedure was adjusted to include any object with a size of 50 - 2000μm2 and no shape 
constraints were applied. 
3.2.4  Genotyping 
Primers were purchased from Eurofins (www.eurofins.com), as per Table 1-1. Ear 
notches were lysed with 30μl lysis buffer (25nM NaOH and 0.2mM EDTA) by shaking at 
300 rpm, 90°C for 25 minutes. Lysed samples were then neutralised with 30μl 
neutralising buffer (40mM Tris-HCL, pH 7.4). Each 20μl polymerase chain reaction 




Target Gene Forward Reverse 
TRAP2 mutant CCT TGC AAA AGT ATT ACA TCA 
CG 
GAA CCT TCG AGG GAA GAC G 
TRAP2 wild type  GTC CGG TTC CTT CTA TGC AG GAA CCT TCG AGG GAA GAC G 
TABLE 3-1 PCR PRIMERS USED FOR GENOTYPING THE TRAP2 MICE. 
 
Component Volume (μl) 
DNA lysis sample 1 
10X Buffer  2 
Primer mix (10μM) 0.4 
dNTPs 0.4 
Taq DNA Polymerase 0.2 
PCR water Up to 20 μl 
TABLE 3-2 PCR REACTION MIXTURE. 
 
Step Number Temperature °C Time (seconds) Note 
1 94 120  
2 94 20  
3 65 15 0.5°C decrease per cycle 
4 68 10  
5 - - Repeat steps 2-4 for 10 cycles  
6 94 15  
7 60 15  
8 72 10  
9 - - Repeat steps 6-8 for 28 cycles 
10 72 120  
11 10 hold  





Table 1-3. On completion of the PCR, 1μl loading dye was added, and the solution 
mixed by pipetting several times. To prepare gels, 0.5g agarose was added to 50ml 
Tris-Acetate-EDTA (TAE) buffer and placed in a microwave for 30 seconds, repeated as 
necessary to ensure the agarose powder had completely dissolved. Once the solution 
had cooled but not set, 1μl ethidium bromide was added, the solution poured into the 
electrophoresis gel chamber, and combs were added. The electrophoresis chamber 
was filled with TAE buffer, 10μl of completed PCR solution with loading dye was added 
to each well, and the samples electrophoresed at 120V for 45 minutes. Gels were 
imaged using a Syngene G:Box XT4 with Genesys software (www.syngeneintl.com). 
3.2.5  4-Hydroxytamoxifen preparation 
The z-isomer of 4-hydroxytamoxifen (4-OHT) is the active isomer (www.tocris.com). It 
was dissolved in chen oil using the following method (Guenthner et al. 2013).  Firstly, 
4-OHT was dissolved in neat ethanol at 20mg/ml by shaking at 400rpm and 37°C for  
30-60 minutes until fully dissolved. Two parts chen oil for every one part ethanol was 
then added, and the ethanol was evaporated off using a vacuum centrifuge leaving a 
final solution of 10mg/ml in chen oil. 4-OHT was freshly prepared on the day of use, 
and if not used immediately, was kept in solution in the oil by shaking at 400 rpm at 
37°C. Once in solution, the drug was protected from light. 
3.2.6  Statistical analyses 
Data are presented as mean ± standard deviation when normally distributed, 
otherwise it is presented as median [interquartile range]. Statistical analyses were 
carried out using GraphPad Prism version 6.07 (www.graphpad.com). The ANOVA and 





FIGURE 3-4 EXAMPLE SURFACE TEMPERATURE PROFILES IN EXPERIMENT 3.1  
Example traces from four mice entering torpor following a fast at 18°C ambient temperature 
(A), compared to four controls that were held at 18°C with free access to food (B), and four 
controls held at 30°C and fasted (C). Torpor (red line) is defined as a period lasting at least 60 
minutes during which surface temperature remained at least four standard deviations below 







FIGURE 3-5 EXAMPLE C-FOS LABELLING FROM EXPERIMENT 3.1. 
A, nuclei labelled for c-Fos (green) in the posterior hypothalamus, corresponding region shown 
by grey rectangle on C. B, sagittal section of mouse brain at 120µm from midline, showing the 
regions of interest across the hypothalamus. C, corresponding region from Mouse Brain Atlas. 
Abbreviations: PVH, paraventricular hypothalamus; AH, anterior hypothalamus; PH, posterior 
hypothalamus; MPA, medial preoptic area; Arc, arcuate nucleus; DMH, dorsomedial 














FIGURE 3-6 C-FOS POSITIVE NUCLEI COUNTS FROM EXPERIMENT 3.1 
Counts of c-Fos positive nuclei across hypothalamic regions of interest in female mice culled 90 
minutes into a torpor bout induced by the ‘Cold Fast’ protocol (red, n = 6), compared to 
controls that were either fasted at 30°C ambient(dark blue, n = 7) or exposed to 18°C with free 
access to food (light blue, n = 7). Abbreviations: PVH, paraventricular hypothalamus; AH, 
anterior hypothalamus; PH, posterior hypothalamus; MPA, medial preoptic area; Arc, arcuate 
nucleus; DMH, dorsomedial hypothalamic nucleus.  
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FIGURE 3-7 LINEAR REGRESSION OF TORPOR DURATION AGAINST C-FOS POSITIVE CELL COUNT BY REGION IN SIX 
MICE THAT ENTERED TORPOR 
The c-Fos positive cell count is plotted against the duration of torpor in mice from experiment 
3.1 (n = 6, female mice). Linear regression indicates the c-Fos positive cell count in the PVH is 
significantly negatively correlated with torpor duration (r2 = 0.81, F(1,4) = 17.39, p < 0.05) .  
Abbreviations: PVH, paraventricular hypothalamus; AH, anterior hypothalamus; PH, posterior 
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non-normal data. Power calculations were performed using G-power (v.3.1.9.4, 
www.psychologie.hhu.de). Based on the pilot data from experiment 3.1, for 
experiment 3.2 a power calculation was performed with the following assumptions: a 
mean TRAPed cell count of 300 in non-torpid mice, and 400 in torpid mice, and a 
standard deviation of 100, with α 0.05 and power of 0.8. This would require six animals 
per group.  
3.3  Results 
3.3.1  Experiment 3.1: Hypothalamic c-Fos labelling in torpor  
Seven out of eight mice exposed to a reduction in ambient temperature from 30°C to 
18°C followed by a fast from lights off (the ‘Cold Fast’ protocol, see Chapter 2) entered 
torpor. The remaining mouse exhibited a drop in surface temperature typical of early 
torpor, but did not meet the definition of torpor. This mouse was likely beginning to 
enter torpor when it was culled, but because the formal analysis of torpor could only 
be applied to the data in retrospect it was culled too early. It was therefore excluded. 
A further mouse in the torpor group did not show any c-fos labelling, and was also 
excluded. This was thought to be immunohistochemistry failure as the tissue 
histologically looked normal. None of the controls, either those exposed to a fast at 
30°C ambient temperature, or those exposed to 18°C ambient temperature with free 
access to food, exhibited torpor (n = 7 per group, see Figure 3-4).  
C-Fos labelling 
Labelled nuclei were seen across all hypothalamic regions of interest (see Figure 3-5 
and Figure 3-6). C-Fos labelled cell counts were the same across all groups when data 







FIGURE 3-8 SURFACE TEMPERATURE PROFILES IN EXPERIMENT 3.2 
Calorie - restricted mice administered 4-OHT to ‘TRAP’ neurons active during torpor. A, five 
mice that entered torpor after 4-OHT. B, five mice that did not enter torpor after 4-OHT 






























FIGURE 3-9 TRAPED CELLS  EXPRESSING FLUOROPHORE FOLLOWING 4-OHT 
Calorie restricted mice administered 4-OHT prior to torpor entry, resulting in td-Tomato expression in active neurons (red). A, coronal section showing POA neurons; 
B, DMH and Arc neurons; C, PH neurons. D, sagittal schematic showing corresponding anterior-posterior location of coronal sections A, B, and C; E, high 
magnification image showing DMH torpor-active neurons expressing td-Tomato. Abbreviations: aca, anterior commissure (anterior part); A14, A14 dopamine cells; 
MPO, medial preoptic nucleus; MPA, medial preoptic area; VLPO, ventrolateral preoptic nucleus; 3V, third ventricle; MT, mammillothalamic tract; DMH, dorsomedial 
hypothalamic nucleus; Arc, arcuate nucleus; FR, fasciculus retroflexus; PH, posterior hypothalamic nucleus











FIGURE 3-10 TRAPED CELL COUNT BY HYPOTHALAMIC REGION OF INTEREST 
Counts of td-Tomato-positive cells by region of interest in calorie-restricted mice that entered 
torpor following 4-OHT (red) or did not enter torpor following 4-OHT (blue). Torpor was 
associated with higher numbers of ‘TRAPed’ cells in the DMH and POA compared to animals 
that did not enter torpor. Mixed ANOVA comparing TRAPed cell count in mice that entered 
torpor with those that did not for each of the four regions of interest, with Fisher’s least 
significant differences multiple comparisons,** indicates p<0.01, * indicates p<0.05. Data 
shown are mean and standard deviation. Abbreviations: PH, posterior hypothalamic nucleus; 
DMH, dorsomedial hypothalamic nucleus; POA, preoptic area; Arc, arcuate nucleus. Female 














FIGURE 3-11 LINEAR REGRESSION OF TORPOR DURATION OR DEPTH SCORE AGAINST TRAPED CELL COUNT BY REGION IN FIVE MICE THAT ENTERED TORPOR 
The TRAPed cell count is plotted against the duration (A) and depth (B) of torpor mice from experiment 3.2 (n = 5). None of the regression lines significantly deviated 
from a slope of zero.  Abbreviations: PH, posterior hypothalamus; DMH, dorsomedial hypothalamic nucleus; POA, preoptic area; Arc, arcuate nucleus. 
 
  



















































FIGURE 3-12 MINIMAL LEAK IN THE TRAP X TOMATO MICE 
TRAP x Tomato mice not given 4-OHT showed minimal leak, with no tdTomato-expressing cell bodies seen in either the POA (A) nor the DMH (B). Occasional fibres 
were noted that expressed tdTomato, presumably reflecting spontaneous recombination in cells whose bodies lie distant to the section (C) . Abbreviations: A14, A14 
dopamine cells; aca, anterior commissure (anterior part); DHA, dorsal hypothalamic area; DMH, dorsomedial nucleus of the hypothalamus; MPA, medial preoptic 




(F(2,17) = 0.02, p = 0.98)). C-Fos positive cell counts did not differ systematically by 
hypothalamic region of interest (two-way mixed ANOVA no main effect for 
hypothalamic nucleus (F(5,85) = 2.24, p = 0.06)). There was a region by group 
interaction (F(10,85) = 2.17, p < 0.05). Multiple comparison testing did not reveal any 
significant differences between c-Fos labelled nuclei counts in torpid animals 
compared to either control group for any region analysed (Fisher’s least significant 
difference test, p > 0.05 throughout). 
A significant correlation between the c-Fos positive cell count and torpor duration or 
aggregate torpor depth score would support the hypothesis that neurons in this region 
are involved in generating torpor. No region of interest demonstrated a significant 
positive correlation, although the count in the PVH was negatively correlated with 
torpor duration (r2 = 0.81, F(1,4) = 17.39, p < 0.05) (see Figure 3-7). 
3.3.2  Experiment 3.2: TRAPing torpor-active neurons 
Sixteen TRAP x Tomato mice were entered into the calorie restriction protocol and 
given 4-OHT in anticipation of torpor. Of these, five mice that  entered torpor within 
three hours of administration of 4-OHT, and five that did not enter torpor within 24 
hours of administration of 4-OHT, were included for analysis. The remaining six mice 
either entered torpor more than 3 hours after 4-OHT administration, or else displayed 
equivocal patterns of temperature reduction and were excluded. Their respective 
surface temperature profiles are shown in Figure 3-8. The mean time between 





Mice in the torpor group received 4-OHT on day 5 [3.5 -5]. There was no significant 
difference between groups in the weight loss of animals from the first day of calorie 
restriction to the day of 4-OHT administration, either in terms of absolute weight loss, 
or percentage weight loss (mean weight loss torpor 2.6 ± 0.7g, versus 2.4 ± 0.3g 
control, t(8) = 0.66, p = 0.46; percentage weight loss torpor 11.6 ±2.3% versus 11.0 ± 
1.2% control, t(8) = 0.57, p = 0.58).  
TdTomato expression 
Widespread recombination resulting in tdTomato expression was seen throughout the 
hypothalamus in both groups, as expected given that both groups were calorie 
restricted (see Figure 3-9). Based on the c-Fos labelling in experiment 3.1 as well as 
review of the literature described in Chapter 1 section 1.6, four hypothalamic nuclei 
were selected a-priori for tdTomato positive cell counting: PH, DMH, POA, and Arc. 
Two-way mixed ANOVA revealed main effects for torpor versus no torpor (F(1,8) = 
6.03, p <0.05), and for nucleus of interest (F(3,24) = 57.9, p < 0.0001. There was a 
significant region by group interaction (F(3,24) = 3.80,p<0.05). Fisher’s least significant 
difference indicated that torpor was associated with significantly more tdTomato 
positive cells in the DMH (mean difference 185.6, confidence interval (CI) 76 - 295) and 
in the POA (mean difference 135, CI 26 – 245) (see Figure 3-10). Within the torpor 
group, the TRAPed cell count did not significantly correlate with torpor duration or 
depth score (see Figure 3-11). 
Controls 
Two TRAP x Tomato mice were processed to assess for leak of the Cre-ERT2 system in 




with no transduced cell bodies observed in either the DMH or the POA. Occasional 
fibres that appeared to express tdTomato were noted, indicating spontaneous 
recombination in neurons outside the section (see Figure 3-12).  
3.4  Discussion 
The results of this chapter indicate that the dorsomedial hypothalamic nucleus, and 
the preoptic area contain cells that are preferentially active in torpid mice compared to 
controls. This conclusion is drawn from the data in experiment 3.2, and validates the 
TRAP2 mouse as a model that allows direct genetic access to neurons that are active 
during torpor. The POA as defined here represents several preoptic hypothalamic 
nuclei grouped together, including the medial and lateral parts of the medial preoptic 
nucleus, the ventromedial and ventrolateral preoptic nuclei, the medial and lateral 
preoptic areas, and parts of the strio-hypothalamic, the septo-hypothalamic, the 
median preoptic, and the periventricular nuclei. The observation that weight loss was 
equivalent in mice that entered torpor compared to controls that did not supports the 
assertion that the difference in the number of TRAPed cells represents activation of a 
torpor circuit rather than response to an increasing energy deficit per se.  
The DMH and POA have been identified in previous studies of torpor using c-fos as a 
surrogate for neural activation. The first performed c-fos mRNA ISH in hibernating 
ground squirrels and found that the ventrolateral part of the medial preoptic area was 
highly labelled during entrance into torpor (Bratincsák et al. 2007a). It is striking that 
despite the different species examined, and the fact that the animals were undergoing 
seasonal hibernation rather than daily torpor, the findings agree with the data 




tanycytes lining the third ventricle. These cells would have been counted within the 
region defined as the preoptic area in my studies.  
The second study was published during the completion of these experiments, and 
performed IHC against c-Fos protein (Hitrec et al. 2019). The authors found that 
amongst several regions showing increased labelling during torpor, the DMH torpor-
active neurons also projected to the raphe pallidus (RPa), making this group of neurons 
a plausible candidate for suppressing BAT thermogenesis during torpor. Again, it is 
striking that despite using a different means to induce torpor (acute cold exposure 
during a prolonged fast), this paper also identified that the DMH appears to become 
active during torpor. This paper found significant differences in the number of c-Fos 
positive cells between torpid mice and controls in several other regions. These include 
the paraventricular hypothalamus, the periaqueductal grey, the arcuate, the lateral 
hypothalamus, and the parabrachial nucleus.  
While some of these regions were not analysed in the data presented here, the 
arcuate and paraventricular hypothalamus were, and yet significant differences were 
not found. Indeed, the c-Fos labelling in experiment 3.1 found a negative correlation 
between the cell count in the PVH and torpor duration. There are several reasons why 
these differences might exist. The study by Hitrec et al. employed a different method 
for inducing torpor: a prolonged fast lasting 36 hours, followed by a drop in ambient 
temperature. They also used a different c-Fos antibody, which may have had differing 
affinity for the c-Fos protein, or differing tissue penetration. Finally, in the paper by 
Hitrec et al., each region of interest was counted in its anterior-posterior extent across 




animal. In contrast, the data presented here was obtained from a single count from a 
near-midline sagittal section. The former approach is likely to reduce variability by 
sampling multiple sections and then taking the mean count for each mouse, increasing 
the likelihood of gaining statistical significance. 
The data from experiment 3.1 did not identify any statistically significant regional 
differences in c-fos labelling in torpid compared to control mice, which is in contrast to 
experiment 3.2. There are several factors that probably contribute to the different 
results observed in experiment 3.1 and 3.2. Firstly, the experimental protocols were 
fundamentally different. The control group in experiment 3.2 was more similar to the 
torpid group, since both were under a calorie-restriction protocol while maintained at 
21°C ambient temperature. This makes it a more powerful experimental design. 
Additionally, the means of identifying active neurons was different. In experiment 3.2, 
the fluorescence signal was generated by permanently switching on the gene for 
tdTomato. The tdTomato signal was sufficiently bright to obviate the need for 
immunohistochemical amplification. In contrast experiment 3.1 relied upon antibody-
labelling of c-Fos, and subsequent labelling of that antibody with a secondary. The 
variance in the IHC labelling of c-Fos positive cells between animals in experiment 3.1 
was high. This is despite efforts to validate the newer antibody against one that was 
better established. Variability in c-Fos antibody labelling is a recognised challenge 
(Kawashima, Okuno, and Bito 2014), and may reflect unreliable binding of antibody to 
the c-Fos protein, variability in the amount of c-Fos protein generated between 




Failure to differentiate c-Fos labelling in torpid animals compared to controls may also 
be secondary to experimental factors that led to the c-Fos signal being missed. For 
example, if the animals were culled prematurely before the peak signal generated by 
the torpor bout. Although, the observation that no region demonstrated a positive 
correlation between the number of labelled cells and the duration of torpor suggests 
that this may not have been the case. Another important consideration is whether 
there are distinct neuronal populations that induce, maintain, and terminate a torpor 
bout. Hypothetically there might exist separate populations or circuits of neurons that 
are responsible for each stage of the torpor bout. If this is the case, then it is possible 
that the induction of torpor could require a brief period of activity in the induction 
neurons, which then remain relatively silent. This burst of activity would be easy to 
miss when labelling c-Fos. Alternatively, a single population might induce torpor, and 
their persistent activity could determine the length of the torpor bout. In this case, if 
the c-Fos signal is greatest at the point of maximal increase in firing (Kovács 2008), 
then again it might be easily missed.  
It is also worth considering the possibility that as mice enter torpor, the reduction in 
their metabolic rate slows down the usual timescale of c-fos gene transcription and c-
Fos protein production. Hence, the usual practice of culling animals 90-120 minutes 
after the behaviour of interest in order to capture the peak c-Fos signal may be too 
early in the setting of torpor.  
It is possible that non-neuronal cells express c-Fos and that some of the labelling seen 
in both experiments presented here could in fact represent this. Double labelling with 




other hand, non-neuronal cells may play a role in torpor. Tanycytes lining the third 
ventricle sit in close proximity to the neurons of the DMH and the POA, have been 
implicated in the control of metabolism (Ebling and Lewis 2018), and were observed to 
express c-fos mRNA in hibernating ground squirrels, peaking around the time of 
arousal (Bratincsák et al. 2007b). Likewise, glia have been implicated in control of 
energy balance and food intake (MacDonald et al. 2019).  
An additional consideration is that a group of neurons could be strongly active during a 
torpor bout if their usual role is to counteract a drop in core body temperature. If the 
process of torpor induction involves inhibiting part of the circuit downstream of these 
neurons, then they will continue to detect and react to changes in body temperature. 
Hence, as body temperature drops, their activity may increase dramatically. This could 
give the impression that they are active during torpor and lead to the false conclusion 
that they are part of the induction process when in fact the opposite is the case, they 
are part of a counter-regulatory system that attempts to defend normothermia.  
Despite these caveats, experiment 3.2 generated results that sit within the framework 
of the known literature of torpor. Based on the literature review in Chapter one, and 
the schematic presented in Chapter one, Figure 1-2, one might hypothesise that the 
preoptic area cells identified here are part of the warm-sensing GABAergic projection 
to the DMH, which inhibit the projections from the DMH to the RPa, reducing BAT 
thermogenesis (Tan et al. 2016; Z. Zhao et al. 2017). The observation that DMH 
neurons are active during torpor is more intriguing. Activation of DMH neurons, be 
they glutamatergic or GABAergic, is usually associated with a rise in core temperature 




associated with activation of neurons within the DMH. Either these neurons represent 
a novel population of DMH neurons that inhibit thermogenesis, or else they represent 
a response to hypothermia and an effort to correct body temperature described 
above. 
Conclusions  
The findings here lay the foundations for experiments that utilise TRAP system to 
introduce DREADDs into the torpor induction circuit. By manipulating the activity of 
populations of neurons that are identified by their activation during torpor, it will be 
possible to begin to answer some key questions. Such questions include whether there 
are distinct neuronal populations that induce, maintain, and terminate a torpor bout? 
A related question is whether there is a central master switch for torpor, which once 
activated is capable of inducing all the different physiological and behavioural facets of 
torpor. On the other hand, those distinct facets – such as the thermoregulatory, 
cardiorespiratory, and behavioural adjustments – might each be triggered 
independently of one another but in parallel, by centres that individually detect and 
respond to the cues for torpor.  Chapters 4 and 5 describe a series of experiments that 
attempt to answer some of the questions raised in this discussion, by introducing 



























Chapter 4 Generating synthetic torpor 
4.1  Introduction 
It has been widely assumed, but never definitively demonstrated, that torpor is 
controlled by central neural mechanisms. However, this is not the only possibility, and 
a circulating factor in the serum of hibernators – the so-called ‘Hibernation Induction 
Trigger (HIT)’ - has also been proposed (Bolling et al. 1997; Oeltgen et al. 1988; L. C. H. 
Wang et al. 1988; Hong et al. 2005). While these two possibilities are not mutually 
exclusive, and a central mechanism could trigger HIT release, the contribution of either 
or both remains to be established. To date, attempts to manipulate the probability of 
an animal entering or remaining in torpor have relied on the administration of 
pharmacological agents that act, for example, on beta-3 receptors (Swoap et al. 2006), 
adenosine receptors (Silvani et al. 2018; Tamura et al. 2012; Iliff and Swoap 2012), NPY 
receptors (John Dark and Pelz 2008; Paul et al. 2005), or ghrelin (Gluck, Stephens, and 
Swoap 2006). These pharmacological approaches are undertaken alone or in 
combination with lesions to specific hypothalamic nuclei (Gluck, Stephens, and Swoap 
2006), or with the use of genetically-modified modified mice (Swoap et al. 2006; 
Bechtold et al. 2012; Gavrilova et al. 1999). These experiments, reviewed in Chapter 1, 
identified some potential signalling systems, and hypothalamic nuclei, that might 
contribute to torpor induction, maintenance, or recovery. However, none has yet 
identified a definitive mechanism of torpor induction.  
Chemogenetics is the process of engineering receptors so that they no longer respond 
to their native ligand, instead they interact with a non-native molecule (reviewed, 
Roth, 2016). By expressing chemogenetically altered receptors in biological tissues, it is 




activated by designer drugs (DREADDs) are an example of a chemogenetic tool, which 
provide a means to modulate the activity of specific populations of neurons 
(Armbruster et al. 2007). DREADDs are mutated G protein-coupled receptors that no 
longer bind to their native ligand, but instead bind a variety of small molecule ligands. 
These designer ligands are selected to be pharmacologically inert, minimising off-
target activity, and hence provide a means to selectively activate (or inhibit) only those 
neurons that express the DREADD. One pair of DREADDs, hM3Dq and hM4Di, are 
chemogenetically engineered muscarinic acetylcholine receptors, which no longer bind 
native acetylcholine but instead bind to exogenously applied clozapine-N-oxide (CNO) 
(Armbruster et al. 2007). The hM3Dq receptor acts via phospholipase C to activate 
protein kinase C, resulting in intracellular calcium release and membrane 
depolarisation (Mizuno and Itoh 2009). The hM4Di receptor activates G-protein 
inwardly rectifying potassium (GIRK) channels, and may also alter synaptic release 
(Armbruster et al. 2007). Administration of CNO in-vivo causes depolarisation and 
increased firing in neurons expressing hM3Dq (Alexander et al. 2009), and 
hyperpolarisation and reduced firing rates in neurons expressing hM4Di (Zhu et al. 
2014).  
DREADDs have the advantage over alternative actuators such as optogenetics, in not 
requiring the implantation of an optrode and associated optical cables or wireless 
headset. Instead DREADDs rely on the administration of an i.p. injection of the 
DREADD ligand for their activation. This permits the study of behaviour under more 
naturalistic settings. They have been used to identify the circuits involved, for example,  
in thermoregulation (Z. Zhao et al. 2017; Tan et al. 2016) and sleep (Harding et al. 




either by genetically modifying the animal, or by vectorised delivery. In order to gain 
meaningful data, DREADD expression should be limited to specific neuronal 
populations. Such selectivity can be achieved by placing the expression of a DREADD 
gene under a cell-type specific promoter, or by ‘Floxing’ the gene (see Chapter 3) such 
that expression is dependent on the presence of Cre recombinase. Selectivity of 
expression is then achieved by placing the Cre under the control of a cell-type specific 
promoter, or by vectorised local delivery.  
The TRAP2 mouse provides a model that utilises Cre recombinase and can be used to 
produce conditional expression of DREADDs in neurons that are active during the time 
window defined by administration of 4-OHT (see Chapter 3). This approach has the 
advantage of not mandating a-priori decisions about which neurons to target, and has 
been used, for example, within the hypothalamus to target neurons involved in thirst 
(Allen et al. 2017).  
The aim of this chapter was to use the TRAP2 mouse bred with a line that expresses a 
Cre-dependent excitatory DREADD to test the hypothesis that torpor is a centrally-
driven behaviour (see Figure 4-1).  
4.2  Methods 
4.2.1  Mice 
Wild type female C57Bl/6J mice were purchased from Charles River laboratories 
(www.charlesriver.com). Two genetically modified mouse lines were used. The first 
was the TRAP2 line described in Chapter 3. To recapitulate briefly, two female 
heterozygous TRAP2 mice were obtained directly from the Liqun Luo laboratory in 




generate a homozygous colony. The line is now available from the Jackson Laboratory 
(https://www.jax.org/strain/0303230).  
The second line, RC::L-hM3Dq, was obtained from Jackson Laboratories 
(https://www.jax.org/strain/026943). The RC::L-hM3Dq mice carry a Cre-dependent 
inverted hM3Dq/mCherry fusion protein and an EGFP sequence under the control of 
the endogenous Gt(ROSA)26Sor promoter and the synthetic CAG promoter. The 
orientation of the gene cassettes and Cre binding sites (Lox sites) result in EGFP 
expression in all tissues prior to Cre exposure. Subsequent exposure to Cre 
recombinase results in a switch from green to red fluorescence and excitatory DREADD 
expression (see Figure 4-2) (Sciolino et al. 2016). A founder colony for this mouse line 
was bred and maintained as homozygous.  
‘TRAP x DREADD’ mice were generated by crossing TRAP2 mice with RC::L-hM3Dq 
mice. For experiment 4.1, the TRAP2 parents were heterozygous and offspring 
genotyped to identify double-transgenic individuals carrying both the TRAP2 gene and 
the floxed hM3Dq gene. By the time of initiating experiment 4.2, the TRAP2 line had 
been bred to homozygosity and breeding pairs consisting of one homozygous TRAP2 
mouse and one homozygous hM3Dq mouse were established. All offspring from these 
parents were double heterozygous carrying one copy of each transgene.  
All mice were at least 8 weeks of age on entry into experiments. Mice were maintained 
on a 12-hour reversed light/dark cycle. At all times mice had free access to water and 
standard mouse chow (LabDiet, St. Louis, MO 63144, USA), except during periods of 
fasting or calorie restriction. They were housed in groups of up to four. All studies had 





FIGURE 4-1 SCHEMATIC OF THE TORPOR TRAP PROTOCOL 
Mice carrying a Cre-dependent excitatory DREADD gene were crossed with the TRAP2 mouse to 
generate double heterozygotes in which administration of 4-OHT results in expression of 
excitatory DREADD in active neurons. These mice received 4-OHT around the time of a natural 
torpor bout. Administration of CNO tested for successful TRAPing and reactivation of the 
























FIGURE 4-2 SCHEMATIC OF THE FLOXED DREADD GENE CONSTRUCT IN THE RC::L-HM3DQ MOUSE 
Several possible recombination events can occur in the presence of Cre recombinase. For recombination to occur, Cre must bind either both LoxP 
sites or both Lox2272 sites (indicated by yellow stars). Recombination at Lox sites that are facing towards each other results in inversion of the 
orientation of the interleaving DNA. Recombination at Lox sites that are facing in the same orientation results in excision of the interleaving DNA.  
Some configurations are reversible, indicating that repeated binding of Cre can result in further recombination. Other configurations result in 




in accordance with the UK Animals (Scientific Procedures) Act, under Professor 
Anthony Pickering’s project licence number 30/3362. 
4.2.2  Experiment protocols 
Experiment 4.1: TRAPing ‘Cold-Fast’ torpor 
Female TRAP x DREADD mice were entered into the ‘Cold-Fast’ protocol as described 
in Chapter 2. Briefly, this involved housing at a thermoneutral ambient temperature of 
30°C for a minimum of five days prior to a drop in the ambient temperature to 18°C, 24 
hours prior to a fast that commenced at lights off. Mice were monitored remotely via a 
thermal imaging camera placed above the cage (see Chapter 2).  
Because the criteria developed in Chapter 2 for identifying torpor bouts could only be 
applied in retrospect, torpor was identified from the raw, unsmoothed trace on the 
thermal imaging camera software, as a persistent drop in surface temperature 
combined with cessation of locomotor activity.  
Approximately 90 minutes into a torpor bout, 4-OHT (50mg/kg, i.p.) was administered 
in order to ‘TRAP’ active neurons, and allow expression of the DREADD. This time 
period was selected to target the peak of c-Fos protein levels, on the assumption that 
this should coincide with peak Cre-ERT2 protein levels. After a period of a minimum of 
one week to allow DREADD expression, animals housed at 21°C ambient and with free 
access to food were given CNO (www.tocris.com) at doses from 0.5 to 5mg/kg, i.p., to 
test for induction of synthetic torpor. Those that did not show a response to CNO at 




Experiment 4.2: TRAPing ‘Calorie Restriction’ torpor 
Female TRAP x DREADD mice were entered into the ‘Calorie-Restriction’ protocol for 
torpor induction (see Chapter 2). Briefly, mice were housed at an ambient temperature 
of 21°C, and provided a single timed meal at lights off, which delivered approximately 
70% of their unrestricted daily intake, for five days. For the first four days of calorie 
restriction, mice were acclimatised to a daily i.p. injection of chen oil (vehicle) seven  
hours after lights off. This was done to minimise the response to the injection on the 
day of administering 4-OHT and hence to avoid disturbing the occurrence of torpor, 
and to minimise the risk of TRAPing the stress response to injection. On day five, when 
all mice were reliably entering torpor, 4-OHT (50mg/kg, i.p.) was given at seven hours 
after lights off, in anticipation of a subsequent torpor bout. 
After at least two weeks, mice were given CNO 5mg/kg, i.p., while surface temperature 
and activity were recorded. In addition, to test whether there was an alteration in the 
probability or depth of torpor, these mice were entered into a randomised, crossover 
design, calorie restriction trial. During this trial, each mouse was randomly assigned to 
receive either daily CNO (5mg/kg, i.p.) or daily 0.9% saline injections (5ml/kg, i.p.) 
during the five days of calorie restriction. The occurrence and depth of torpor was 
monitored with surface thermography. Following this first arm of the study, and after 
at least five days with free access to food, the process was repeated with mice that 
initially received saline now receiving CNO and vice versa. Torpor depth scores were 
calculated daily for each mouse, as the area of the 24-hour temperature profile that 




In order to test for an effect of CNO on torpor in the absence of DREADDs, wild-type 
mice were entered into the randomised crossover design calorie restriction trial and 
received CNO followed by saline, or vice versa in order to exclude an effect of CNO on 
torpor in the absence of DREADD expression. 
Experiment 4.3: TRAPing the response to DMSO 
Experiment 4.1 used dimethyl sulfoxide (DMSO) as a vehicle for 4-OHT injection. It was 
subsequently realised that DMSO alone can cause hypothermia in mice (Orlando and 
Panuska 1972; Worthley and Schott 1969) and therefore a control experiment was 
performed to exclude the possibility that any hypothermia seen on administration of 
CNO was the result of TRAPing and reactivating a hypothermic response to DMSO. 
Female TRAP x DREADD mice housed at 21°C ambient temperature with free access to 
food were injected with DMSO (www.tocris.com) and immediately afterwards injected 
with 4-OHT (50mg/kg, IP). After at least two weeks to allow DREADD expression, these 
mice were given CNO (5mg/kg, i.p.).  
Torpor definition  
In all experiments, mouse surface temperature was monitored and recorded as 
described in Chapter 1. Surface temperature profiles were plotted and the occurrence 
of natural torpor or DREADD-induced synthetic torpor was confirmed or excluded 
using the threshold derived in Chapter 2, that is, a period of time lasting at least 60 
minutes during which mouse surface temperature remained at least four standard 




4.2.3  Immunohistochemistry 
Mice were culled by terminal anaesthesia with intraperitoneal pentobarbitone 
(175mg/kg, Euthatal). They were trans-cardially perfused with 10ml heparinised 0.9% 
saline (50 units/millilitre) followed by 20ml of 10% neutral buffered formalin. Brains 
were removed and stored in fixative solution for 24 hours at 4°C before being 
transferred to 20% sucrose in 0.1M phosphate buffer (PB), pH 7.4, and again stored at 
4°C.  
The same histological approach was used as in Chapter 3 (section 3.2.3). Coronal 
sections were cut at 40µm thickness on a freezing microtome. Immunohistochemical 
analysis of hM3Dq-mCherry fusion protein expression was performed using a rabbit 
anti-mCherry primary (Biovision 5993, 1:2000), with donkey anti-rabbit secondaries 
(Alexafluor594, 1:1000). Sections were imaged using the same widefield microscope 
described in Chapter 3. Cell counting was again performed using an automated 
approach as described in Chapter 3, with areas of interest defined by comparison with 
the brain atlas (Franklin and Paxinos 2007). 
4.2.4  Drug preparation 
4-Hydroxytamoxifen  
4-OHT was initially prepared by dissolving in neat DMSO at 10mg/ml. This approach 
was taken for the first animals in experiment 4.1 (n = 6). However, it subsequently 
realised that neat DMSO may cause hypothermia in mice (Orlando and Panuska 1972; 
Worthley and Schott 1969) and therefore a revised approach was taken. The first step 
taken was to increase the concentration of 4-OHT in DMSO in order to reduce the dose 




the final animals in experiment 4.1 (n = 5), and all subsequent experiments, 4-OHT was 
prepared by dissolving in chen oil as described in Chapter 3.  
Clozapine-N-Oxide 
CNO was dissolved at 1mg/ml in sterile water at room temperature. Aliquots were 
stored protected from light for up to one week at room temperature.  
SR 59230A 
The selective beta-3 adrenoceptor antagonist, SR 59230A (3-(2-ethylphenoxy)-1-[(1,S)-
1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate, www.tocris.com), was 
dissolved in sterile water at 0.2mg/ml. Solutions were stored at -20°C for up to 4 
weeks.  
Genotyping 
Mouse genotyping was performed as described in Chapter 3.  Primer construction, PCR 
reaction mixture, and PCR conditions were as shown in tables 3-1, 3-2, and 3-3, 
respectively.  
4.2.5  Statistical analyses 
Data are presented as mean ± standard deviation when normally distributed, 
otherwise it is presented as median [interquartile range]. The Kolmogorov-Smirnov 
test for normal distribution was used. Statistical analyses were carried out using 
GraphPad Prism version 6.07 (www.graphpad.com). ANOVA and t-tests were used for 
normally distributed data, otherwise the Mann-Whitney U and Wilcoxon signed rank 
tests were used. A power calculation was performed using G-power (v.3.1.9.4, 




effect of CNO on torpor entry during calorie restriction. A sample size of four mice 
would give 90% power to detect a change in the first appearance of torpor from day 4 
when mice received saline to day 2 when they received CNO, with a standard deviation 
of 0.8 and α =0.05. 
4.3  Results 
Experiment 4.1: TRAPing ‘Cold-Fast’ torpor 
Eleven mice were used in experiment 4.1. Of these, nine entered torpor and received 
4-OHT (see Figure 4-3 for example torpor bouts). The remaining two mice displayed a 
drop in surface body temperature but did not reach the threshold for torpor, and were 
excluded from further analysis. During these experiments, two mice receiving 4-OHT at 
10mg/ml in DMSO had to be culled due to persistent hypothermia and inactivity, a 
feature not seen previously during torpor induction. Hence, seven mice completed the 
experimental protocol and were analysed. Persistent hypothermia and inactivity could 
have been secondary to DMSO toxicity, which on subsequent investigation was noted 
to produce a period of hypothermia in mice with free access to food (see Figure 4-18). 
Hence, a reduced volume of DMSO was used in two subsequent mice before 
transitioning to dissolving the drug in chen oil for the final two animals in experiment 
4.1 and all subsequent experiments.  
Synthetic torpor – defined as torpor induced by excitatory DREADD activation in the 
absence of any natural stimulus for torpor – was observed on administration of CNO at 
doses ranging from 1 to 5mg/kg. The effect was seen in one mouse from experiment 
4.1 (identified as TRAP x DREADD mouse #1), and involved a robust, repeatable, dose-




accompanied by reduction in activity. During synthetic torpor, a hunched position was 
assumed with the tail tucked beneath the mouse, a posture indistinguishable from 
natural torpor. Additionally, the mouse was responsive to external stimuli, as would be 
expected in natural torpor. Synthetic torpor was seen when the mouse was given CNO 
while housed at 21°C ambient temperature with free access to food, a scenario that 
would not naturally elicit torpor (see Figure 4-4A). Vehicle (0.9% saline) injections did 




FIGURE 4-3 EXAMPLE MOUSE SURFACE TEMPERATURE PROFILES DURING TORPOR TRAP IN EXPERIMENT 4.1 
TRAP x DREADD mice were induced to enter torpor using the ‘cold-fast’ protocol. Once torpid, 







FIGURE 4-4 SYNTHETIC TORPOR IN RESPONSE TO INCREASING DOSES OF CNO 
A. Synthetic DREADD-driven torpor in a mouse housed at 21°C ambient temperature with free access to food, therefore with no natural stimulus for torpor entry. 
The mouse received, from left to right: vehicle (saline); 0.5mg/kg CNO (no synthetic torpor), 1mg/kg CNO (synthetic torpor), and 5mg/kg CNO (synthetic torpor). 
Synchronous with the drop in core body temperature, mouse activity is suppressed or halted during synthetic torpor. B, a different mouse undergoing the same 












FIGURE 4-5 SYNTHETIC TORPOR DEPTH INCREASES WITH TIME FROM THE DAY OF TRAPING 
The mouse that demonstrated synthetic torpor was administered 5mg/kg i.p. CNO at several time points following the TRAP day. Ambient temperature was 21°C 
and food was freely available, hence no natural stimulus for torpor entry.  Torpor duration increases, nadir surface temperature reached reduced and aggregate 
torpor depth score increases with time. 








































































































Synthetic torpor depth increased with the dose of CNO, reflected by deeper and longer 
torpor bouts. Following 5mg/kg i.p. of CNO, the synthetic torpor bout persisted for up 
to 11 hours, and reached a nadir surface temperature of 23.0°C. By comparison, the 
median torpor bout duration seen during calorie restriction-induced natural torpor, 
which occurred at the same ambient temperature, was 4.05 hours [2.29 – 6.15], while 
the mean nadir surface temperature seen during calorie restriction-induced natural 
torpor was 25.3 ±1.3°C. Hence, synthetic torpor has the capacity to be both deeper 
and longer than natural torpor.  
The effect was detectable within eight days following the TRAPing event and persisted 
until the mouse was culled at eight months of age. The response to a given dose of 
CNO increased with time from the day of TRAPing, both in terms of the depth and the 
duration of synthetic torpor (see Figure 4-5).  
While synthetic torpor was striking and repeatable in TRAP x DREADD mouse #1, the 
remaining six mice from experiment 4.1 did not show synthetic torpor (see Figure 
4-4B). These six mice are useful controls, since they indicate that the effect is not, for 
example, a side-effect of CNO administration, nor is it a non-specific consequence of 
the torpor TRAP protocol. Mean nadir surface temperature in these mice in the 
absence of CNO was 30.8 ±1.3°C, compared to 30.7 ±0.4°C in the six hours following 
CNO at 5mg/kg i.p. (paired t(5) = 0.20, p = 0.85). 
There were some differences between the natural torpor bout on the day of TRAPing 




show synthetic torpor in response to CNO. The successfully TRAPed bout was longer, 
lasting 3.8 hours, compared to a median of 2.2 hours [1.3 – 3.1] in the mice that did 
not generate synthetic torpor. Likewise, the aggregate torpor depth score was higher, 
at 27528s.°C compared to 12479 (4655 – 18793)s.°C in those mice that did not 
generate synthetic torpor. The time between torpor entry and delivery of 4-OHT was 
1.3 hours, compared to 1.3 hours [0.4 – 1.8] in those mice that did not generate 
synthetic torpor. Hence, successful TRAPing of the torpor circuit was associated with a 
longer and deeper torpor bout at the time of the 4-OHT injection. In contrast, the 
timing of the 4-OHT relative to torpor entry does not appear to have been different 
between animals that did, and those that did not generate synthetic torpor. 
Between doses of CNO, TRAP x DREADD mouse #1 displayed normal surface 
temperature (31.0 ±0.6°C, compared to 31.5 ±0.7°C from baseline data presented in 
Chapter 2), with normal pattern of diurnal variation (see Figure 4-6). Following 
synthetic torpor, the mouse recovered fully each time, gaining weight in line with 
expected values based on data from the Jackson laboratory data sheet for C57BL/6J 
female mice (www.jax.org, see Figure 4-7). 
To test whether blockade of beta-3 receptors interfered with DREADD-induced 
synthetic torpor, TRAP x DREADD mouse #1 was given the beta-3 receptor antagonist 
SR 59230A  at 1mg/kg i.p., one hour prior to administration of CNO 1mg/kg i.p. Pre- 
treating this mouse with the selective beta-3 receptor antagonist prevented synthetic 

















FIGURE 4-6 SURFACE TEMPERATURE PROFILE IN ABSENCE OF CNO IS NORMAL IN TRAP DREADD MOUSE #1 
Surface temperature of the mouse that demonstrates synthetic torpor in response to CNO was 
recorded for three days at 21°C with food freely available. A normal mean surface temperature 
with normal diurnal rhythm is observed, and compared here to baseline surface temperatures 
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FIGURE 4-7 NORMAL WEIGHT GAIN IN MOUSE EXPRESSING SYNTHETIC TORPOR 
The expression of synthetic torpor did not affect the mouse’ weight gain (red circles). At six 
months, weight was 26.3g. Black line indicates expected weight gain based on data for female 
C57BL/6J (the background strain), grey lines indicate standard deviation of expected weight 



























FIGURE 4-8 ADMINISTRATION OF BETA-3 RECEPTOR ANTAGONIST PRIOR TO CNO PREVENTS SYNTHETIC TORPOR 
In the mouse that displayed reliable synthetic torpor in response to CNO, pre-treatment with 
the selective beta-3 receptor antagonist, SR 59230A (1mg/kg IP) prevented synthetic torpor in 





Immunohistochemical analysis of the distribution of hM3Dq-mCherry expression in 
five mice from experiment 4.1 revealed TRAPed cells with DREADD expression in a 
number of hypothalamic areas (see Figure 4-9 and Figure 4-10). These regions also 
expressed c-Fos in the experiments described in Chapter 3. One of the five mice did 
not display any detectable hM3Dq-mCherry labelling.  
Overall TRAPed cell counts in this experiment were relatively high in the posterior 
hypothalamus, the preoptic area, and the dorsomedial hypothalamus, which is 
qualitatively in keeping with the findings in Chapter 3. While acknowledging that the 
methods used to induce torpor were different, and that the timing of 4-OHT relative to 
the torpor bout was also different, a comparison was made between the total number 
of TRAPed cells in experiment 3.2 and this experiment. Median TRAPed cell count in 
the PH, DMH, POA, and Arc combined (these were the common areas counted in both 
experiments), in the TRAP x Tomato mice from experiment 3.2 was 274 cells [77.5 – 
423.3] compared to 30.5 cells [13.3 – 71.0] in the TRAP x DREADD mice used in this 
experiment (Mann-Whitney U = 34.5), p < 0.0001) (see Figure 4-11). This indicates the 
recombination events in TRAP x DREADD mice exposed to 4-OHT were less frequent 
than in TRAP x Tomato mice.  
Within experiment 4.1, comparison of the labelling seen in TRAP x DREADD mouse #1 
with that seen in mice that did not display synthetic torpor demonstrates some 
informative differences. TRAP x DREADD mouse #1 displayed significantly increased 





FIGURE 4-9 DREADD EXPRESSION IN MOUSE DEMONSTRATING SYNTHETIC TORPOR 
Expression of hM3Dq-mCherry DREADD labelled with anti-mCherry immunohistochemistry 
(red). 40µm coronal sections. A, DMH and Arc expression. B, preoptic area expression. C, high 
magnification image from the MPO, grey box on middle left panel shows corresponding area. 
Right side schematics show corresponding position in the antero-posterior plane. Abbreviations: 
DMH, dorsomedial hypothalamic nucleus; Arc, arcuate nucleus; aca, anterior commissure 
(anterior part); MPO(m), medial preoptic nucleus medial part; MPO(l), medial preoptic nucleus 



































FIGURE 4-10 DREADD-EXPRESSING CELL COUNTS BY REGION OF INTEREST 
A, expression of hM3Dq DREADD by region of interest comparing mouse in which synthetic 
torpor was seen (red) and three mice in which it was not (blue). Black lines indicated median 
TRAPed cell count across all mice. B, same data as shown in A but normalised by total TRAPed 
cell count per animal. Abbreviations: PVT, paraventricular thalamus; PH, posterior 
hypothalamus; DMH, dorsomedial hypothalamic nucleus; Arc, arcuate nucleus; PVH, 
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FIGURE 4-11 TRAPED CELL COUNTS IN EXPERIMENT 3.2 VERSUS 4.1 
Significantly greater number of TRAPed cells overall were seen in experiment 3.2 using TRAP x 
Tomato mice compared to experiment 4.1 using TRAP x DREADD mice (Mann-Whitney U = 34.5, 
p <0.0001). Data shown is median and interquartile range. Abbreviations: PH, posterior 
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examined compared to a median total of 95 cells [8 – 191] in those that did not 
demonstrate synthetic torpor. In TRAP x DREADD mouse #1, the regions with the 
highest number of TRAPed, DREADD-expressing cells were the preoptic area, the 
paraventricular hypothalamus, and the paraventricular thalamus. In mice that did not 
generate synthetic torpor, peak TRAPed cell counts were in the posterior 
hypothalamus and the preoptic area.  
Normalising the count by the total number of TRAPed cells for each animal, gives a 
sense of the relative distribution of TRAPed cells. From this analysis, the distribution of 
TRAPed cells is generally similar in most regions between the mouse that displayed 
synthetic torpor and those that did not. However, the paraventricular hypothalamus 
constituted 17.8% of TRAPed cells in TRAP x DREADD mouse #1, compared to 9.4% [9.4 
– 9.5] in those that did not display synthetic torpor. The posterior hypothalamus 
constituted only 8.2% of TRAPed cells in TRAP x DREADD mouse #1, compared to 
28.7% [27.7 – 37.5] in those mice that did not display synthetic torpor.  
Experiment 4.2: TRAPing ‘Calorie Restriction’ torpor 
This experiment was designed to reduce the probability of disturbing the natural 
torpor bout on injection of 4-OHT and/or TRAPing arousal circuits that respond to the 
injection. It aimed to achieve this by firstly habituating the mice to daily vehicle 
injections, and secondly establishing a pattern of daily torpor bouts, the timing of 
which could be predicted so that the 4-OHT could be administered just before the 
expected torpor bout.  
Twelve TRAP x DREADD mice were used in this experiment. Four entered torpor within 






FIGURE 4-12 TORPOR TRAP USING THE CALORIE RESTRICTION PROTOCOL IN EXPERIMENT 4.2 
TRAP x DREADD mice (n = 4) were calorie restricted for 5 days. On the fifth day (pictured here), 





time between 4-OHT and first torpor entry on the day of TRAPing in these four mice 
was -0.15 hours [-0.55 – 1.41] hours, with two mice entering torpor prior to 4-OHT 
administration, and then re-entering subsequently (animals 2 and 3 in Figure 4-12). 
The remaining eight mice either did not enter torpor on day five following 4-OHT, or 
entered a delayed torpor bout. These mice were excluded from further analysis. 
Hence, four mice were investigated for a response to CNO.  
None of these mice subsequently demonstrated synthetic torpor when given CNO at 
5mg/kg IP in an ambient temperature of 21°C with free access to food. Given that 
chemogenetic activation of the TRAPed neurons was insufficient to induce synthetic 
torpor, I next tested the hypothesis that chemogenetic activation of these neurons 
might promote torpor under the calorie restriction torpor induction protocol, using a 
crossover design in which each mouse underwent two periods of five days consecutive 
calorie restriction receiving CNO or saline (see Figures 4-13, 4-14, and  4-15).  
The total number of torpor bouts was equivalent in calorie restriction trials in which 
mice received CNO compared to when they received saline (see Figure 4-14). Total 
number of bouts: CNO trials 3.5 [1.5-4.8] versus 3.5 [0.8-4.8] in saline trials (Wilcoxon 
matched-pairs signed rank test, n = 4, p >0.99). Likewise, torpor emerged after 
equivalent duration of calorie restriction (see Figure 4-14). First torpor bouts emerged 
on day 2.5 [1.3-5.3] in CNO trial arms versus day 3 [2-4.8] in saline arms (Wilcoxon 
matched-pairs signed rank test, n = 4, p >0.99). Animals that failed to enter torpor 
across the complete five days of a trial were given a value of 6 for analysis. 
Administration of CNO 5mg/kg i.p. during calorie restriction did have subtle promoting 




trials than in saline trials (see Figure 4-15). Two-way repeated measures ANOVA 
evaluating duration of torpor across days of calorie restriction in CNO compared to 
saline trials found no main effect for CNO versus saline (F(1,3) = 1.65, p = 0.29. There 
was a main effect for day of torpor, with time spent in torpor increasing with 
subsequent days of calorie restriction (F(4,12) = 8.35, p < 0.005). There was a 
treatment by day of calorie restriction interaction (F(4,12) = 3.35, p < 0.05), with the 
effects of CNO treatment being greater in later days of calorie restriction. Fisher’s least 
significant differences test confirmed that on days four and five mice spent more time 
in torpor when treated with CNO than when treated with saline (day four 4.70 ±3.60 
versus 2.54 ±2.55 hours, p < 0.05; day five 7.49 ±3.74 versus 4.08 ±3.03 hours, p < 0.01, 
respectively).  
In addition to more time spent in torpor, mice reached lower nadir surface 
temperatures when receiving CNO than they did when receiving saline, although this 
was only significant on day five of calorie restriction (see Figure 4-15). Two-way 
repeated measures ANOVA evaluating nadir surface temperature across days of calorie 
restriction in CNO compared to saline trials again found no main effect for CNO versus 
saline (F(1,3) = 0.43, p = 0.56). There was a main effect for day of calorie restriction on 
nadir surface temperature reached with nadir temperature reducing with progressive 
days of calorie restriction (F(4,12) = 15.49, p = 0.0001). There was no significant 
interaction. Fisher’s least significant differences test confirmed that on day five nadir 






FIGURE 4-13 EXAMPLE CNO VS SALINE CROSSOVER TRIAL TESTING FOR MODULATION OF THE PROBABILITY OF 
TORPOR IN EXPERIMENT 4.2 
Example from a single mouse, which had previously received 4-OHT during calorie restriction in 
order to TRAP torpor-active neurons. Top panel shows a trial of five consecutive days’ calorie 
restriction with CNO administered daily. Bottom panel shows another trial of five consecutive 






FIGURE 4-14 TOTAL NUMBER OF DAYS IN WHICH TORPOR OCCURRED AND DAY OF FIRST TORPOR BOUT IN CNO VS SALINE TREATED, CALORIE RESTRICTED MICE IN EXPERIMENT 4.2 
CNO had no effect on the total number of torpor bouts, on the mouse weight at which torpor first appeared, nor on the day at which torpor first appeared during 
five days of calorie restriction in TRAP-DREADD mice (n = 4, female mice) that had previously received 4-OHT prior to torpor induced by calorie restriction (Wilcoxon 








FIGURE 4-15 TIME SPENT IN TORPOR, NADIR SURFACE TEMPERATURE, AND TORPOR DEPTH SCORES IN CNO VS 
SALINE TRIALS 
CNO increased the total time spent in torpor, decreased the nadir surface temperature, and 
increased the aggregate torpor depth score on days four and/or five of calorie restriction (* and 
** indicate Fisher’s least significant difference test p < 0.05 and < 0.01, respectively, n = 4 





compared to when they receive saline (nadir surface temperature 24.7 ±1.0 versus 
26.2 ±2.0°C, p < 0.05).  
In keeping with increased time spent in torpor and decreasing nadir surface 
temperature, the aggregate torpor depth score, calculated as the area below the 
torpor threshold line, was higher when mice received CNO compared to when they 
received saline on day five (see Figure 4-15). Two-way repeated measures ANOVA 
once more found no main effect for treatment with CNO compared to saline. There 
was a main effect of day of calorie restriction on torpor depth score, which increased 
with increasing days of calorie restriction (F(4,12) = 8.34, p < 0.005). Fisher’s least 
significant difference test confirmed that by day five of calorie restriction, torpor depth 
scores were higher in mice receiving CNO compared to when they received saline 
(59814 ±34852 versus 33214 ±34798s.°C, p < 0.05).  
There was no significant difference between the weights of each mouse on entry into 
calorie restriction trials with CNO administration compared to saline administration 
(23.8g [22.7 - 25.2] versus 23.5g [23.3 – 25.7] respectively, Wilcoxon matched-pairs 
signed rank test, p 0.63). This is an important observation because it indicates that any 
difference in the torpor behaviour on CNO compared to saline trials is not due to 
differences in weight. There was also no significant difference in the mean weight at 
which torpor first appeared in CNO compared to saline trials (20.7g [20.3 – 23.6] 







FIGURE 4-16 EFFECT OF CNO VS SALINE ON THE PROBABILITY OF TORPOR IN CALORIE RESTRICTED WILD TYPE CONTROL MICE 

















































FIGURE 4-17 TIME SPENT IN TORPOR, NADIR SURFACE TEMPERATURE, AND TORPOR DEPTH SCORES IN CNO VS 
SALINE TRIALS IN WILD-TYPE CONTROL MICE 
CNO did not affect the total time spent in torpor, the nadir surface temperature, or the 
aggregate torpor depth score on any day of calorie restriction (Fisher’s least significant 
difference test p > 0.05 on CNO vs saline comparisons for each day of calorie restriction, n = 4 






Wild-type control mice (n = 4) did not show any modulation of torpor probability, 
duration, or depth when receiving CNO at 5mg/kg i.p. compared to when they 
received saline during five days of calorie restriction (see Figure 4-16). Median number 
of torpor bouts observed during CNO trials was 3.0 [0.5 – 4.8] versus 2.0 [0.0 – 4.0] 
during saline trials (Wilcoxon matched-pairs signed rank test, p = 0.75). Torpor first 
appeared after 3.0 days [1.3 – 5.5] of calorie restriction during CNO trials, compared to 
4.0 days [2.0 – 6.0] during saline trials (Wilcoxon matched-pairs signed rank test, p = 
0.75). Two-way repeated measures ANOVA found no main effect for CNO versus saline 
treatment in either duration of time spent in torpor, nadir surface temperature, or 
aggregate torpor depth score Figure 4-17). Fisher’s least significant differences 
multiple comparisons test found no significant differences across those same 
measurements between CNO and saline trials on any individual days. Hence, CNO (in 
the absence of DREADD expressed in neurons that are active during torpor) has no 
effect on torpor in calorie-restricted mice.  
Experiment 4.3: TRAPing the response to DMSO 
Administration of DMSO in the absence of any natural stimuli for torpor induced 
hypothermia (see Figure 4-18). Co-administration of 4-OHT at the time of DMSO 
injection did not result in a TRAPed hypothermic response, as demonstrated by the 
lack of subsequent response to CNO. This supports the hypothesis that the synthetic 








FIGURE 4-18 DMSO INDUCED HYPOTHERMIA IS NOT TRAPED 
Mice administered DMSO display hypothermia (n = 2, left panels), TRAPing this response by 4-
OHT 50mg/kg administration in TRAP x DREADD mice (left column), did not recapitulate the 
hypothermia as demonstrated by the lack of response to CNO 5mg/kg (right column) two weeks 




4.4  Discussion 
The data from experiment 4.1 demonstrates that DREADD-driven reactivation of cells 
that were active during torpor can drive synthetic torpor with suppressed body 
temperature and activity even in a mouse that is fully fed and has ongoing unlimited 
access to food. This was termed “synthetic torpor” to highlight its occurrence in the 
absence of any natural stimulus for torpor. It was repeatable, reliable, and dose 
dependent.  
The duration and depth of the synthetic torpor bout was proportional to the dose of 
CNO used to reactivate the circuit, which probably reflects the pharmacodynamics of 
CNO. An interesting future experiment, and one that would further support the 
hypothesis that synthetic torpor is indeed equivalent to natural torpor, would be to 
administer CNO to animals housed at varying ambient temperatures. If the synthetic 
torpor exhibited a defended minimum body temperature despite reducing ambient 
temperatures, that would support the assertion that the hypothermia was 
physiologically equivalent to torpor (see Chapter 1). On the other hand, if there was no 
evidence of a minimum, defended temperature that might indicate the phenomenon 
relates more to a global shutting down of thermoregulation. It would also be useful to 
compare additional physiological parameters such as heart rate, and oxygen 
consumption during synthetic and natural torpor.   
These findings support the hypothesis that torpor is induced by a central mechanism. 
However, there is a caveat. It should be acknowledged that the TRAP x DREADD mouse 
contains a copy of both transgenes in every cell of the body. Some peripheral tissues 




some also use Gq-protein-coupled receptors and the phospholipase C/protein kinase 
C/calcium signalling system to control their function (Gautam et al. 2006). It is 
theoretically possible that peripheral tissue could both express the DREADD, and 
respond to its activation by CNO to generate the synthetic torpor seen here. However, 
the immunohistochemistry identified an order of magnitude higher number of TRAPed 
cells in the hypothalamus of the animal that generated synthetic torpor compared to 
those that did not. This adds support to the hypothesis that torpor is indeed induced 
by a central neural circuit. In order to definitively answer this question, one would 
either need to inject CNO locally, or restrict the expression of the DREADD to the 
specific central nervous system loci – an approach that is taken in Chapter 5. 
Since a single mouse demonstrated synthetic torpor in these experiments, statistical 
analysis of the distribution of TRAPed neurons is not possible. However, two 
observations emerge from review of this data. Firstly, there was considerable 
variability in the effectiveness of the 4-OHT in triggering recombination and DREADD 
expression in experiment 1, with the highest expression being seen in the mouse that 
exhibited synthetic torpor. Secondly, in the mouse that exhibited synthetic torpor, 
expression was high in DMH and preoptic regions, in keeping with the data from 
Chapter 3. In addition, the PVT, and PVH showed high levels of DREADD expression. 
The PVH is implicated in the stress response and regulation of energy balance (Qin, Li, 
and Tang 2018) and has been implicated in torpor (Hitrec et al. 2019), while the PVT is 
implicated in sleep-wake cycling (Ren et al. 2018). 
The observation that synthetic torpor was prevented by pre-treatment with a beta-3 




natural torpor has been observed to depend on suppression of leptin release via 
activation of beta-3 receptors on white adipose tissue (Swoap et al. 2006). If the 
observation that beta-3 receptor antagonists block synthetic torpor proves 
reproducible, it has some interesting implications for the process of torpor induction. It 
would imply that the central circuit for torpor induction acts on white adipose tissue 
beta-3 receptors to suppress leptin, and that suppressed leptin is then either detected 
peripherally to induce torpor, or else the suppressed leptin acts to inhibit but not 
activate downstream central neurons in order to generate torpor.  
The latter assertion is based on the fact that if suppressed leptin was detected 
centrally and resulted in excitation of neurons, then one would expect those activated 
neurons to have been TRAPed. If the neurons that responded to the suppression of 
leptin were TRAPed, then the need to suppress leptin during synthetic torpor would be 
bypassed with CNO, hence beta-3 receptor antagonists should not block synthetic 
torpor.  
These are interesting hypotheses, which warrant further investigation. However, being 
based on a single observation in a single mouse, a more mundane explanation might 
be responsible. For example, the CNO injection in this experiment might have failed 
either due to delivery into the bowel or bladder (unlikely, but possible), or else the 
CNO solution used in the experiment might have degraded, precipitated, or a simple 
drug delivery error made. 
Experiment 4.2 was designed to reduce the risk that the process of injecting 4-OHT on 
the day of TRAPing would disturb the natural torpor bout and potentially TRAP 




itself. This approach failed to generate any mice that displayed synthetic torpor. 
However, by employing a randomised crossover design trial in calorie restricted mice, 
it was possible to assess any subtle effects on either the propensity to enter torpor, or 
the depth or duration of torpor when it does occur. A torpor-promoting effect was 
found towards the fourth and fifth days of calorie restriction when CNO was given. 
Hence, the effect of activating the DREADD receptors in the neurons that were TRAPed 
prior to a natural torpor bout is only evident when those neurons are simultaneously 
driven by a natural stimulus for torpor.  
These torpor-promoting effects, which depend on coincident calorie restriction, may 
reflect DREADD expression in a different population of neurons compared to those 
TRAPed in the mouse that demonstrated synthetic torpor. Alternatively, the same 
population might have been TRAPed but with less DREADD expressed, or a smaller 
proportion of the same population TRAPed compared to the mouse from experiment 
4.2. Finally, an additional population of neurons may have also been TRAPed, which 
antagonise torpor entry and are only suppressed or overcome when the mouse is 
additionally calorie restricted.  
It is important to understand why one TRAP x DREADD mouse showed dramatic 
synthetic torpor while others either failed to do so, or required additional calorie 
restriction to see any effect of DREADD activation. There are several stages at which 
the experiment could fail.  
Given the evidence from the immunohistochemistry in experiment 4.1, the process of 
4-OHT triggered recombination appears to be variable in the TRAP x DREADD mouse. 




observed in the TRAP x Tomato mouse line. Furthermore, with the caveats that the 
experimental protocols were different, the TRAP x Tomato mice appeared to TRAP 
more cells during torpor than did the TRAP x DREADD mice. This suggests a problem 
might lie with the Floxed DREADD transgene component, rather than the TRAP2 
component of the TRAP x DREADD mouse. The RC::L-hM3Dq mouse used here has a 
somewhat complicated transgene structure. Several configurations resulting from 
recombination do not result in expression of the DREADD, while others do result in 
DREADD expression but if Cre binds to Lox sites again, the gene structure can revert 
back to a non-expressing configuration (see Figure 4-2).  
Hence, prolonged exposure to the Cre recombinase may be necessary in order to allow 
the transgene recombination to finally settle upon one of two configuration that are 
both irreversible and result in DREADD expression. It is possible that using the 
inducible 4-OHT dependent Cre here does not allow sufficient time for this to happen, 
because the Cre translocates into the nucleus for only a period of a few hours when 4-
OHT is present. In hindsight, this may have been a key issue. An additional 
consideration is that each neuron only contained a single copy of the TRAP2 gene and 
the floxed DREADD gene. It is possible that this “gene dose” was not able to generate 
sufficient Cre recombinase and/or DREADD to reliably generate a behavioural 
response.  
It is also possible that the decreasing temperature of the mouse during torpor affects 
the kinetics of the biochemical process of Cre-driven recombination. Generally, one 
would expect lower body temperatures to dramatically slow down biochemical 




such an extent that the process was effectively blocked, then the experiment would 
fail. On the other hand, Le Chatelier’s principle (Brunning 2017) states that if a dynamic 
equilibrium is perturbed by an alteration in the conditions, the net movement of the 
equilibrium will shift in a direction that counteracts that perturbation. Assuming the 
reaction between the Cre-recombinase / modified oestrogen receptor complex and 
Hsp90 represents a dynamic equilibrium (albeit gated by the presence of 4-OHT), then 
if the dissociation of Hsp90 were an endothermic process, a reduction in the 
temperature of the mouse will favour the continued association and therefore will 
prevent Cre entering the nucleus and exerting recombination. Either of these 
situations could impair the process of TRAPing neurons during torpor.   
In addition to failing to express DREADD in the desired circuit as described above, it is 
possible that DREADD could be expressed in off-target neurons, which then interfere 
with expression of the behaviour of interest. Experiment 4.1 involved administering 4-
OHT while the mice were torpid, which frequently resulted in a brief arousal. This 
would, in principle at least, result in TRAPing the arousal circuit – subsequent 
administration of CNO might generate an amalgamation of signals for both torpor 
induction and arousal, resulting in failure to induce synthetic torpor.  
The timing of administration of 4-OHT relative to the natural torpor bout on the day of 
TRAPing is also a potential source of experiment failure. Administering the 4-OHT too 
soon will result in missing the activity of the torpor inducing neurons, too late and one 
might TRAP neurons responsible for arousal from torpor. Experiment 4.1 delivered 4-
OHT 90 minutes into a torpor bout, and successfully resulted in synthetic torpor in one 




a pending bout. Two mice from this cohort entered prior to the 4-OHT injection, and 
returned to torpor subsequently (see second and third profiles in Figure 4-12). These 
two mice that entered torpor either side of the 4-OHT injection still did not exhibit 
synthetic torpor comparable to that seen in experiment 4.1. This suggests that the 
timing of 4-OHT was not the reason for failure to generate synthetic torpor in mice 
from experiment 4.1 and 4.2.  
Conclusions 
Despite the caveats and the challenges described here, this set of experiments 
successfully used the TRAP2 mouse to target cells that are active during torpor. By 
reactivating those cells in the absence of any natural stimulus for torpor, synthetic 
torpor has been generated. At the time of completing this experiment, this was the 
first demonstration of synthetic torpor, driven by DREADD activation in a circuit that 
was selected based on its role in natural torpor. While the observation was only seen 
in a single mouse, it was reliably induced in this mouse every time it was given CNO. 
Related to this, a second cohort of mice (experiment 4.2) demonstrated that it is 
possible to shift the propensity of torpor by DREADD activation of neurons involved in 
inducing natural torpor. Chapter 5 develops this work by targeting specific 
hypothalamic nuclei, ruling out the possibility that peripheral tissues are responsible 
for synthetic torpor, and adding to the evidence that the POA and DMH play significant 


























Chapter 5 The role of the dorsomedial hypothalamus 
in torpor 
5.1  Introduction 
Chapter 4 established the principle that the TRAP2 mouse could be used to target 
DREADD expression in neurons that were active during torpor. Reactivation of those 
neurons in the absence of any natural stimulus for torpor was sufficient to generate a 
synthetic torpor state. However, several questions follow on from these experiments. 
Firstly, was synthetic torpor really induced by reactivation of TRAPed central nervous 
system cells, or is there a population of peripheral cells that express c-Fos and were 
TRAPed during the protocol, which were in fact responsible for the synthetic torpor? 
Secondly, and related, if indeed the effect was driven by central neural reactivation, is 
it possible to identify a single region capable of driving entry into torpor - a torpor 
master switch? Thirdly, if a population of neurons within a local region are sufficient to 
induce torpor and synthetic torpor, what is the phenotype of these cells?  
Data presented in Chapter 3 indicates that alongside the preoptic area, the 
dorsomedial hypothalamus (DMH) is preferentially activated in calorie restricted mice 
that entered torpor compared to calorie restricted mice that did not enter torpor. This 
agrees with the published literature, where a rise in c-Fos labelling was observed in the 
DMH of torpid mice (Hitrec et al. 2019). As well as being a key hub in thermoregulation 
(DiMicco and Zaretsky, 2007), the DMH also plays a role in adjusting circadian rhythms 
of body temperature, wakefulness, and activity to coincide with the availability of food 
(Gooley, Schomer, and Saper 2006). This is important, because torpor itself clearly 
represents a profound adjustment of body temperature, wakefulness, and activity 




role in suppressing energy expenditure in response to reduced food availability outside 
of the context of torpor (Bi, Robinson, and Moran 2003). 
However, with regards to thermoregulation, DMH neurons are more commonly 
associated with driving thermogenesis, rather than hypothermia (Tan and Knight 2018; 
Zhao et al. 2017). And so, a causal role for the DMH in inducing torpor has not been 
established. Hence, the increased activity associated with torpor in Chapter 3, and 
reported elsewhere (Hitrec et al. 2019), might simply reflect counter-regulatory 
processes that respond to the hypothermia associated with torpor.  
The aim of this chapter was to target DREADD expression specifically to neurons in the 
DMH that are active during torpor. By directing expression of excitatory DREADDs to 
DMH neurons that are active during torpor, a promoting or even sufficient role for 
these neurons in torpor can be tested. Likewise, the use of inhibitory DREADDs, which 
hyperpolarise transduced neurons and reduce presynaptic release (K. S. Smith et al. 
2016), allows testing of the necessity of those neurons in torpor induction. In order to 
achieve targeted DREADD expression, Cre-dependent viral vectors were used in the 
TRAP2 mouse. These Cre-dependent vectors operate on the same principle as the 
transgenic approach described in Chapter 4, only in this case DREADD expression is 
limited not only by the requirement for Cre exposure to drive recombination, but also 
by the fact that the transgene is only delivered locally within a region defined by the 
microinjection. Further control is gained by the use of vectors that employs a synapsin 
promoter, which, following recombination, limits DREADD expression to neurons. By 
first injecting the Cre-dependent vector into the DMH of TRAP2 mice, and then giving 




expression of the DREADD to a select population of neurons defined by their location 
within the vector injection site, and their activation during torpor.  
Having used this approach to explore the role of the DMH in torpor, the expression 
phenotype of DMH torpor-TRAPed cells was investigated using Multiplex RNA in-situ 
hybridisation (RNAscope Hiplex assay, www.acdbio.com (F. Wang et al. 2012)). This 
technique allows histological detection of several different RNA transcript targets at a 
single cellular level, and can be used to quantify those transcripts at the single 
molecule level (Erben and Buonanno 2019). Hence, it provides a means to phenotype 
cells within histological sections, and to compare expression of multiple RNA targets. 
RNAscope relies upon the complementary hybridisation of several pairs of RNA 
oligonucleotide probes to each target RNA molecule. These probes are then bound by 
distinct signal amplifying reagents, followed by fluorophore labelling and imaging. 
Fluorophores can then be cleaved, and further rounds in which fluorophores label 
different amplifying tags allows sequential imaging of multiple RNA targets. In this 
assay up to twelve targets can be imaged on the same tissue section using only four 
fluorescence channels.  
Identifying the phenotype of neurons involved in torpor induction is not just 
academically interesting. If synthetic torpor is to be useful in a clinical or even long-
distance space flight scenario, then the use of viral vectors to target those neurons is 
likely to be complicated at best. A more practical approach would be to activate those 
neurons in a pharmacologically selective manner, and in order to do this, it is 





5.2  Methods 
5.2.1  Mice 
Female TRAP2 mice were used in this experiment. As described in previous chapters, 
briefly, a homozygous colony was generated from two female heterozygous TRAP2 
mice received by donation from the Liqun Luo laboratory at the University of Stanford. 
The mice are now available from Jackson laboratories (www.jax.org).  
All mice were at least 8 weeks of age on entry into experiments. Mice were maintained 
on a 12-hour reversed light/dark cycle. At all times mice had free access to water, and 
except during calorie restriction, mice had free access to standard mouse chow 
(LabDiet, St. Louis, MO 63144, USA). They were housed in groups of up to four. All 
studies had the approval of the local University of Bristol Ethical Committee and were 
carried out in accordance with the UK Animals (Scientific Procedures) Act, under 
Professor Anthony Pickering’s project licence number 30/3362. 
5.2.2  Viral vectors 
Three viral vectors were used in this experiment: 
• pAAV2-hSyn-DIO-hM3Dq-mCherry was a gift from Bryan Roth (Addgene viral 
prep #44361-AAV2; www.addgene:44361) (Krashes et al. 2011); 4.6x1012 viral 
genome copies per ml. This vector delivered a Cre-dependent mCherry-tagged 
excitatory DREADD gene under the human synapsin promoter. It was mixed in 
a 4:1 ratio with the eGFP-expressing vector described below, giving a final titre 
for this vector of 3.7x1012 viral genomes per ml. 
• pAAV2-hSyn-DIO-hM4Di-mCherry was a gift from Bryan Roth (Addgene viral 




genome copies per ml. This vector delivered a Cre-dependent mCherry-tagged 
inhibitory DREADD gene under the human synapsin promoter. It was mixed in 
a 1:2 ratio with the EGFP-expressing vector described below, and the resulting 
vector mixture further diluted in a 1:9 ratio with sterile phosphate buffered 
saline (PBS, www.sigma.com), giving a final titre of 6.7x1011 viral genomes per 
ml. 
• pAAV2-CMV-PI-EGFP-WPRE-bGH was a gift from James M. Wilson (Addgene 
viral prep #105530-AAV2; www.addgene:105530); 7x1012 viral genome copies 
per ml. This vector delivered the gene coding for enhanced green fluorescent 
protein (EGFP) under a ubiquitous CMV promoter. This vector was used to 
confirm the localisation of injection, because the expression of mCherry 
fluorescence in the two vectors above is contingent on successful TRAPing (and 
so would not be visible if the injected area is not TRAPed). 
5.2.3  Vector injections 
Mice were anaesthetised with ketamine (70mg/kg i.p.) and medetomidine (0.5mg/kg 
i.p.). Depth of anaesthesia was assessed and monitored by loss of hind paw withdrawal 
reflex and failure to respond to corneal brush. Additional i.p. injections of anaesthetic 
were administered as needed to maintain surgical depth of anaesthesia. Core 
temperature was maintained using a servo-controlled heat pad and a rectal 
temperature probe (Harvard Apparatus). The planned incision site was shaved, and 
skin cleaned with iodine solution. Sterile drapes were applied, and sterile gloves, 
gowns and a mask were worn to ensure sterility was maintained throughout. 




atraumatic ear bars and skull position maintained horizontal by an incisor bar (David 
Kopf Instruments, USA).  
Microcapillary pipettes were made by heating and pulling microcapillary glass (Sigma, 
USA) on a pipette puller (Harvard Apparatus, UK). Pipettes were filled with mineral oil 
and vector was back-filled using a robotic microinjector (Nano-W wireless capillary 
microinjector, Neurostar, Germany), resulting in a vector-mineral oil interface. A 
midline incision gained access to the skull, and burr holes made bilaterally at bregma -
1.8mm, lateral ±1mm with a robotic drill attachment (Neurostar, Germany). The 
microcapillary pipette was inserted at an angle of 8° towards the midline ±1mm lateral 
on the brain surface. Bilateral injections were made at of 5 and 4.75mm depth relative 
to the surface of the brain, each injection was 180nl and was delivered at a rate of 
100nl/minute. The injection pipette remained in place for one minute following the 
first injection and for five minutes before removing.  
Following vector injections, the wound was closed with non-absorbable suture and 
dressed with antibacterial wound powder. Anaesthesia was reversed with IP 
atipamezole (1mg/kg, Antisedan, Zoetis), and SC buprenorphine (0.1mg/kg, Vetergesic, 
Ceva Animal Health) was administered for analgesia. Mice were recovered on a heat 
pad, then housed individually for three days following surgery and monitored daily 
until they recovered to baseline weight.  
5.2.4  Drug preparation 
4-Hydroxytamoxifen  
The z-isomer of 4-hydroxytamoxifen (4-OHT) is the active isomer (www.tocris.com). It 




4-OHT was dissolved in neat ethanol at 20mg/ml by shaking at 400rpm and 37°C for 
30-60 minutes until fully dissolved. Two parts chen oil for every one part ethanol was 
then added, and the ethanol was evaporated off using a vacuum centrifuge leaving a 
final solution of 10mg/ml in chen oil. Drug was prepared on the day of use, and if not 
used immediately, was kept in solution in the oil by shaking at 400 rpm at 37°C. Once 
in solution, the drug was protected from light. 
Clozapine-N-Oxide 
CNO was dissolved at 1mg/ml in sterile water at room temperature. Aliquots were 
stored protected from light for up to one week at room temperature.  
5.2.5  Experiment 5.1: chemoactivation of DMH torpor-TRAPed 
neurons 
Viral vectors were used to deliver Cre-dependent hM3Dq excitatory DREADD 
transgenes into the DMH of TRAP2 mice. After at least two weeks recovery, mice were 
entered into the calorie restriction torpor induction protocol (see chapter two) and 
received vehicle (chen oil) injections seven hours after lights off on days one to four, in 
a protocol identical to that described in experiment 4.2. On day five, and in 
anticipation of torpor entry, mice received 4-OHT 50mg/kg i.p, which was given seven 
hours after lights off, as usual. These mice were called ‘hM3Dq-DMH-torpor-TRAP’. 
Following a further two weeks to allow return to baseline weight and to allow 
expression of the DREADD protein, mice were screened for synthetic torpor in 
response to chemoactivation of the DMH torpor-TRAPed neurons with CNO at 5mg/kg 
i.p. If no synthetic torpor response was observed with surface thermography then the 





FIGURE 5-1 PROTOCOL FOR VECTOR INJECTION AND TORPOR TRAPING 
TRAP2 mice underwent injection of either excitatory or inhibitory Cre-dependent DREADD into 
the DMH, followed by five days of calorie restriction with 4-OHT administration at 7 hours after 
lights off on day 5, prior to an anticipated natural torpor bout. Mice were then assessed for a 





experiment 4.2. This was conducted to identify any effect of DREADD activation on the 
probability or depth of torpor. During this trial, each mouse was randomly assigned to 
receive either daily CNO (5mg/kg, i.p.) or daily 0.9% saline injections (5ml/kg, i.p.) 
during the five days of calorie restriction. The occurrence and depth of torpor was 
monitored with surface thermography. Following this first arm of the study, and after 
at least five days with free access to food, the process was repeated with mice that 
initially received saline now receiving CNO, and vice versa. Torpor depth scores were 
calculated daily for each mouse, as the area of the 24-hour temperature profile that 
was below the threshold for torpor as defined in chapter two. 
Cell phenotyping: RNAscope target selection  
As discussed in Chapter 1, the DMH and adjacent hypothalamic nuclei contain 
heterogenous populations of neurons, many of which express transmitters and/or 
receptors that are implicated in the control of energy balance, sleep, or 
thermogenesis. These include leptin (Zhang et al., 2011), neuropeptide Y (NPY) (Bi, 
Robinson, and Moran 2003), galanin (Qualls-Creekmore et al. 2017), kappa opioids 
(Tamura et al. 2012), orexin, and thyrotropin-releasing hormone (TRH) (Chou et al. 
2003). Complimentary probes targeting RNA molecules that code for these 
transmitters and /or their receptors were selected, in addition to probes targeting 
vesicular glutamate transporter (VGLUT2), vesicular inhibitory amino acid transporter 
(VGAT), and acetyl choline esterase (ChAT), mCherry (to identify TRAPed neurons), and 








Round 1 Round 2 Round 3 Round 4 
AF488 Leptin Receptor B  
(cat # 402731) 
NPY  
(cat # 313321) 
ChAT  
(cat # 408731) 
mCherry  
(cat # 431201) 
Atto550 Kappa opioid 
receptor  
(cat # 316111) 
TRH  
(cat # 4368110 
Galanin  
(cat # 400961) 
VGLUT2 
(cat # 319171) 
Atto647 NPY receptor 1  
(cat # 4270210 
Orexin  
(cat # 490461) 
VGAT  
(cat # 319191) 
NeuN  
(cat # 313311) 
 
TABLE 5-1 RNA PROBE TARGETS FOR RNASCOPE IN EXPERIMENT 5.1 
Three RNA targets were imaged in each round, alongside DAPI. The fluorophores were cleaved 
and then attached to the next round of targets across four rounds. Abbreviations: NPY, 
neuropeptide Y; TRH, thyrotropin releasing hormone; ChAT, choline acetyl transferase; VGAT, 




RNAscope: tissue harvesting and sectioning 
Brain tissue from hM3Dq-DMH-torpor-TRAP mice in experiment 5.1 was prepared for 
RNAscope. Mice were culled by terminal anaesthesia with intraperitoneal 
pentobarbitone (175mg/kg, Euthatal). Fresh frozen tissue was prepared by removal of 
the brain, which then was then mounted in optimal cutting temperature compound 
(www.fishersci.com) and drop-frozen in a metal container of isopentane on dry ice. 
Brains were stored at -70°C, then 15µm coronal sections were cut using a cryostat. 
Sections were individually mounted directly onto slides (Superfrost Plus, 
Thermoscientific), placed into slide boxes in sealed zip-lock bags, and stored at -70°C.  
RNAscope: tissue fixation and dehydration 
Slides were removed from the -70°C freezer, placed in a rack, and immediately 
immersed in fresh 10% neutral buffered formalin solution for one hour at room 
temperature. Slides were then rinsed twice in fresh PBS. Finally, sections were 
dehydrated by placing the slides in 50% ethanol, followed by 70% ethanol, followed by 
100% ethanol, each step for five minutes at room temperature, the 100% ethanol step 
was repeated once.  
Immunohistochemistry performed on sections prepared for RNAscope 
Every third section was taken for standard immunohistochemistry (IHC) in order to 
confirm appropriate injection targeting and expression of the DREADD-mCherry fusion 
protein, which indicates successful TRAPing of cells. The protocol for IHC was the same 
as described in experiments 3 and 4, using a rabbit anti-mCherry primary (Biovision 
5993, 1:2000), and donkey anti-rabbit secondaries (Alexafluor594, 1:1000). Sections 




excitation system, excitation filter 546/12nm, dichroic mirror 580nm, emission filter 
590nm.   
RNAscope protocol 
One slide containing the dorsomedial hypothalamus at bregma -1.94mm was selected 
from each animal to be processed for RNAscope. Slides were removed from 100% 
ethanol and allowed to air dry for five minutes at room temperature. A hydrophobic 
barrier was drawn around the sections using an Immedge pen (www.fishersci.com). 
Slides were then treated with a proprietary protease (Protease IV, www.acdbio.com) 
for thirty minutes at room temperature, then washed twice in PBS. Four drops of each 
of the twelve RNA probes were applied to each slide, where were then incubated in a 
humidified oven at 40°C for two hours. Following this, slides were washed twice for 
two minutes each time at room temperature in fresh proprietary wash buffer 
(www.acdbio.com).  
Four drops of RNAscope HiPlex Amp 1, an amplification step that binds to the tail of 
the RNA  probe pairs, were applied to each slide, and incubated in a humidified oven at 
40°C for thirty minutes, then again washed twice for two minutes each time at room 
temperature using proprietary wash buffer. The process was repeated for two further 
amplification steps using RNAscope HiPlex Amp 2, then 3.  
Next, four drops of RNAscope HiPlex Fluor T1-3 were added and incubated in a 
humidified oven at 40°C for fifteen minutes, then again washed twice for two minutes 
each time at room temperature using proprietary wash buffer. This step applied three 
fluorescent labels in AF488, Atto550, and Atto647, that each bind to one of the specific 




DAPI was applied to the sections for thirty seconds at room temperature, followed by 
1-2 drops of Prolong Gold antifade mountant (www.thermofisher.com), and a 
coverslip was applied. Sections were then imaged using a confocal microscope (see 
below). 
After imaging the DAPI, AF488, Atto550, and Atto647 channels, coverslips were 
removed by soaking in 4X saline sodium citrate (SSC, www.thermofisher.com) for thirty 
minutes. Proprietary cleaving solution (www.acdbio.com) was applied to each section 
and incubated at room temperature for fifteen minutes to remove the fluorophores 
from the RNA probe amplifiers, followed by two washes in PBST (PBS with 0.5% 
Tween). This cleaving process was repeated once.  
The entire protocol, from the point of applying the fluorophores to imaging and 
cleaving, was then repeated three further times. On each occasion DAPI plus three 
RNA target probes were imaged until all twelve targets had been processed.  
RNAscope imaging 
Sections for RNAscope were imaged using a Leica SP8 AOBS confocal laser scanning 
microscope attached to a Leica DMi8 inverted epifluorescence microscope using HyD 
detectors (‘hybrid’ SMD GaAsP detectors) with 405nm diode and white light lasers. A 
40x oil immersion lens with NA of 1.3 (Leica HC PLAPO CS2 lens) was used. Laser 
settings are shown in Table 1-2.  
The images generated from each round were z-projection compressed in Image-J 
(Schindelin et al. 2012), then proprietary software (www.acdbio.com) was used to 




Fluorescent label Excitation wavelength (nm) Emission wavelength (nm) 
DAPI (blue) 415 415-458 
AF488 488 500-540 
Atto550 550 571-605 
Atto647 650 669-703 
 





ensured that fluorescent signal from a given cell could be compared across imaging 
rounds. Aligned images were then processed in Image-J. Image processing involved 
first applying a 50 pixel radius rolling ball background subtraction. Then, for each 
fluorescence channel that was used a total of four times for each section (each time 
labelling a different RNA target probe), a median projection was generated. This 
provided a measure of the background or autofluorescence for each fluorescence 
channel, since such a signal would appear in the same position across all imaging 
rounds. This median projection was then subtracted from the images generated in 
each round, as a means of subtracting the background fluorescence signal. After this, 
the contrast and brightness were adjusted using the automatic function in Image-J.  
Each DAPI-stained nucleus was identified and marked with a 12µm diameter area of 
interest. This created a map of all the nuclei within the imaged section, which could 
then be projected onto the fluorescence images from each round of RNA target 
visualisation for that section. DAPI-stained nuclei lining the third ventricle were 
excluded as these were assumed to represent ependymal cells. Where two DAPI nuclei 
appeared to overlap, both were excluded on the basis that it would not be possible to 
distinguish to which nucleus a given RNA probe signal was attached. Nuclei were 
manually counted and deemed to be positive for a given RNA target if three or more 
bright spots were visible within the 12µm diameter area centred around the DAPI 
stained nucleus. This threshold was chosen pragmatically as it distinguished positive 
cells clearly above any background signal.  
5.2.6  Experiment 5.2: inhibition of DMH torpor-TRAPed neurons 
The purpose of this experiment was to assess the effect of inhibiting neurons in the 




DMH neurons that are active during torpor is necessary for torpor to occur. An 
identical experimental protocol was used as described in Experiment 5.1 with the 
exception that the vector carrying a transgene for an inhibitory DREADD, hM4Di, was 
injected bilaterally into the DMH. The brains from these mice were not processed for 
multiplex fluorescent RNA in-situ hybridisation. These mice were called ‘hM4Di-DMH-
torpor-TRAP’, 
5.2.7  Controls 
Control #1: does the Cre-dependent vector leak? 
Control experiment #1 tested for vector leak by withholding 4-OHT in mice that had 
undergone bilateral injection of the Cre-dependent excitatory DREADD vector (pAAV2-
hSyn-DIO-hM3Dq-mCherry). Experiments performed in Chapter 3 demonstrated that 
the TRAP2 mouse exhibited minimal leak, manifest as no fluorescent cells observed  in 
the preoptic area or the dorsomedial hypothalamus in TRAP x tomato mice that had 
not received 4-OHT (see experiment 3.2). However, the use of viral vectors in this 
chapter, adds an additional potential source of leak. In the context of experiments 5.1 
and 5.2, leak would manifest as DREADD expression in neurons that are not defined by 
their activity around the time the mouse received 4-OHT, i.e. neurons that are not 
necessarily involved in torpor induction.  
Six weeks after DMH vector injection, mice were culled, and tissue processed for 





 Control #2: are the effects of chemoactivation specific to torpor-TRAPed neurons? 
TRAP2 mice received bilateral DMH injections of Cre-dependent excitatory DREADD 
vector, and following a recovery period of at least two weeks, received 4-OHT in the 
homecage at an ambient temperature of 21°C, with free access to food (‘hM3Dq-DMH-
Homecage-TRAP’). Following a further two weeks to allow expression of the DREADD 
protein, mice entered the same randomised, crossover design, calorie restriction trial 
as described above.  
This control was included in order to demonstrate that any effect from 
chemoactivation of TRAPed neurons was specific to their role in torpor, and not a 
general consequence of activating neurons within vector-targeted region.  
Immunohistochemistry for controls 
Brain tissue from control experiments was processed for immunohistochemistry as 
described in chapter three. Immunohistochemical analysis of hM3Dq-mCherry fusion 
protein expression was performed using a rabbit anti-mCherry primary (Biovision 
5993, 1:2000), with donkey anti-rabbit secondaries (Alexafluor594, 1:1000). Sections 
were imaged using a Zeiss Axioskop II inverted microscope with a CooLED pE-100 
excitation system, excitation filter 546/12nm, dichroic mirror 580nm, emission filter 
590nm. 
5.2.8  Statistical analyses 
Data is presented as mean ± standard deviation when normally distributed, otherwise 
it is presented as median [interquartile range]. The Kolmogorov-Smirnov test for 
normal distribution was used. Statistical analyses were carried out using GraphPad 




distributed data, Mann-Whitney U, and Wilcoxon matched-pairs signed rank tests 
were used for non-normally distributed data.  
5.3  Results 
5.3.1  Experiment 5.1: Neurons in the dorsomedial hypothalamus 
promote torpor entry 
Chemoactivation of torpor-TRAPed DMH neurons  
Nine TRAP2 mice had injection of the Cre-dependent excitatory DREADD (pAAV2-hSyn-
DIO-hM3Dq-mCherry) into the dorsomedial hypothalamus, followed by five days of 
calorie restriction with 4-OHT injection on day five. Of these mice, seven entered 
torpor following 4-OHT administration and were evaluated for synthetic torpor in 
response to CNO with free access to food, and then for an augmentation of torpor 
during calorie restriction. Mean time from 4-OHT injection until torpor entry was 2.53 
±1.23 hours. Mean torpor duration following 4-OHT was 4.52 ±2.85 hours and mean 
nadir temperature reached was 25.1 ±1.4°C.  
Chemoactivation of these hM3Dq-DMH-torpor-TRAP mice did not induce synthetic 
torpor in an ambient temperature of 21°C with free access to food. However, CNO 
delivered each day, seven hours after lights off, to calorie restricted mice,  increased 
the probability of the mice entering torpor over five days. Torpor emerged earlier in 
the calorie restriction protocol during arms in which mice received CNO compared to 
those in which they received saline (torpor first appeared on day 3.0 [2.0 - 4.0] versus 
day 5.0 [4.0 – 6.0], Wilcoxon matched-pairs signed rank test, p < 0.05) (Figure 5-2, 
Figure 5-3, and Figure 5-4). There were more torpor bouts in total on the CNO arms 






FIGURE 5-2 EXAMPLE TORPOR BOUTS ACROSS FIVE DAYS OF CALORIE RESTRICTION WITH EITHER CNO OR SALINE 
IN AN HM3DQ-DMH-TRAP MOUSE IN EXPERIMENT 5.1 
Example surface temperature plots for a single hM3Dq-DMH-torpor-TRAP mouse under five 
days of calorie restriction with either daily CNO 5mg/kg i.p. (top row) or daily 0.9% saline 5µl/g 





matched-pairs signed rank test, p < 0.05). All hM3Dq-DMH-torpor-TRAP mice entered 
torpor at least once when receiving CNO during five days of calorie restriction. Two 
mice did not enter torpor at all after completing five days calorie restriction when 
receiving saline (for analyses they were assumed to enter torpor on the next day and 
given a value of 6). The weights of mice on entry into the CNO arm of the trial were 
equivalent to their weights on entry into the saline arm (24.7 ±2.7g versus 24.7 ±2.7g 
respectively, mean difference -0.014g, paired t(6) = 0.049, p = 0.96). Hence, the 
increased propensity to enter torpor observed with chemoactivation of hM3Dq-DMH-
torpor-TRAP mice, compared to when they received saline, was not due to systematic 
differences in their weights.  
The weight at which torpor bouts first appeared was greater in mice receiving CNO 
compared to when they received saline (21.5 ±2.4g versus 20.7 ±2.7g, mean difference 
0.7g, paired t(6) = 2.99, p < 0.05). This indicates that one of the effects of activating the 
torpor-TRAPed neurons within the DMH is to lower the threshold for torpor. As 
described in chapter four, CNO administration had no effect on the probability of 
torpor entry nor its depth in wild type calorie restricted control mice.  
During calorie restriction arms in which mice were given CNO, they spent more time in 
torpor than in the arms when they received saline. On day three of calorie restriction, 
mice spent 2.89 hours [0 – 3.92] in torpor in the CNO arm of the trial compared to 0 [0-
0] hours on day three of the saline arm. By day five of calorie restriction this difference 
had increased with mice spending 6.67 hours [3.46 – 11.0] in torpor in the CNO arm, 
and 3.60 hours [1.09 – 4.37] hours in torpor in the saline arm (2-way repeated 







FIGURE 5-3 EFFECT OF CNO VS SALINE ON THE PROBABILITY OF TORPOR AND THE WEIGHT AT WHICH MICE ENTERED TORPOR IN CALORIE RESTRICTED HM3DQ-DMH-TRAP MICE IN EXPERIMENT 
5.1 
CNO increased the total number of days in which torpor occurred, and resulted in torpor occurring after a shorter period of calorie restriction (n = 7 female mice, 











FIGURE 5-4 TIME SPENT IN TORPOR, THE NADIR SURFACE TEMPERATURE, AND TORPOR DEPTH SCORES IN CNO 
VS SALINE TRIALS IN HM3DQ-DMH-TRAP MICE FROM EXPERIMENT 5.1 
CNO increased the total time spent in torpor (A), decreased the nadir surface temperature 
reached (B), and increased the aggregate torpor depth score (C) in calorie restricted mice (n = 7 
female mice, 2-way repeated measures ANOVA # indicates significant main effect for CNO vs 
saline trials, p < 0.05; Fisher’s least significant difference test *,**,***,*** indicate significant 





0.05); main effect for day of calorie restriction (F(4,24) = 18.16, p < 0.001), with 
Fisher’s least significant difference test identifying significant differences between CNO 
and saline treatment trials on days three, four, and five (p < 0.05, <0.01, <0.005, 
respectively)).  
Likewise, during calorie restriction trials in which mice were given CNO, the nadir 
temperature reached was lower than when they were given saline. On day three of 
calorie restriction nadir temperature reached was 26.4 ±1.4°C in the CNO arm of the 
trial compared to 28.7 ±0.8°C in the saline arm (2-way repeated measures ANOVA, 
main effect for treatment with CNO versus saline (F(1,6) = 12.2, p < 0.05); main effect 
for day of calorie restriction (F(4,24) = 50.9, p < 0.0001); with Fisher’s least significant 
difference test identifying significant differences between CNO and saline treatment 
trials on days three, four, and five (p <0.0005, <0.0001, <0.001, respectively)).  
When hM3Dq-DMH-torpor-TRAP mice were given CNO during calorie restriction the 
aggregate torpor depth score (i.e. the area below the torpor threshold line) was 
greater than when they received saline. This effect was evident on days four and five 
of calorie restriction (2-way repeated measures ANOVA, main effect for treatment 
with CNO versus saline (F(1,6) = 8.06, p < 0.05); main effect for day of calorie 
restriction (F(4,24) = 12.12, p < 0.0001); with Fisher’s least significant difference test 
identifying significant differences between CNO and saline treatment trials on day four 
and five , p < 0.05 and p < 0.0001, respectively)). 
DMH Injection site mapping 
The distribution of DREADD expressing TRAPed cells was mapped from the 






FIGURE 5-5 DREADD EXPRESSION IN TRAPED NEURONS FROM AN INDIVIDUAL HM3DQ-DMH-TRAP MOUSE 
mCherry labelling (red) indicating DREADD expression in TRAPed cells in an hM3Dq-DMH-TRAP mouse. Expression in the dorsomedial hypothalamus (DMH) and 
dorsal hypothalamic area (DHA). Immunohistochemistry performed labelling the mCherry component of the hM3Dq-mCherry fusion protein. Arrows indicate 








FIGURE 5-6 DREADD EXPRESSION ACROSS ALL SEVEN HM3DQ-DMH-TRAP MICE 
Mapped extent of mCherry-labelled cell bodies, indicating TRAPed cells expressing DREADD. TRAPed cells were observed in the dorsomedial hypothalamus (DMH, 
marked in green) and dorsal hypothalamic area (DHA) of all mice (n=7). Injections tracts visible in A at bregma -1.34mm, resulting in TRAPed cells in the cortex. Two 




mCherry fusion protein in the seven hM3Dq-DMH-torpor-TRAP mice (Figure 1-5 and 
Figure 1-6). In all animals, DREADD expression was seen in fibres and on cell bodies 
from bregma -1.34mm to bregma -2.06mm in the anterior-posterior axis within the 
hypothalamus from the midline to approximately 0.5mm laterally, a zone that included 
the DMH and the dorsal hypothalamic area. There was good reproducibility between 
animals. DREADD expression was additionally observed in the medial tuberal nucleus 
in two animals (Figure 1-6C & D). Sparse DREADD expression was also occasionally 
observed in the cortex and thalamus along the injection pipette tracts (Figure 1-6 A). 
Phenotyping torpor-TRAPed DMH neurons: RNAscope  
A single section from each of five hM3Dq-DMH-torpor-TRAP mice was selected for 
RNAscope analysis (Figure 1-7). Of the 12 RNA probes used, 11 produced the 
anticipated pattern of labelling centred around DAPI-stained nuclei. One target probe, 
NeuN, did not produce a meaningful pattern of labelling, and this probe was therefore 
disregarded (Figure 1-8 and Figure 1-9). Further discussions with the manufacturers of 
the RNAscope assay indicated that NeuN RNA expression levels are low and that this 
probe therefore usually only works well if imaged in the first round of the assay.  
From each section, the region immediately lateral to the dorsal part of the third 
ventricle at bregma -1.94mm was imaged. This included the dorsal and compact parts 
of the dorsomedial hypothalamus. The area scanned measured 387 x 387µm and was 
scanned across 10µm in the z plane in 0.7 µm steps (Figure 1-7). A total of 1771 DAPI-
stained nuclei were identified across five animals (345 ±65 cells per animal). DAPI-
stained nuclei that appeared to express both VGLUT2 and VGAT were excluded from 




overlapping cells (n = 7). Nuclei that expressed no target were removed from the 
analysis (n = 542). Hence, the data presented here was generated from 1222 cells 
across five sections from five mice.  
Of these, 1222 cells, 615 expressed mCherry while 607 expressed at least one other 
RNA target but not mCherry. Hence, of the included cells, 50.3% were TRAPed and 
expressed mCherry RNA, indicating DREADD expression (equivalent to 35% of all cells 
imaged). After mCherry, the most commonly expressed RNA target within this region 
of the DMH was VGLUT2, which was expressed in 43.6% of all cells. There were 
significant differences in the total number of cells expressing each RNA target probe, 
with VGLUT2, VGAT and galanin indicating the most common transmitter phenotype, 
while leptin and kappa opioid were the most common receptor types expressed (2-
way mixed ANOVA, main effect for RNA target (F(9,36) = 10.13), p < 0.0001)) (Table 5-3 
& Figure 5-10).  
None of the ten mRNA target probes showed a different pattern of expression 
between TRAPed and non-TRAPed cells. Hence, it was not possible to state that the 
mCherry-labelled, TRAPed cells were predominantly glutamatergic, GABAergic, or that 
they preferentially expressed any of the other RNA probes (2-way mixed ANOVA, no 
main effect for mCherry positive versus mCherry negative (F(1,4) = 0.00008, p = 0.99), 
with no differences between mCherry positive and mCherry negative cells in the 
labelling for any of the individual probes on Fisher’s least significant difference 
multiple comparisons, p >0.05 throughout). Just 16% of 79 NPY positive cells were 






RNA target probe Cell count Proportion (%) 
mCherry 620 51 
VGLUT2 540 44 
VGAT 298 24 
ChAT 55 5 
Galanin 249 20 
NPY 77 6 
TRH 55 5 
Orexin 5 <1 
Leptin Receptor B 390 32 
Kappa opioid receptor  335 27 
NPY receptor 1 65 5 
 







FIGURE 5-7 EXAMPLE AREA PROCESSED FOR MULTIPLEX RNA IN-SITU HYBRIDISATION (RNA SCOPE) 
Left, DAPI stained image showing the 387 x 387µm area processed for RNAscope in hM3Dq-
DMH-torpor-TRAP mice in experiment 5.1. Right, corresponding atlas section, black square 






FIGURE 5-8 RNA SCOPE EXAMPLE LABELLING FOR EACH OF THE 12 RNA TARGET PROBES USED.  
Nuclei stained with DAPI, RNA targets labelled white. Scale bars represent 50µm. Abbreviations: ChAT, Choline acetyltransferase; VGAT, vesicular GABA transporter; 






FIGURE 5-9 EXAMPLE COMPOSITE IMAGES SHOWING LABELLING OF SEVERAL RNA TARGETS IN SINGLE SECTIONS 







FIGURE 5-10 RNASCOPE COUNTS OF CELLS EXPRESSING EACH RNA TARGET 
Top, mean positive cell count per section for each RNA target (n = 5, 1 section from each of 5 
animals, mean and standard deviation). Bottom, distribution of cells expressing each target 
grouped according to mCherry positive vs negative (indicating TRAPed or non-TRAPed, 
respectively). 2-way repeated measures ANOVA found a main effect for RNA target (2-way 
mixed ANOVA, main effect for RNA target (F(9,36) = 10.13), p < 0.0001) but no main effect for 
mCherry positive vs negative, and no significant differences on multiple comparisons (Fisher’s 






FIGURE 5-11 RNA SCOPE TARGET EXPRESSION PATTERNS ACROSS MCHERRY POSITIVE VS MCHERRY NEGATIVE 
CELLS 
Patterns of RNA target expression were compared across mCherry positive (TRAPed) and 
mCherry negative (non-TRAPed) cells. In all plots, the Y axis indicates the expression profile from 
number 1 to number 32. A, the expression profiles, yellow indicates RNA target expressed, blue 
indicates target not expressed. B, the percentage of all cells with each expression profile that 
also expressed mCherry, ranging from 100% mCherry positive (yellow) to 100% mCherry 
negative (blue). C, RNA target expression profile cell count split for each individual mouse 
analysed. X axes indicates the animal number, Y axis indicates the RNA expression profile, left 
column is the count of mCherry positive cells with a given profile, right column is the count of 
mCherry negative cells with a given profile. The only profile of RNA expression that showed a 
significant difference in distribution between mCherry positive and negative cells was profile #1, 
which expressed none of the 11 non-mCherry targets By definition, these cells could only be 
counted as mCherry positive because those cells that expressed none of the RNA targets were 






FIGURE 5-12 RNA EXPRESSION PROFILE COUNTS BY MCHERRY POSITIVE VS NEGATIVE 
Count of each expression profile that was either mCherry positive (red) or mCherry negative (blue). Dashed lines link counts from the same section (mean and 
standard error). The only profile of RNA expression that showed a significant difference in distribution between mCherry positive and negative cells was profile #1, 
which expressed none of the 11 non-mCherry targets. By definition, these cells could only be counted as mCherry positive because those cells that expressed none 




This is a surprising observation, as one would anticipate NPY-expressing neurons to be 
active during calorie restriction (Billington et al. 1991; Bewick et al. 2005), but it is 
important to note that these differences were not found to be statistically significant 
on multiple comparisons testing. 
Although TRAPed mCherry positive cells did not appear to show any tendency to 
preferentially express any given individual RNA target, this did not exclude the 
possibility that they might preferentially express certain combinations of those RNA 
targets. Therefore, an analysis was performed to compare the combinations of RNA 
target expression seen across TRAPed and non-TRAPed cells. A total of 81 different 
profiles of RNA target expression were seen across the 1222 cells. Of these 
combinations 49 occurred in fewer than five cells in total and were considered unlikely 
to be key to explaining the augmentation of torpor observed in the hM3Dq-DMH-
torpor-TRAP mice. Therefore, only those profiles that were observed more than five 
times were analysed (a total of 32 profiles). The only profile that appeared significantly 
more frequently in TRAPed cells than in non-TRAPed cells expressed only mCherry, 
which by definition could not appear in the mCherry negative cells. This expression 
profile was observed in 70 cells across the five animals.  
The co-expression of VGLUT2 and galanin was only seen in mCherry positive cells, 
however across all five animals this pattern only appeared in six cells and therefore did 
not reach statistical significance, nor is this small number of cells biologically plausible 
as a cause for the torpor-promoting effect observed in experiment 3.2. All other 
profiles appeared equally frequently in TRAPed and non-TRAPed cells (2-way mixed 




TRAPed versus non-TRAPed (F(1,4) = 0.005, p = 0.95); there was a significant 
interaction (F(31,124) = 1.57, p < 0.05)). Holm-Sidak’s multiple comparison test was 
used to compare the expression of each profile in TRAPed versus non-TRAPed cells. A 
single profile expressing only mCherry emerged as discussed above, no other profile 
showed a significant difference in distribution between TRAPed and non-TRAPed cells 
(Figure 5-11 and Figure 5-12).  
5.3.2   Experiment 5.2: Inhibition of torpor-TRAPed neurons in the DMH 
Twelve TRAP2 mice underwent injection of the Cre-dependent inhibitory DREADD 
(pAAV2-hSyn-DIO-hM4Di-mCherry) into the dorsomedial hypothalamus (hM4Di-DMH-
torpor-TRAP), followed by five days of calorie restriction with 4-OHT injection on day 
five. Of these mice, seven entered torpor following 4-OHT administration and were 
evaluated for an inhibition of torpor in response to CNO compared to saline during 
further trials of calorie restriction. Five mice were excluded because following 
administration of 4-OHT one or more of the mice managed to cross the cage quadrant 
dividers. Due to the method used to measure mouse surface temperature, it then 
became impossible to discern the mice that occupied the same quadrant. Time from 4-
OHT injection until torpor entry was 2.13 ±1.11 hours. Duration of torpor following 4-
OHT was 3.28 ±1.34 hours and nadir surface temperature reached was 26.1±1.4°C. 
These TRAP day torpor bout characteristics were similar to those observed in the 
hM3Dq-DMH-torpor-TRAP mice (see section 5.1.9). 
Hence, seven hM4Di-DMH-TRAP mice were entered into the same randomised, 
crossover design, calorie restriction trial described in experiments 5.1 and 4.2. This 
time, chemo-inhibition of torpor-TRAPed DMH neurons was expected to reduce the 





FIGURE 5-13 EFFECT OF CNO VS SALINE ON THE PROBABILITY OF TORPOR AND THE WEIGHT AT WHICH MICE ENTERED TORPOR IN CALORIE RESTRICTED HM4DI-DMH-TRAP MICE 
CNO did not affect the total number of days in which torpor occurred, nor the first day on which torpor occurred, nor the weight at which torpor first occurred 







FIGURE 5-14 TIME SPENT IN TORPOR, THE NADIR SURFACE TEMPERATURE, AND TORPOR DEPTH SCORES IN CNO 
VS SALINE TRIALS IN HM4DI-DMH-TRAP MICE FROM EXPERIMENT 5.1 
CNO did not affect the duration of torpor bouts, the nadir surface temperature reached, or 
 the aggregate torpor depth score in calorie restricted mice (n = 7 female mice, 2-way repeated 
measures ANOVA, no main effect for CNO vs saline across all days, with Fisher’s least significant 





Chemoinhibition of torpor-TRAPed DMH neurons in calorie restricted mice did not 
reduce the total number of days of torpor (1 bout [0 – 3] in the CNO arm compared to 
2 bouts [0 – 3] in the saline arm, paired Wilcoxon matched-pairs signed rank test, p = 
0.66). Nor did it delay the onset of torpor across the five days of calorie restriction 
(4.29 ±1.38 days of calorie restriction prior to appearance of torpor in the CNO arm, 
versus 4.29 ±1.50 days in the saline arm, paired t(6) = 0.0, p >0.99) (Figure 5-13)). 
Mouse weight on entry into CNO arms was equivalent mouse weight on entry into 
saline arms of the trial (25.6 ±3.2g versus 25.4 ±3.1g respectively, paired t(6) = 0.30, p 
= 0.77). 
There were no differences between calorie restriction trials in which mice received 
CNO compared to when they received saline, in terms of time spent in torpor, nadir 
surface temperature reached, or aggregate torpor depth score. Two-way repeated 
measures ANOVA for each of these variables found main effects for day of calorie 
restriction, indicating more time was spent in torpor (F(4,24) = 8.86, p < 0.0005), nadir 
surface temperature decreased (F(4,24) = 26.35, p < 0.0001), and torpor depth scores 
were greater with increasing days of calorie restriction (F(4,24) = 8.52, p < 0.0005). 
There were no main effects for CNO versus saline in terms of time spent in torpor 
(F(1,6) = 0.26, p = 0.63), nadir surface temperature reached (F(1,6) = 0.08, p = 0.79), or 
aggregate torpor depth score (F(1,6) = 0.23, p = 0.65). There were also no significant 
differences between CNO trials and saline trials on any of these measurements when 
analysed on a day-by-day basis (Fisher’s lest significant difference test, p > 0.05 in all 




The weight at which torpor bouts first appeared was equivalent in mice receiving CNO 
compared to when they received saline (21.3 ±2.1g versus 21.6 ±1.6g, paired t(6) = 
0.56, p = 0.60, Figure 1-13). Hence, activating inhibitory DREADDs in hM4Di-DMH-
torpor-TRAP mice did not affect the expression of torpor during five days of calorie 
restriction. 
5.3.3  Controls 
Five female TRAP2 mice underwent DMH injection of the pAAV2-hSyn-DIO-hM3Dq-
mCherry vector for two control experiments. 
Control # 1: does the vector leak? 
The purpose of this control was to assess for leakiness of the Cre-dependent vector, 
which would manifest as hM3Dq-mCherry expression in mice that had not been given 
4-OHT. 
One hM3Dq-DMH-injected mouse was used in this experiment. There was evidence of 
spontaneous DREADD expression in the absence of 4-OHT administration, with cell  
bodies and fibres labelled with anti-mCherry antibody indicating leaky DREADD 
expression (Figure 1-15, A1-3). Qualitatively, leaky DREADD expression observed in the 
absence of 4-OHT was less than expression seen in mice that were given 4-OHT in 
experiment 5.1. A non Cre-dependent vector that expresses EGFP was co-injected 
alongside the Cre-dependent DREADD vectors. Initially this was performed in order to 
confirm appropriate vector targeting, in the event of not seeing any TRAPed cells. 
However, EGFP expression allows a qualitative comparison of the expression of a non 





FIGURE 5-1 TRANSGENE EXPRESSION IN THE ABSENCE OF 4-OHT 
Sections from two TRAP2 mice that had bilateral pAAV2-hSyn-DIO-hM3Dq-mCherry injections. 
One (A) did not receive 4-OHT, the other (B) did. Coronal sections labelled with anti-mCherry 
antibody (red). A1 and B1, low magnification image of DMH and DHA. A2 and B2, higher 
magnification showing neuronal cell bodies. A3, composite image showing EGFP (green) 
expression from a non-Cre dependent vector that was co-injected with the pAAV2-hSyn-DIO-
hM3Dq-mCherry for comparison. Note, sections in A are 15µm thick, sections in B are 40µm 




More cells expressed EGFP than demonstrated leaky expression of DREADD (Figure 
5-15, A3). Hence, the degree of leaky expression was less than the expression seen in a 
Cre-independent vector. Quantification of the degree of leak was not possible due to 
only having a single mouse in this control group, but this is an important future 
experiment. 
Control #2: are the effects of chemoactivation specific to DMH torpor-TRAPed neurons? 
The purpose of this control was to demonstrate that the torpor-promoting effects of 
chemoactivating DMH neurons were specific to targeting neurons that are active 
during torpor. The alternative hypothesis being that the observed effect is a generic 
consequence of chemoactivating a non-specific population of neurons within the 
DMH.  
Four mice underwent hM3Dq vector injection into the DMH followed by 4-OHT while 
fully fed in the homecage, ‘hM3Dq-DMH-Homecage TRAP’. They were then entered 
into the randomised, crossover design, calorie restriction trial as described in 
experiments 4.2, 5.1 and 5.2. During the first calorie restriction trial, two mice, both 
randomised to receive CNO, demonstrated delayed and abnormally long torpor bouts, 
and having reached a Home Office licence end point were culled. This effect was 
unlikely to be due to chemoactivation of DMH homecage-TRAPed neurons for two 
reasons. Firstly, a similar pattern of prolonged torpor during calorie restriction was 
seen in a littermate mouse that had not received 4-OHT nor CNO (in another 
experiment). Secondly, the abnormal torpor did not appear on day one following CNO, 
which would be expected if it were the result of a profound response to 







FIGURE 5-16 TIME SPENT IN TORPOR, THE NADIR SURFACE TEMPERATURE, AND TORPOR DEPTH SCORES IN CNO 
VS SALINE TRIALS IN HM3DQ-DMH-HOMECAGE-TRAP MICE 
CNO was associated with reduced the total time spent in torpor, increased nadir surface 
temperature, and reduced aggregate torpor depth score in calorie restricted mice (n = 2 female 
mice, 2-way repeated measures ANOVA # indicates significant main effect for CNO vs saline 
trials, p < 0.05; Fisher’s least significant difference test *,** indicate significant difference 




and several hours after the CNO injection. It is possible that this litter carried a 
subclinical infection, and that calorie restriction unmasked this.  
The remaining two hM3Dq-DMH-Homecage TRAP mice continued in a truncated four-
day CNO versus saline crossover trial. CNO administration appeared to suppress torpor 
in these mice. However, due to only having two mice in the analysis, it is not possible 
to statistically analyse the number of torpor bouts over the four days, nor the day of 
first torpor entry. Although when the mice received saline there were 2 and 3 torpor 
bouts compared to 0 and 2 bouts, respectively, when they received CNO.  
During the CNO arm of the calorie restriction trial, hM3Dq-DMH-Homecage TRAP mice 
spent less time in torpor than they did in the saline arm (2-way repeated measures 
ANOVA, main effect for treatment with CNO versus saline (F(1,1) = 2104, p < 0.05); 
main effect for day of calorie restriction (F(1,1) = 11.86, p < 0.05); with Fisher’s least 
significant difference test identifying significant differences between CNO and saline 
treatment trials on days three and four (p < 0.05, , <0.005, respectively)) (Figure 5-16). 
Likewise, during the CNO arm of the calorie restriction trial, the nadir temperature 
reached was higher than when they were given saline (2-way repeated measures 
ANOVA, main effect for treatment with CNO versus saline (F(1,1) =247.8, p < 0.05); 
main effect for day of calorie restriction (F(3,3) = 13.94, p < 0.05); with Fisher’s least 
significant difference test identifying significant differences between CNO and saline 
treatment trials on days three and four (p <0.05, respectively)).  
The loss of half the cohort of mice renders interpretation of this experiment 
challenging. However, the signal is that in contrast to the effects of chemoactivating 




reduces the propensity to enter torpor. This supports the conclusion that the 
promotion of torpor observed in experiment 5.1 represents a specific effect of 
chemoactivating neurons in the DMH that have a genuine role in torpor. Hence, 
TRAPing and chemoactivating DMH neurons that are active in the homecage fed state 
appears to have the effect of blocking torpor. Given that the mice were housed at 
21°C, and were fully fed, the activity in the DMH in this environment would be 
expected to signal a positive energy balance and a need to stimulate thermogenesis – 
two signals that are the opposite of the state during torpor. However, due to the small 
number of animals that completed the experiment, it must be repeated before firm 
conclusions are drawn. 
5.4  Discussion 
The data presented in this chapter demonstrates that the dorsomedial hypothalamus 
contains a population of neurons that are active in the period leading up to a torpor 
bout, and whose role is to promote torpor entry. DREADDs were selectively expressed 
in neurons within the DMH that are active during torpor. Subsequent chemoactivation 
of those same neurons increased the probability of torpor, as well as the depth and 
the duration of torpor, in calorie restricted mice. Importantly, chemoactivation of 
these torpor-TRAPed DMH neurons resulted in torpor entry after less weight loss than 
controls, indicating that the threshold for torpor had been lowered. 
 Previous studies (Hitrec et al. 2019), and data presented in Chapter 3, identified that 
the DMH contains neurons that activate the c-fos gene around the time of torpor. 
However, until now it was not possible to determine whether those neurons are 




regulatory function. Here, by chemoactivating those DMH neurons that switch on c-fos 
around the time of torpor, it has been possible to show that they do indeed contribute 
to the generation of torpor. This data supports the hypothesis that torpor is generated 
by central mechanisms. This is because in these experiments, DREADD expression was 
limited to central nervous system tissue through the focal injection of a viral vector 
carrying the gene to the dorsomedial hypothalamus.  
Chemoactivation of these DMH neurons did not suppress body temperature after 
single doses of CNO delivered to mice with free access to food. This is an important 
observation because it supports the hypothesis that the TRAPed neurons play a 
specific role in promoting torpor under calorie restricted conditions. They likely form 
part of a chorus of signals that indicate negative energy balance and the need to 
engage torpor. If on the other hand, the TRAPed neurons were simply part of a circuit 
that inhibits thermogenesis under normal conditions, then one would expect 
chemoactivation to produce a physiological response that is independent of calorie 
restriction. Finally, one might argue that chemoactivation of these DMH neurons 
simply increased energy expenditure in these already calorie restricted mice. This 
would result in a greater energy deficit under CNO arms of the calorie restriction trials, 
and so it would appear that chemoactivation was promoting torpor when in fact it was 
simply increasing energy deficit. However, the observation that chemoactivation of 
DMH torpor-TRAPed neurons resulted in torpor occurring at higher body weights 
makes this interpretation unlikely, instead, it supports the hypothesis that the 




Whether there is a single group of neurons capable of inducing torpor, i.e. a torpor 
‘master switch’ remains unknown. One might argue that the observation of torpor-
promoting effects following chemoactivation of hM3Dq-DMH-torpor-TRAP mice, 
rather than full synthetic torpor, supports the hypothesis that a network of regions 
contributes to torpor induction. The DMH would then be considered one part of this 
network. However, it is possible that either the master switch lies outside the DMH, or 
else that the number of neurons from within the DMH that were TRAPed was 
insufficient to induce torpor without additional calorie restriction.  
Another important question is whether torpor is triggered, maintained, and 
terminated by the activity of a single population of neurons, or whether different 
populations are each responsible for timing the different phases. While the findings 
presented here do not definitively answer this question, the observation that 
chemoactivating DMH torpor-TRAPed neurons not only increases the number of torpor 
bouts during five days of calorie restriction, but also increases their duration and depth 
hints that torpor may be induced and maintained by the same population of neurons. 
If on the other hand the effect of chemoactivation of DMH torpor-TRAPed neurons 
was to either increase the probability but not the duration or vice versa, then this 
would equally tentatively support the hypothesis that these phases of torpor are 
governed by distinct neuronal populations.  
The finding that activation of neurons with in the DMH contributes to torpor induction 
- a physiological response that includes suppression of thermogenesis - is particularly 
interesting. Chapter 1 introduced the current understanding of hypothalamic 




driver rather than inhibitor of thermogenesis, at least in rodents (Z. Zhao et al. 2017; 
Rezai-Zadeh et al. 2014). Under normal physiological circumstances in rodents housed 
in sub-thermoneutral conditions, the DMH is tonically active, driving the activity of 
sympathetic premotor neurons within the raphe pallidus, which in turn drive brown 
adipose tissue (BAT) thermogenesis. Body temperature is thus determined by the 
balance of activity of the projection from DMH to raphe, versus inhibitory inputs to the 
DMH from regions that respond to increases in skin, visceral, or hypothalamic 
temperature, such as the preoptic area (Cao, Fan and Morrison, 2004; DiMicco and 
Zaretsky, 2007). Hence, these torpor-TRAPed neurons appear to suppress 
thermogenesis, which is not a common feature of DMH neurons. 
This raises the question of what is the phenotype of these DMH neurons? One might 
anticipate that they would be GABAergic, either acting as local inhibitory neurons or 
else projecting, for example, to the raphe to suppress BAT thermogenesis. 
Alternatively, a less well-studied population of cholinergic neurons within the DMH 
respond to increases in ambient temperature, project to the raphe pallidus, and 
suppress BAT thermogenesis. This population might also be involved in suppressing 
thermogenesis during torpor (Jeong et al. 2015).  
Multiplex RNA in-situ hybridisation was performed in an attempt to establish the 
phenotype of the DMH torpor-promoting neurons, which were identified in this 
chapter. In the data presented here, the major transmitters expressed within the DMH 
were found to be glutamate, GABA, and galanin. These cell types have all been 
previously identified within the DMH. For example, both glutamatergic and GABAergic 




galanin-expressing neurons with a role in directing food-seeking behaviour have been 
identified (Qualls-Creekmore et al. 2017). Previous work has also identified DMH 
expression of NPY (Bi, Kim, and Zheng 2012), orexin (Nollet et al. 2011) and TRH (Chou 
et al. 2003). In the experiments presented here, leptin and kappa opioid receptor 
expression predominated over NPY receptor 1 within the DMH. Leptin receptor-
expressing neurons in the DMH drive thermogenesis and locomotor activity (Rezai-
Zadeh et al. 2014). Kappa opioid receptors are believed to be widespread throughout 
the hypothalamus (Weems et al. 2016). Hence, the multiplex RNA scope assay 
successfully identified neuronal phenotypes within the DMH, in a pattern that agrees 
with the literature. 
However, it was not possible to identify a common phenotype amongst the neurons 
that were TRAPed, in terms of individual RNA target expression or combinations of 
expression. A group of seventy TRAPed neurons did not express any of the other RNA 
targets, and these may represent a population that contribute to the augmentation of 
torpor seen in in this chapter. That they express neither VGLUT2, VGAT, nor ChAT 
might raise the possibility that they are glia, which have been implicated in controlling 
food intake and energy balance (MacDonald et al. 2019; Argente-Arizón et al. 2017), 
and are capable of expressing c-fos, hence they could be TRAPed (Edling, Ingelman-
Sundberg, and Simi 2007). However, the use of the synapsin promoter in the vectors 
described here means that they are unlikely to express the viral transgene even if they 
were TRAPed. Alternatively, this group of TRAPed neurons could conceivably only 




Overall, 35% of all cells within the medial portion of the DMH expressed mCherry, 
indicating that they had been TRAPed. Even if 35% of neurons within the DMH really 
had fired sufficiently to activate c-fos gene expression around the time of the 4-OHT 
injection in experiment 5.1, it seems unlikely that they would all be involved in torpor 
induction. The high proportion of TRAPed cells probably accounts for why it was not 
possible to identify a single phenotype. There are two reasons why such a high 
proportion of neurons might express mCherry. Firstly, it is possible that the reduced 
body temperature associated with torpor reduces the rate of clearance or alters the 
volume of distribution of 4-OHT (Zhou and Poloyac 2011), such that neurons that are 
active many hours after the time of the injection are TRAPed. Secondly, the leak 
observed in mice given DMH pAAV2-hSyn-DIO-hM3Dq-mCherry vector injections but 
no 4-OHT might account for the high proportion of TRAPed cells. If neurons that are 
transduced with the vector can express the DREADD without 4-OHT exposure then 
over time an increasing proportion of neurons within the DMH will do so, independent 
of whether they are active during torpor.  
Results from Chapter 3, in which TRAP x Tomato mice were not given 4-OHT indicates 
that the TRAP component of the system exhibits minimal leak (Figure 3-12). That is to 
say, in the absence of 4-OHT, any Cre generated by activation of the c-fos gene 
promoter remains in the cytoplasm and does not enter the nucleus to recombine the 
floxed transgenes. Hence, the leak observed in the experiments from this chapter is 
likely to originate predominantly from the vector. Leak in supposedly Cre-dependent 
vectors is a recognised phenomenon (Fischer, Collins, and Callaway 2019). The process 
of generating vectors from plasmids produces a small but detectable proportion of 




orientation and will therefore result in transgene expression in the absence of Cre. 
Also, there is evidence of low-level transcription of the inverted ‘unreadable’ 
transgene in-situ after vector transfection. 
Vector leak, resulting in expression of the DREADD in neurons that are not necessarily 
active during torpor, would be expected to reduce the probability of seeing a torpor-
promoting effect on chemoactivation. The signal from those neurons that were 
appropriately torpor-TRAPed might be obscured by signal from off-target neurons 
expressing the vector due to leak. At worst, given the role of the DMH in driving 
thermogenesis, DREADD expression through leak in non-torpor inducing neurons 
might actively counteract torpor entry. Given that chemoactivation of DREADD-
expressing DMH neurons did promote torpor entry, either the degree of leak is not 
physiologically important, or else the torpor-promoting neurons within the DMH have 
a potent effect that over-rides any off-target chemoactivation due to leak. The 
RNAscope assay used here is capable of identifying single RNA molecules (Wang et al. 
2012). This means that the assay can detect even very low levels of RNA transcription. 
Low levels of transcription might occur when a cell is transduced by a single vector that 
carries the transgene in the non-inverted orientation, or else by the occasional 
transcription of the transgene that remains in the inverted orientation. Hence, low 
level leaky transgene RNA levels, which may not result in physiologically relevant 
DREADD expression, might still be detectable using RNAscope.  
The excitatory DREADD vector (pAAV2-hSyn-DIO-hM3Dq-mCherry) was used at a final 
titre of 3.7x1012 viral genomes per ml. Future experiments might mitigate some of the 






FIGURE 5-17 PUTATIVE TORPOR-PROMOTING DMH NEURON FIRING RATE VS EFFECT 
Under calorie restriction conditions in which natural torpor occurs, DMH torpor-promoting 
neurons are sufficiently active to be TRAPed but have a small effect on the probability or depth 
of torpor (2). Chemoinhibition of these neurons, reducing their activity below the level that was 
present when they were TRAPed has minimal effect on the overall probability or depth of torpor 
because the rate is already far to the left on the activity-response curve (1). Increasing the firing 
of these neurons above the level that was present when they were TRAPed has a significant 





load of vectors that potentially carry the transgene in the readable orientation. It 
would also reduce the number of copies of the transgene per neuron, reducing the 
probability of leaky transcription of the genes that are appropriately in the inverted 
‘unreadable’ orientation. An important future experiment would assess the degree of 
leak at differing vector titres, and to compare that to the expression in animals that 
have been exposed to 4-OHT in order to find the optimal balance between leak and 
inducible expression.  
Chemoinhibition of DMH torpor-TRAPed neurons did not prevent torpor induction in 
calorie restricted mice. It is worth noting that incomplete suppression of neuronal 
firing with the inhibitory DREADD, hM4Di, has been reported (K. S. Smith et al. 2016). 
Therefore, this result could be simply due to failure to inhibit these DMH neurons 
sufficiently to prevent their contribution to torpor. Ex-vivo slice recordings from the 
DMH of torpor-TRAPed neurons might help to clarify the degree of neuronal silencing 
achieved by CNO. However, taken at face value, this finding suggests that while the 
torpor-TRAPed DMH neurons are capable of promoting torpor entry, their activity is 
not required for it. This makes it less likely that the ‘master switch’ for torpor lies 
within the population of torpor-TRAPed DMH neurons. It also implies that torpor-
TRAPed DMH neurons are sufficiently active during calorie restriction-induced torpor 
to be TRAPed, but that reducing this level of activity has little effect on the likelihood 
of torpor. On the other hand, chemoactivation of these neurons generates a significant 
torpor-promoting effect (Figure 5-17). Hence, under the conditions of five days calorie 
restriction used to induce and TRAP natural torpor, the DMH may not play the major 




promote torpor both in terms of the probability of its occurrence, and the subsequent 
depth and duration.  
Conclusion 
This chapter provides direct evidence to support the hypothesis that torpor is a 
centrally driven phenomenon, since modulation of central neuronal activity affects the 
probability and depth of torpor. The data here indicates that the DMH contains 
neurons that promote torpor entry and increase its depth and duration, but that these 
neurons are not necessary for torpor induction. The next chapter describes a similar 
experiment targeting neurons in the preoptic area, and explores their contribution to 













Chapter 6 The preoptic area contains a torpor switch 
6.1  Introduction 
Chapter 3 identified the dorsomedial hypothalamus (DMH) and preoptic areas (POA) 
as regions of the mouse brain that show preferential activation during torpor. Chapter 
5 tested the role of these torpor-active neurons in the DMH. Presenting evidence that 
they were capable of promoting torpor both in terms of the probability of a bout 
occurring during calorie restriction, and the duration and depth of those bouts when 
they did occur. However, the torpor-TRAPed DMH neurons did not appear sufficient to 
trigger synthetic torpor – i.e. torpor in the absence of calorie restriction. This chapter 
focuses on the role of the POA in torpor.  
As discussed in Chapter 1, the POA is a key region involved in thermoregulation, sleep, 
and control of energy expenditure. Signals regarding the external environmental 
temperature, core body, and hypothalamic temperature are integrated in the median 
and medial preoptic nuclei, which modulate a descending GABAergic pathway to the 
DMH. Activation of this GABAergic projection to the DMH inhibits thermogenesis (Z. 
Zhao et al. 2017; Tan and Knight 2018; Song et al. 2016). The POA also contains 
neurons that drive entry into sleep, and link the induction of NREM sleep with the 
accompanying drop in core temperature (Harding et al. 2018). Finally, the POA is rich 
in leptin receptors, which provide a signal regarding the stored energy reserves (Myers 
and Cowley 2008). Activating these leptin receptor expressing POA neurons inhibits 
thermogenesis (Yu et al. 2016). Reduced leptin signalling has been implicated in torpor 
induction (Swoap et al. 2006). Hence, the POA is well positioned to orchestrate many 




It is perhaps no surprise then, that both data from Chapter 3, and another published 
study looking at c-fos gene transcription in hibernating ground squirrels, find evidence 
of increased activity in this hypothalamic area during torpor (Bratincsák et al. 2007b). 
The question persists, however: is the activation of the POA causal in torpor induction, 
or is it simply activation of a cold-sensing pathway, detecting the drop in core 
temperature?  
This chapter aims to begin to answer this question, as well as those introduced in 
previous chapters, such as whether there is a torpor ‘master switch’, and whether 
torpor is induced and maintained by the same population of neurons. In order to do 
this, a similar approach was taken to that described in chapter 5, using TRAP2 mice and 
Cre-dependent vectors to conditionally express excitatory DREADDs in neurons within 
the POA that are active during torpor.  
6.2  Methods: 
6.2.1  Mice 
Mice bred and housed as described in Chapter 5.  
6.2.2  Viral vectors 
Two viral vectors were used in this experiment: 
• pAAV2-hSyn-DIO-hM3Dq-mCherry was a gift from Bryan Roth (Addgene viral 
prep #44361-AAV2; www.addgene:44361) (Krashes et al. 2011); 4.6x1012 viral 
genome copies per ml. This vector delivered a Cre-dependent mCherry-tagged 
excitatory DREADD gene under the human synapsin promoter. It was mixed in 
a 4:1 ratio with the eGFP-expressing vector described below, giving a final titre 
for this vector of 3.7x1012 viral genomes per ml. 
• pAAV2-CMV-PI-EGFP-WPRE-bGH was a gift from James M. Wilson (Addgene 




per ml. This vector delivered the gene coding for enhanced green fluorescent 
protein (EGFP) under a ubiquitous CMV promoter. This vector was used to 
confirm the localisation of injection, because the expression of mCherry 
fluorescence in the two vectors above is contingent on successful TRAPing (and 
so would not be visible if the injected area is not TRAPed). 
6.2.3  Vector injections 
Viral vector injection procedures were as described in Chapter 5, with the exception 
that the injection coordinates differed in the following manner. Burr holes made 
bilaterally at bregma +0.5mm, lateral ±1mm with a robotic drill attachment (Neurostar, 
Germany). The microcapillary pipette was inserted at an angle of 10° towards the 
midline ±1mm lateral on the brain surface. Bilateral injections were made at of 4.5 and 
4.25mm depth relative to the surface of the brain, each injection was 180nl and was 
delivered at a rate of 100nl/minute. The injection pipette remained in place for one 
minute following the first injection and for five minutes before removing.  
6.2.4  Drug preparation 
4-Hydroxytamoxifen  
The z-isomer of 4-hydroxytamoxifen (4-OHT) is the active isomer (www.tocris.com). It 
was dissolved in chen oil using the following method (Guenthner et al. 2013).  Firstly, 
4-OHT was dissolved in neat ethanol at 20mg/ml by shaking at 400rpm and 37°C for 
30-60 minutes until fully dissolved. Two parts chen oil for every one part ethanol was 
then added, and the ethanol was evaporated off using a vacuum centrifuge leaving a 
final solution of 10mg/ml in chen oil. Drug was prepared on the day of use, and if not 
used immediately, was kept in solution in the oil by shaking at 400 rpm at 37°C. Once 





CNO was dissolved at 1mg/ml in sterile water at room temperature. Aliquots were 
stored protected from light for up to one week at room temperature.  
Beta-3 adrenoceptor antagonist (SR-59230A) 
SR-59230A was dissolved in sterile water at 0.2mg/ml. Solutions were stored at -20°C 
for up to 4 weeks.  
6.2.5  Chemoactivation of POA torpor-TRAPed neurons 
Viral vectors were used to deliver Cre-dependent hM3Dq excitatory DREADD 
transgenes into the POA of TRAP2 mice. After at least two weeks recovery, mice were 
entered into the calorie restriction torpor induction protocol (see chapter two) and 
received vehicle (chen oil) injections seven hours after lights off on days one to four, in 
a protocol identical to that described in experiments 4.2, 5.1, and 5.2. On day five, and 
in anticipation of torpor entry, mice received 4-OHT 50mg/kg i.p., which was given 
seven hours after lights off, as usual. These mice were called ‘hM3Dq-POA-torpor-
TRAP’. 
Following a further two weeks to allow return to baseline weight and to allow 
expression of the DREADD protein, mice were screened for synthetic torpor in 
response to chemoactivation of the POA torpor-TRAPed neurons with CNO at 5mg/kg 
i.p. If no synthetic torpor response was observed with surface thermography then the 
mice entered a randomised, crossover design, calorie restriction trial as described in 
experiments 4.2, 5.1, and 5.2. This was conducted to identify any effect of 
chemoactivation on the probability or depth of torpor. During this trial, each mouse 




injections (5ml/kg, i.p.) during the five days of calorie restriction. The occurrence and 
depth of torpor was monitored with surface thermography. Following this first arm of 
the study, and after at least five days with free access to food, the process was 
repeated with mice that initially received saline now receiving CNO, and vice versa. 
Torpor depth scores were calculated daily for each mouse, as the area of the 24-hour 
temperature profile that was below the threshold for torpor as defined in chapter two. 
6.2.6  Immunohistochemistry  
Mice were culled by terminal anaesthesia with intraperitoneal pentobarbitone 
(175mg/kg, Euthatal). They were trans-cardially perfused with 10ml heparinised 0.9% 
saline (50 units/millilitre) followed by 20ml of 10% neutral buffered formalin. Brains 
were removed and stored in fixative solution for 24 hours at 4°C before being 
transferred to 20% sucrose in 0.1M phosphate buffer (PB), pH 7.4, and again stored at 
4°C. Coronal sections were cut at 40µm thickness on a freezing microtome. 
Immunohistochemical analysis of hM3Dq-mCherry fusion protein expression was 
performed using a rabbit anti-mCherry primary (Biovision 5993, 1:2000), with donkey 
anti-rabbit secondaries (Alexafluor594, 1:1000). Sections were imaged using a Zeiss 
Axioskop II inverted microscope with a CooLED pE-100 excitation system, excitation 
filter 546/12nm, dichroic mirror 580nm, emission filter 590nm. 
6.2.7  Statistical analyses 
Data is presented as mean ± standard deviation when normally distributed, otherwise 
it is presented as median [interquartile range]. The Kolmogorov-Smirnov test for 
normal distribution was used. Statistical analyses were carried out using GraphPad 




distributed data, Mann-Whitney U, and Wilcoxon matched-pairs signed rank tests 
were used for non-normally distributed data.  
6.3  Results 
Chemoactivation of POA torpor-TRAPed neurons generates synthetic torpor 
Six TRAP2 mice underwent bilateral injection of the pAAV2-hSyn-DIO-hM3Dq-mCherry 
vector into the preoptic area. Following recovery, they were entered into the calorie 
restriction torpor induction protocol and received 4-OHT (50mg/kg i.p.). All six mice 
entered torpor following 4-OHT administration on day five of calorie restriction (Figure 
1-1). Mean time from 4-OHT administration to torpor entry was 2.90 ±1.23 hours. 
Duration of torpor following 4-OHT was 2.50 ±1.49 hours, nadir surface temperature 
reached was 26.1 ±1.6°C.  
In one hM3Dq-POA-torpor-TRAP mouse (‘Mouse #2’), chemoactivation of POA torpor-
TRAPed neurons resulted synthetic torpor while housed at 21°C ambient temperature 
and with free access to food, that is to say, in the absence of any natural stimulus for 
torpor (Figure 1-2). As observed in Chapter 4, experiment 4.1, synthetic torpor was 
again CNO dose dependent, both in terms of depth and duration. Mouse #2 responded 
to a CNO dose as low as 0.25mg/kg, generating a synthetic torpor bout with nadir 
surface temperature of 27.5°C and a duration of 7.39 hours. A dose of 5mg/kg 
generated a synthetic torpor bout with nadir surface temperature of 24.9°C and 
duration of 19.30 hours. In contrast to this, in experiment 4.1, 1mg/kg CNO was 
required in order to induce synthetic torpor Hence, synthetic torpor in the hM3Dq-
POA-torpor-TRAP mouse #2  was elicited at lower doses of CNO than that seen in the 




during synthetic torpor, a hunched position was assumed with the tail tucked beneath 
the mouse, a posture indistinguishable from natural torpor. Additionally, the mouse 
was responsive to external stimuli, as would be expected in natural torpor. 
Once again, the effect of beta-3 adrenoceptor blockade on synthetic torpor was 
assessed. In this case, administration of SR-59230A prior to delivery of CNO did not 
prevent synthetic torpor in response to CNO at 1mg/kg (Figure 1-3), a dose that 
otherwise generated a robust synthetic torpor bout. However, beta-3 blockade was 
associated with a reduced amount of time spent in synthetic torpor (7.38 compared to 
17.08 hours) and a reduced nadir temperature reached (27.5 versus 26.4°C), which 
might indicate partial inhibition of synthetic torpor.  
Between synthetic torpor bouts Mouse #2 continued to gain weight as expected 
(Figure 1-4) and showed no behavioural abnormalities. Synthetic torpor was 
reproducible during testing across more than eight weeks until the animal was culled 
for histological analysis of TRAPed neurons. 
The remaining five mice showed no synthetic torpor in response to CNO at 5mg/kg 
(Figure 1-2B). Four of these hM3Dq-POA-TRAP mice were entered into calorie 
restriction with CNO or saline given over five days followed by a crossover repeat trial 
(analogous to experiments 4.2 and 5 for the DMH). These mice showed no 
augmentation of torpor when receiving CNO compared to saline during calorie 
restriction (Figure 1-5 and Figure 1-6). No effect of CNO was seen on the first day of 
torpor appearance (3.5 days [2.3 – 4] on CNO trials versus 4.5 days [1.8 – 5] on saline 
trials, Wilcoxon matched-pairs signed rank test, p  = 0.75), nor on the total number of 




versus 2 bouts [1.3 – 2.8] on saline trials, Wilcoxon matched-pairs signed rank test, p = 
0.63), nor the weight of mice at which torpor first appeared (23.3g [22.0 – 25.5] versus 
24.0g [21.6 – 25.4], Wilcoxon matched-pairs signed rank test, p = 0.88). There were no 
systematic differences in the weight of mice on entry into the CNO compared to the 
saline trial arms (27.7g [26.3 – 30.2] on CNO trials versus 26.2g [25.4 – 30.2] on saline 
trials, Wilcoxon matched-pairs signed rank test, p = 0.25).  
There were no differences between calorie restriction trial arms  in which mice 
received CNO compared to when they received saline, in terms of time spent in torpor, 
nadir surface temperature reached, or aggregate torpor depth score. Two-way 
repeated measures ANOVA for each of these variables found main effects for day of 
calorie restriction, indicating more time was spent in torpor (F(4,12) = 4.01, p < 0.05), 
and nadir surface temperature decreased (F(4,12) = 14.87, p = 0.0001). There were no 
main effects for CNO versus saline in terms of time spent in torpor (F(1,3) = 0.71, p = 
0.46), nadir surface temperature reached (F(1,3) = 0.18, p = 0.70), or aggregate torpor 
depth score (F(1,3) = 0.58, p = 0.50). There were also no significant differences 
between CNO trial arms and saline trial arms on any of these measurements when 
analysed on a day-by-day basis (Fisher’s lest significant difference test, p > 0.05 in all 
analyses).  
Hence, although one mouse demonstrated a profound and reliable synthetic torpor in 
response to CNO in the presence of food, the remaining four mice did not show subtle 




POA injection site mapping 
The distribution of DREADD-expressing TRAPed cells was mapped from 
immunohistochemistry performed against the mCherry component of the hM3Dq-
mCherry fusion protein in five of the six hM3Dq-POA-TRAP mice (Figure 6-7 and Figure 
6-8). The brain from mouse #2, which demonstrated synthetic torpor, was kept aside 
for RNAscope analysis (which has not yet been possible to complete due to 
interruption caused by the Covid-19 outbreak). However, an initial review of the 
distribution of TRAPed neurons in Mouse #2 was made, on coronal sections cut at 
15µm thickness as required for the RNAscope assay, (see Chapter 5 section 5.2.5), and 
relying on the native fluorescence of the mCherry tag that is fused to the hM3Dq 
DREADD (Figure 6-9).  
Examination of the hM3Dq-POA-torpor-TRAP mice that did not show synthetic torpor 
revealed mCherry-labelled fibres and cell bodies from bregma +0.62mm to bregma -
0.58mm in the anterior-posterior axis, around the midline and extending laterally 
approximately 0.75mm. This was the area that was targeted, and included the median 
preoptic nucleus, the medial septal nucleus, the medial preoptic area, the medial 
preoptic nucleus, the septohypothalamic nucleus, the paraventricular thalamus and 
hypothalamus, and the reuniens thalamic nucleus.   
Comparison of the distribution of TRAPed neurons in Mouse #2 with the remaining 
mice that showed no response to chemoactivation reveals some minor differences. 
TRAPed neurons in Mouse #2 tended to be seen in a more ventral, medial, and rostral 
distribution. Hence, TRAPed cells were concentrated in a smaller region that 




nucleus, the medial preoptic nucleus, the periventricular hypothalamic nucleus, and 
the subfornical organ (Figure 6-8 and Figure 6-9) .    
6.4  Discussion 
At the time of completing these experiments, they represented the first demonstration 
of synthetic torpor driven by chemoactivation of neurons within a discrete and defined 
region of the brain. These observations have significant implications for our 
understanding of torpor. They confirm that torpor can be induced by the activation of 
central neurons, because the transgenes were delivered only to a focal region within 
the hypothalamus. This data indicates that those neurons, which potentially represent 
a torpor ‘master switch’, lie in a relatively limited region within the antero-medial 
portion of the preoptic area.  
Another question in the field of neural control of torpor is whether a single population 
of neurons both triggers and maintains torpor, or whether distinct populations provide 
each of these roles (Bratincsák et al. 2007b). The data presented here cannot 
definitively answer this question, however, one might hypothesise that if a group of 
neurons that only trigger torpor but do not maintain it were TRAPed, then the result of 
chemoactivation might be to induce several repeated short-lived bouts. On the other 
hand, if just a population that maintain torpor were TRAPed, then additional stimuli – 
such as calorie restriction - might be required to first trigger torpor, after which the 
effect of chemoactivation would be to prolong those bouts. Chemoactivation of 
torpor-TRAPed POA neurons resulted in synthetic torpor that lasted up to twenty 
hours. This persistent synthetic torpor, in the absence of a natural stimulus for torpor, 




both triggers and maintains torpor. Having said that, on one occasion (Figure 6-2, CNO 
5mg/kg dose), administration of CNO at 5mg/kg generated an oscillation in core 
temperature that could represent several distinct torpor bouts caused by driving 
torpor induction without driving its maintenance. 
It is also possible that the TRAPed POA population here includes two separate groups 
of neurons, one of which induces and the other maintains torpor. Chemoactivating 
these two populations simultaneously could, conceivably, generate a prolonged 
synthetic torpor bout such as is presented in this chapter. Clearly, further work is 
needed to determine whether or not torpor is induced and maintained by the same 
neurons. Approaches to answer this question might include using smaller volume of 
viral vector delivering the floxed DREADD vectors into smaller discrete nuclei so that 
the effect of chemoactivation of more limited populations of neurons can be assessed. 
This might allow TRAPing of only the induction or the maintenance neurons - if such 
distinct populations exist. Alternatively, if DREADD expression were directed to 
neuronal phenotypes using specific gene promoters  to drive Cre expression, one 
might be able to establish one phenotype that induces torpor, and another that 
maintains it. 
It is important to also consider whether synthetic torpor is indeed an analogue of 
natural torpor, or whether instead synthetic torpor represents disruption of normal 
thermoregulation. As introduced above, and in Chapter 1, several investigators have 
demonstrated that chemoactivation of thermoregulatory neurons within the POA 
induces hypothermia (Tan et al. 2016; Z. Zhao et al. 2017; Song et al. 2016; Yu et al. 




targeted neurons were warm sensing, that is to say, they increase their firing in 
response to increased core or ambient temperature. Hence, they represent part of the 
normal thermoregulatory system whereby rising temperature inhibits thermogenesis. 
The use of activity dependent TRAPing in the experiments presented in this chapter 
means that it is unlikely that synthetic torpor represents activation of purely warm-
sensing thermoregulatory neurons. Warm-sensing neurons would be expected to show 
minimal activity in calorie restricted mice held at 21°C in the period leading up to 
torpor initiation. Hence, on the day of TRAPing, when 4-OHT was administered, they 
would not be active and therefore should not be TRAPed. 
So, it is unlikely that synthetic torpor is induced by off-target TRAPing of a circuit 
whose sole function is to maintain normal body temperature homeostasis without a 
role in torpor. However, that is not to say that some of those warm-sensing neurons 
could not also play a role in natural and synthetic torpor. If thermoregulatory circuits 
were also sensitive to calorie deficit, then they might be engaged to induce torpor, 
driven now by energy deficit rather than rising temperature. Expression of leptin 
receptors in the preoptic area indicates that at least some neurons in this region are 
able to sense white adipose tissue energy stores (Yu et al. 2016).  
Several approaches could explore this further. Firstly, conditional expression of genes 
that allow in-vivo calcium imaging (e.g. GCaMP) alongside the excitatory DREADD 
would allow an analysis of the natural stimuli that activate the TRAPed neurons, hence 
one could establish whether neurons that are TRAPed during torpor are also active 
during exposure to a warm environment. Secondly, if there were an additional marker 




from chemoactivation of warm-sensing thermoregulatory neurons. Such a marker has 
not been established, but might involve: suppression of heart rate or oxygen 
consumption beyond that expected simply from the degree of hypothermia; changes 
to vascular tone, since neurons that drive a response to warm ambient temperatures 
should cause a decrease in total peripheral resistance (TPR), whereas torpor is 
associated with increased TPR (Swoap and Gutilla 2009); finally, one might identify 
torpor through measurement of mitochondrial function, since mitochondrial 
metabolism appears to be actively suppressed during torpor (Brown and Staples 2010).  
The phenotype of the neurons responsible for this synthetic torpor is not known, and 
the brain from Mouse #2 has been prepared for RNAscope, which might allow a cell 
type to be identified. Candidates include those discussed above: warm-sensing 
GABAergic neurons that project to DMH and inhibit thermogenesis in response to 
increased core or ambient temperature (Z. Zhao et al. 2017; Tan et al. 2016); warm-
sensing glutamatergic neurons that express leptin receptors, suppress body 
temperature, and may contribute to maintenance of body weight in light of changing 
energy demands from thermogenesis (Yu et al. 2016); or finally, warm-sensing 
glutamatergic neurons that express nitric oxide synthase, whose activation drives a 
drop in core temperature and entry into NREM sleep (Harding et al. 2018). However, is 
also possible that the neurons responsible for torpor induction do not form part of 
circuits that contribute to any other physiological processes, including 
thermoregulation or sleep. In this case, an altogether different phenotype might be 




Synthetic torpor in Mouse #2 was not blocked by pre-treatment with the beta-3 
adrenoceptor antagonist, SR-59230A. This finding is consistent with a model for torpor 
induction in which circulating leptin inhibits torpor-inducing neurons. Depletion of 
WAT energy stores reduces circulating leptin and disinhibits the neurons responsible 
for torpor induction. Another hypothesis proposes that the sympathetic nervous 
system drives suppression of leptin release via the action of beta-3 adrenoceptors on 
WAT, with the drop in leptin then triggering torpor (Swoap et al. 2006; Swoap and 
Weinshenker 2008). Within this model, in order for synthetic torpor to be independent 
of the activation of beta-3 adrenoceptors, a population of neurons that lie at or 
downstream of the detection of reduced leptin must have been TRAPed.  
Synthetic torpor in Mouse #2 from this chapter was generated by lower doses of CNO 
than the synthetic torpor seen in experiment 4.1. This might reflect the higher number 
of transgene copies that are delivered using vectors than were present in the neurons 
of the double-transgenic TRAP x DREADD mouse used in experiment 4.1. Higher 
transgene copy number might allow greater DREADD expression and therefore greater 
sensitivity to CNO. It might also be that selected delivery of the transgene system into 
the preoptic area allowed for fewer off-target,  or potentially counter-regulatory 
responses to be TRAPed alongside the target torpor-inducing population.  
Similar to the findings in experiment 4.1 using double transgenic TRAP x DREADD mice, 
the hM3Dq-POA-TRAP mice presented here demonstrated a heterogenous response to 
the experiment protocol. Mouse #2 generated a profound, reproducible synthetic 




hand, the remaining five mice did not. Indeed, the remainder did not show even a 
subtle modulation of the propensity to torpor during calorie restriction.  
One potential explanation for this divergence could be that the torpor bout following 
4-OHT administration in Mouse #2 was in some way different to the bouts seen in the 
remaining mice. However, examination of the torpor bout profiles (Figure 1-1) does 
not suggest that this accounts for the different responses to chemoactivation. The 
torpor nadir in Mouse #2 following 4-OHT was 27.3°C compared to 26.3 ±1.5°C for the 
cohort as a whole. Likewise, the duration was just 1.04 hours compared to 2.54 ±1.35 
hours. The time between 4-OHT administration and entry into torpor was 3.14 hours 
compared to 2.90 ±1.23 hours. Hence, the torpor seen in Mouse #2 on the day of 
TRAPing was neither the deepest, nor the longest, nor did it occur closest to the time 
of 4-OHT administration when compared to the cohort as a whole. Therefore, it is 
unlikely that differences in the timing, the depth, or the duration of the torpor bout on 
the day of TRAPing accounts for the heterogenous results from this experiment.  
One qualitative difference between the torpor bout following 4-OHT in Mouse #2 and 
the other mice in this experiment, is that Mouse #2 showed three distinct phases of 
reducing surface temperature following 4-OHT. This is not an unusual pattern, indeed 
Mouse #s 1, 4, and 5 showed two such phases of temperature reduction following 4-
OHT ((Figure 6-1). However, it is possible that each of these decreases in surface 
temperature reflect bursts of activity in the torpor-inducing neurons within the POA. 
This might have provided a particularly strong c-fos signal in Mouse #2 that allowed 
more nuclear translocation of Cre and in turn generated greater DREADD expression. 




or, because the vectors can introduce multiple copies of the Cre-dependent DREADD 
gene per cell, it might be the result of more copies of the DREADD gene being 
recombined and expressed per cell. 
Another possible explanation for the different response observed in Mouse #2 could 
lie in the distribution or density of the TRAPed neurons. Mouse #2 showed TRAPed 
neurons in slightly more rostral and more ventral regions of the POA , including in the 
anteroventral periventricular nucleus. As well as slightly different distribution of 
TRAPed neurons there could be differences in the number of transduced cells. Such a 
difference is not immediately obvious from comparison of the histology from Mouse 
#2 with the remainder of the cohort. Quantitative assessment of total TRAPed cell 
counts, and analysis of the phenotypes of TRAPed neurons in different nuclei within 
the POA of Mouse #2 compared to the remainder of the cohort is an important future 
experiment.   
Conclusion 
The data presented in this chapter represents the conclusion of a thread of evidence 
that runs through the thesis. In chapter 3, the preoptic area was identified as one of 
two regions that show increased activity dependent TRAPing in mice that enter torpor. 
Chapter 4 established that it is possible to use the same activity dependent TRAPing to 
chemoactivate neurons that are involved in torpor, generating a synthetic torpor state. 
Finally, in this chapter, torpor-TRAPed neurons within the preoptic area were 
chemoactivated, generating a synthetic torpor state even in mice that are fully fed and 





FIGURE 6-1 TORPOR PROFILES FROM HM3DQ-POA-TRAP MICE ON THE DAY OF TRAPING 
Six TRAP2 female mice, having undergone bilateral preoptic area (POA) injection of pAAV2-hSyn-DIO-hM3Dq-mCherry, were calorie restricted for five days. On the 
fifth day (shown here) they received 4-OHT seven hours after lights off in anticipation of a subsequent torpor bout. Animal number 2 showed profound synthetic 



















FIGURE 6-2 SYNTHETIC TORPOR IN HM3DQ-POA-TRAP MOUSE #2 
A, CNO at 0.25mg/kg, 0.5mg/kg, 1mg/kg, and 5mg/kg (from left to right) induced synthetic torpor, consisting of a drop in surface temperature and cessation of 
activity. B, hM3Dq-POA-TRAP mouse #1, underwent identical experimental interventions but showed no synthetic torpor in response to 5mg/kg CNO. Synthetic 
torpor (red line) defined as a period lasting at least one hour during which surface temperature remained at least four standard deviations below the baseline at that 







FIGURE 6-3 BETA-3 BLOCKADE DID NOT IMPAIR SYNTHETIC TORPOR IN HM3DQ-POA-TRAP MOUSE #2 
A, Pre-treatment with a selective beta-3 blocker (1mg/kg i.p., SR-59230A) did not block synthetic torpor in response to subsequent CNO (0.25mg/kg i.p.) in the 
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FIGURE 6-4 NORMAL WEIGHT GAIN IN HM3DQ-POA-TRAP MOUSE EXPRESSING SYNTHETIC TORPOR 
The expression of synthetic torpor did not affect weight gain in Mouse #2 (red circles). Black line 
indicates expected weight gain based on data for female C57BL/6J (the background strain), grey 
lines indicate standard deviation of expected weight gain, data from Jackson laboratory strain 





FIGURE 6-5 EFFECT OF CNO VS SALINE ON THE PROBABILITY OF TORPOR AND THE WEIGHT AT WHICH MICE ENTERED TORPOR IN CALORIE RESTRICTED HM3DQ-POA-TRAP MICE 
CNO did not affect the total number of days in which torpor occurred, the first day on which torpor occurred, nor the weight at which torpor first occurred during 




















FIGURE 6-6 TIME SPENT IN TORPOR, THE NADIR SURFACE TEMPERATURE, AND TORPOR DEPTH SCORES IN CNO 
VS SALINE TRIALS IN HM3DQ-POA-TRAP MICE 
CNO did not affect the total time spent in torpor, the nadir surface temperature reached, or  
 the aggregate torpor depth score in calorie restricted mice (n = 4 female mice, 2-way repeated 
measures ANOVA, no main effect for CNO vs saline, with Fisher’s least significant difference 





FIGURE 6-7 DREADD EXPRESSION IN TRAPED NEURONS FROM AN INDIVIDUAL HM3DQ-POA-TRAP MOUSE 
mCherry labelling (red) indicating DREADD expression in TRAPed cells in an hM3Dq-POA-TRAP 
mouse. Expression in the medial and lateral preoptic nuclei (MPO, LPO), in the medial preoptic 
area (MPA), and in the median preoptic nucleus (MnPO). Immunohistochemistry performed 
labelling the mCherry component of the hM3Dq-mCherry fusion protein. 40µm coronal 



























FIGURE 6-8 DREADD EXPRESSION ACROSS ALL FIVE HM3DQ-POA-TRAP MICE THAT DID NOT SHOW SYNTHETIC TORPOR 
Mapped extent of mCherry-labelled cell bodies, indicating TRAPed cells expressing DREADD. TRAPed cells were observed in the medial and lateral preoptic nuclei 
(MPO, LPO), the medial preoptic area (MPA), and the median preoptic nucleus (MnPO) (all marked in green (n=5). Expression also seen more dorsally in the 































FIGURE 6-9 DREADD EXPRESSION IN HM3DQ-POA-TRAP MOUSE #2, WHICH  DEMONSTRATED  SYNTHETIC TORPOR 
Mapped extent of mCherry-labelled cell bodies, indicating TRAPed cells expressing DREADD. TRAPed cells were observed in the medial and lateral preoptic nuclei 























Chapter 7 Discussion 
Activity-dependent recombination was used to target transgene expression to neurons 
that were active around the time of a natural torpor bout. This technique was first 
used to tag, with a fluorophore, those neurons that are active during torpor. 
Subsequently, the same mouse line was used to conditionally express DREADDs, either 
brain-wide or locally, in those neurons that are active during torpor. The main novel 
findings were that the preoptic area (POA) contains neurons capable of inducing 
torpor, and that the dorsomedial hypothalamus (DMH) contains neurons that promote 
torpor entry but are neither necessary nor sufficient for torpor induction.  
7.1  The preoptic area contains neurons capable of driving entry into 
torpor 
The POA was one of two hypothalamic regions that demonstrated increased activity-
dependent fluorophore expression in calorie restricted mice that entered torpor in 
Chapter 3. In Chapter 6, the POA was then targeted to express excitatory DREADD in 
neurons that were defined by their activation during natural torpor. Chemoactivation 
of torpor-TRAPed neurons in the POA was sufficient to induce a synthetic torpor state 
characterised by reduced body temperature and cessation of locomotor activity. 
Synthetic torpor could be triggered in mice housed at 21°C with free access to food, 
hence in the absence of any natural stimulus for torpor. It was repeatable and reliable 
with no evidence of causing any ill-effect. This established that torpor can be centrally 
triggered, and indicates that the POA contains neurons that act as a ‘master switch’ for 
torpor. 
The ‘preoptic area’ contains several distinct nuclei, several of which demonstrated 




POA-torpor-TRAP Mouse #2, which demonstrated synthetic torpor, suggests that the 
important neurons lie relatively rostral and medial within the anterior POA, an area 
that includes the medial preoptic area, the medial and median preoptic nuclei, and the 
anteroventral periventricular nucleus.  
7.2  The dorsomedial hypothalamus promotes, lengthens, and 
deepens torpor 
The dorsomedial hypothalamus (DMH) also demonstrated increased activity-
dependent fluorophore expression in mice that entered torpor compared to controls 
that did not (Chapter 3). Chemogenetic manipulation of the activity of torpor-TRAPed 
DMH neurons showed that, in the absence of an additional natural stimulus for torpor, 
TRAPed DMH neurons were not sufficient to induce synthetic torpor. However, 
chemoactivation of torpor-TRAPed DMH neurons in calorie restricted mice increased 
the probability of torpor, and increased the duration and depth of those torpor bouts 
(Chapter 5). Chemoinhibition of torpor-TRAPed DMH neurons did not reduce the 
probability of torpor, nor did it affect the depth or duration of torpor bouts. Hence, 
this data indicates that while torpor-TRAPed neurons in the DMH can promote and 
prolong torpor, they are neither necessary nor sufficient.  
7.3  Torpor induction, maintenance, and arousal 
An outstanding, and interesting question is whether torpor is controlled by a single 
group of neurons, whose activity drives entry into torpor and whose continued activity 
maintains torpor, with the bout terminating when those neurons stop firing. An 
alternative scenario would be that separate neurons trigger, maintain, and terminate a 




An experiment that demonstrated an effect on, for example, the depth or duration of 
torpor without also increasing the probability of torpor provides support for the idea 
that torpor is triggered and maintained by independent populations of neurons. On 
the other hand, if chemoactivating a population of neurons drives a single bout of 
synthetic torpor that is prolonged relative to natural torpor then that might support 
the hypothesis that a single population both triggers and maintains torpor.  
In Experiment 4.1 chemoactivation of brain-wide torpor-TRAPed neurons produced 
single prolonged bouts of synthetic torpor, lasting up to ten hours. Likewise, 
chemoactivation of torpor-TRAPed POA neurons in Chapter 6 generally produced 
single prolonged bouts of synthetic torpor that persisted for almost 24 hours. In 
Experiment 5, chemoactivation of DMH torpor-TRAPed neurons promoted torpor 
entry and increased its depth and duration. These observations tentatively support the 
idea that torpor is induced and maintained by a single population of TRAPed neurons. 
On the other hand, chemoactivation of torpor-TRAPed POA neurons with 5mg/kg CNO 
produced an oscillation in the surface temperature that could be interpreted as several 
distinct synthetic torpor bouts (see Figure 6-2A), as might be expected from driving 
torpor induction but not driving its maintenance. Furthermore, in Experiment 4.2, 
chemoactivation of brain-wide torpor-TRAPed neurons in mice that were calorie-
restricted increased the depth and duration of torpor without influencing its 
probability. Hence, the data presented here provides some support for both a single 
population and for multiple populations controlling torpor entry and maintenance 
arousal. Clearly, further work is needed. Future work could focus on recording the 




calcium imaging or implanted electrodes. Alternatively, chemogenetic activation of a 
more limited number of candidate neurons might answer this question. 
Torpor arousal is less well studied, although there is evidence that it requires beta-3 
adrenoceptor activation (Swoap and Weinshenker 2008). It is worth considering the 
possibility that a chemogenetic intervention that prolongs torpor could equally well do 
it by inhibiting arousal rather than activating induction or maintenance mechanisms. 
7.4  The findings in context of recent publications 
The demonstration that chemoactivation of torpor-TRAPed POA neurons generates 
synthetic torpor, while chemoactivation of torpor-TRAPed DMH neurons promotes, 
prolongs, and deepens torpor was novel at the time that the respective experiments 
were completed. However, during the drafting of this thesis, two papers published in 
the June 2020 issue of Nature provided powerful additional evidence on the central 
mechanisms of torpor induction.  
One of these studies, published by the Greenberg group at Harvard University, USA, 
used methods very similar to those presented in this thesis (Hrvatin et al. 2020). The 
authors first took the approach described in experiment 4.1, using a double-transgenic 
mouse that carried the TRAP2 gene and a Cre-dependent excitatory DREADD gene. 
Using this approach Hrvatin et al. demonstrated reliable torpor TRAPing and 
subsequently induced a synthetic torpor comparable to that presented in experiment 
4.1.  
Next, the authors injected TRAP2 mice with a Cre-dependent excitatory DREADD 
vector, AAV8-hSyn-DIO-Gq-mCherry (www.addgene.org/44361). They injected a large 




that includes the preoptic area), and subsequently delivered 4-OHT to the mice as they 
entered torpor. They later correlated the degree of hypothermia induced by CNO with 
the location of the vector delivery. This led to the conclusion that DREADD expression 
in the anterior and ventral portions of the medial and lateral preoptic area (avMLPA) 
was highly correlated with the degree of CNO-driven (synthetic) torpor.  
These torpor-TRAPed avMLPA neurons project to several regions likely to be involved 
in torpor including the dorsomedial hypothalamus. Further experiments suggest that 
within the population of TRAPed preoptic area neurons, a subset of glutamatergic, 
Adcyap1 expressing neurons were capable of generating the drop in temperature and 
activity observed during natural and synthetic torpor. The distribution of these 
glutamatergic-Adcyap1 expressing neurons within the preotic area overlaps with the 
area targeted by vector injections in Chapter 6 of this thesis (see Figure 7-1). 
The use of TRAPing in these experiments means that it is highly likely the 
chemogenetically-driven hypothermia observed is indeed analogous to torpor. 
However, the transition to phenotypic targeting of Adcyap1-expressing neurons, rather 
than activity-based targeting, risks activating neurons that do not naturally play a role 
in torpor, and excluding neurons of a different phenotype that do contribute to torpor. 
This is a recurring issue, and requires a means to objectively differentiate hypothermia 
due to disruption of normal thermoregulation from chemogenetically activated 
‘synthetic’ torpor. This issue will be discussed in more detail below.  
Hrvatin et al. describe an experiment using a double-transgenic approach that is very 
similar to experiments 4.1 and 4.2 described in Chapter 4 of this thesis. They used 




appears that at least ten of the mice entered synthetic torpor when given CNO in the 
fed state. This is in contrast to experiment 4.1, in which just one mouse out of eleven 
showed a response to CNO in the fed state. It is important to understand why these 
different success rates might have occurred.  
The mouse line used to provide the Cre-dependent excitatory DREADD in chapter four 
was the RC::L-hM3Dq (www.jax.org/strain/026943, see section 4.2.1). In contrast, 
Hrvatin et al used the R26-LSL-Gq-DREADD line (www.jax.org/strain/026220). While 
the CAG promoters employed, and the hM3Dq receptor encoded by this transgene is 
identical to that used in Chapter 4, the construction of the transgene and the Lox 
binding sites for Cre recombinase are considerably simpler. The mouse line used in 
experiments 4.1 and 4.2 relies on sequential recombination of the hM3Dq gene before 
a stable configuration is reached (see Figure 4-1). In contrast, the mouse line used by 
Hrvatin et al. relies on the Cre-dependent removal of a floxed STOP cassette. This 
design is simpler, and requires a single recombination event to create stable and 
permanent DREADD expression. Hence, this may be one reason why Hrvatin et al. 
achieved a higher rate of synthetic torpor induction. Additionally, although both 
transgenic lines aimed to insert the transgene into the Gt(ROSA)26Sortm1Sor locus, the 
line used by Hrvatin et al. was found to in fact insert randomly. Again, this can result in 
different patterns of expression.  
Hrvatin et al. delivered the 4-OHT injection while the mice were torpid (no more 
specific detail is  provided). While this was the approach taken in experiment 4.1, all 
other experiments in this thesis aimed to deliver the 4-OHT in the period immediately 




entry was chosen based on the early descriptions of the TRAP mouse (Guenthner et al. 
2013), weighted by a desire to avoid disturbing the occurrence of torpor. However, a 
subsequent publication provided greater detail relating to the optimal timing of the 4-
OHT injection (DeNardo et al. 2019). This data suggested that delivery of the 4-OHT 
three hours prior to the behaviour of interest might be premature and risks being too 
early to TRAP the target neurons. Hence, another possible reason for the improved 
success rate enjoyed by Hrvatin et al. might be their delivery of 4-OHT nearer to the 
point at which the mice entered torpor. Although it is worth noting that there is no 
evidence from the mice that demonstrated synthetic torpor in this thesis (Chapters 4 
and 6) that timing of 4-OHT delivery accounts for the heterogenous results.  
The vectors employed in this thesis and by Hrvatin et al. are identical in terms of the 
transgene structures and function. However, Hrvatin et al. used an AAV8, whereas an 
AAV2 was used in this thesis. Different AAV serotypes have varying rates of 
transduction and cell-type tropism (Zincarelli et al. 2008), and there are structural 
differences between AAV2 and AAV8 (Nam et al. 2007), with AAV8 showing enhanced 
tropism for astrocytes, for example (Aschauer, Kreuz, and Rumpel 2013). Hence, AAV8 
might have a better tropism for the torpor-inducing cells targeted in this thesis and in 
the experiments of Hrvatin et al., or AAV8 might have less tropism for off-target 
neurons that are not involved in torpor.  
Finally, Hrvatin et al., demonstrate that relatively small variations in the specific 
location of the vector delivery can determine whether torpor is successfully TRAPed. 
Indeed, they leverage this variability in the response to chemoactivation in order to 




suggests that synthetic torpor was associated with a more anterior and ventral delivery 
of the vector. Hence, another reason why only one mouse in Chapter 6 demonstrated 
synthetic torpor could be due to relatively small variations in the location of the vector 
injection site.  
The second paper, from the Sakurai group in Japan (Takahashi et al. 2020), used a 
different approach but came to similar conclusions. They targeted expression of 
excitatory DREADDs to hypothalamic neuropeptide pyroglutamylated RFamide peptide 
(Qrfp) neurons. This neuropeptide was previously implicated in the modulation of food 
intake, adrenal activity, and anxiety, but not torpor (Takayasu et al. 2006; Okamoto et 
al. 2016). Chemoactivation of Qrfp-expressing neurons in the medial preoptic area 
(MPA) and the anteroventral periventricular nucleus (AVPe, together termed 
AVPe/MPA) induced a long-lasting torpor-like hypothermic state in mice, with 
suppressed core temperature, oxygen consumption, heart rate, respiratory rate, and 
locomotor activity (termed QIH, for Q-neuron-induced hypothermia and 
hypometabolism). Again, these same regions were targeted and TRAPed in Chapter 6 
(see Figure 7-1).  
QIH was recapitulated by optogenetic activation of the terminals of AVPe/MPA Qrfp 
neurons in the DMH. It was predominantly dependent on glutamatergic transmission 
within the Qrfp neurons population, although GABAergic Qrfp neurons appear to 
contribute to a smaller extent. Finally, blocking synaptic transmission in Qrfp neurons 
impaired normal fasting-induced torpor and reduced the normal diurnal fluctuation in 






FIGURE 7-1 COMPARISON OF ANATOMY FROM THIS THESIS WITH THAT FROM HRVATIN ET AL  
A, section at Bregma +0.14mm from hM3Dq-POA-DMH-TRAP mouse #2 (Chapter 6), which demonstrated synthetic torpor-TRAPed neurons (mCherry, red) in the 
medial and lateral preoptic areas at Bregma +0.14mm. B, comparison section from Hrvatin et al., showing HA labelling (black), demonstrating torpor-TRAPed 
DREADD expressing neurons in the medial and lateral preoptic areas in a mouse that also demonstrated CNO-driven (synthetic) torpor. C, section at Bregma 
+0.26mm from hM3Dq-POA-DMH-TRAP mouse #2 (Chapter 6), which demonstrated synthetic torpor. D, corresponding figure from Takahashi et al. showing the 
distribution of Qrfp neurons within the AVPe/MPA. Abbreviations: aca, anterior commissure (anterior part); MPA, medial preoptic area; LPO, lateral preoptic area; 




Hence, the authors identified a population of Qrfp-expressing neurons whose cell 
bodies lie in the preoptic area, which have a role in torpor induction, and whose 
terminals project to the DMH. Activation of this Qrfp neuron projection from the 
AVPe/MPA to the DMH generates a torpor-like state in mice. RNA in-situ hybridisation 
revealed that approximately 80% of Qrfp neurons also express Adcyap1, indicating 
significant overlap with the torpor-induing neurons identified by Hrvatin et al.  
The data presented by Takahashi et al. largely supports the data presented in this 
thesis. However, they found that activating just the DMH terminals of these POA 
neurons was sufficient to induce QIH, whereas data presented in Chapter 5 suggests 
that torpor-TRAPed DMH neurons promote, prolong, and deepen torpor that must be 
triggered elsewhere. There are several possible explanations for these conflicting 
observations.  
Firstly, Takahashi et al targeted this POA to DMH projection based on the expression of 
Qrfp, not on the activity of these neurons during torpor. Hence, they did not establish 
that this specific projection is active during natural torpor or even plays a role in 
natural torpor. Although, it is likely that Takahashi et al. were activating a 
predominantly glutamatergic projection from the POA Qrfp neurons to DMH, this was 
not definitively demonstrated. This is an important question, since the observed 
hypothermia might, for example, be the result of activating the established POA to 
DMH GABAergic projection that is involved in warm-sensing and thermoregulatory 
homeostasis (Tan et al. 2016), rather than a specific torpor-inducing pathway. In 
contrast, in Chapter 5, torpor-TRAPed neurons were within the DMH were activated 




Indeed, there were some differences between natural torpor and QIH induced by 
Takahashi et al., which appear to relate to whether the mouse is attempting to lose 
heat to the environment. During natural torpor, the mouse adopts a curled-up posture 
consistent with attempts to conserve heat, irrespective of the ambient temperature. 
During  QIH, at high ambient temperature, the mouse adopts an extended posture, 
consistent with attempts to lose heat. In addition, at 21°C ambient temperature, QIH is 
associated with an initial increase in tail surface temperature, indicating vasodilatation. 
In contrast, natural torpor is associated with increased total peripheral resistance, 
which suggests at least on the whole-body scale, vasoconstriction (Swoap and Gutilla 
2009). Hence, there remains a question regarding the degree of overlap between QIH 
and natural torpor.  
When stimulating the DMH terminals of POA Qrfp neurons, Takahashi et al. took steps 
to avoid back-propagation of action potential to the POA Qrfp cell bodies. However, it 
is possible that this was not entirely effective and that the torpor-like state they 
induced was partly driven by activating other projections from the POA, which could 
include activating the proposed torpor ‘master switch’. 
Finally, it is possible that the DMH torpor-TRAPed neurons identified in Chapter 5 
could, under different circumstances have been sufficient to induce synthetic torpor. 
Data from this thesis, and from the Hrvatin et al. paper demonstrate that small 
differences in the location of TRAPed neurons can have significant effects on the 
subsequent induction of synthetic torpor. Hence, the vector delivery into the DMH 
might have missed the crucial neurons that receive inputs from POA Qrfp neurons, or 




7.5  Towards a torpor circuit 
The data presented in this thesis, alongside the studies of Hrvatin and Takahashi 
represent significant advances in our understanding of torpor. From this data, a model 
that emerges is that glutamatergic neurons in the preoptic area, which express 
Adcyap1 and / or Qrfp, project to the dorsomedial hypothalamus and generate torpor.  
The preoptic area is well-placed for the role attributed to it in this model. It is a key site 
involved in thermoregulation and energy balance (see Chapter 1, section 1.3, and 
Chapter 6), receiving information regarding the external environmental temperature  
as well as directly sensing hypothalamic temperature (Song et al. 2016), this 
information is then used to modulate BAT thermogenesis (Tan et al. 2016; Z. Zhao et 
al. 2017).  
Warm-sensing glutamatergic POA neurons also play a role in coordinating the parallel 
decrease in core temperature observed with the onset of NREM sleep (Harding et al. 
2018). NREM sleep has several characteristics in common with torpor (see chapter one 
section 1.5.5): it is a hypoactive, hypometabolic, bradycardic state, with maintained 
thermoregulation despite a reduced core body temperature (Glotzbach and Heller 
1976; Heller and Glotzbach 1977; Kräuchi 2007; Schwimmer et al. 2010). Supposing 
that torpor is induced by the same circuit that links reduced body temperature with 
NREM sleep onset, then the distinction between the two states might rest upon the 
degree to which these POA glutamatergic neurons are activated. This could be either in 
terms of firing frequency, or duration.  
A drop in core temperature preceding sleep onset is also observed in humans 




glutamatergic neurons in the medial preoptic area might represent a common circuit 
that links NREM sleep onset, the core body temperature alterations associated with 
sleep, and torpor. In keeping with this hypothesis, Takahashi et al. (Takahashi et al. 
2020) observed disrupted diurnal temperature variation in mice in which POA Qrfp 
neurotransmission was blocked. It would be very interesting to establish the degree of 
overlap between the POA glutamatergic neurons that drive NREM sleep and cooling as 
identified by Harding et al. (Harding et al. 2018), and the torpor-inducing neurons 
identified by Hrvatin et al., and Takahashi et al. 
In order to contribute to torpor induction, POA circuits with a role in thermoregulation 
and sleep induction within the POA would need to also receive information regarding 
the nutritional status of the animal. Such information might come from circulating 
leptin, receptors for which are indeed found on hypothermia-inducing glutamatergic 
neurons in the POA (Yu et al. 2016).  
The dorsomedial hypothalamus is well-placed to play a role in torpor-induction. 
Established in thermoregulation (see chapter one, section 1.3) (Liedtke 2017; Jeong et 
al. 2015; Z. Zhao et al. 2017), the dorsomedial hypothalamus adjusts circadian rhythms 
based on the timing of food availability (Gooley, Schomer, and Saper 2006). One might 
speculate that the dorsomedial hypothalamus integrates information about the 
availability and timing of food in order to optimise the timing of torpor, the timing of 
which is known to be under circadian control but can be adjusted according to food 
availability (van der Vinne et al. 2018). 
This model describing how POA to DMH projections are involved in torpor induction 






FIGURE 7-2 SCHEMATIC COMPARING THERMOREGULATION WITH TORPOR INDUCTION PATHWAYS 
The current thermoregulatory model (left) proposes predominantly GABAergic projections from 
POA to DMH. These GABAergic projections are activated by skin, viscera, or CNS warming and 
pyrogens. DMH contains both glutamatergic and GABAergic neurons, the activation of which 
causes increased BAT thermogenesis, vasoconstriction, and increased core temperature. The 
location of the second GABAergic neuron in the relay from DMH to raphe pallidus has not been 
established. The emerging model for torpor induction (right) suggests glutamatergic / Adcyap1 / 
QRFP neurons project from POA to DMH. Similar to the effects of activating the GABAergic POA 
to DMH, activating this excitatory POA to DMH pathway reduces body temperature, and in this 
case, induces torpor. The nature of the DMH neurons that are activated by the excitatory POA 




interesting ways (see Figure 1-2). Current understanding of homeostatic 
thermoregulation proposes that a predominantly GABAergic projection from the POA 
synapses on both GABAergic and glutamatergic neurons in the DMH (Zhao et al. 2017; 
Tan et al. 2016). Activation of either the glutamatergic or the GABAergic neurons in the 
DMH drives thermogenesis (Z. Zhao et al. 2017). Hence, core temperature is 
determined by the balance between, on the one hand, the activity of DMH 
glutamatergic and GABAergic neurons, both of which drive thermogenesis, and on the 
other hand, the inhibitory input from the POA GABAergic neurons, which suppresses 
this thermogenic activity in the DMH.  
In contrast, the torpor-inducing pathway appears to involve a predominantly 
glutamatergic projection from the POA to the DMH, consisting of neurons that express 
Adcyap1 and / or Qrfp (Hrvatin et al. 2020; Takahashi et al. 2020). Activation of this 
presumably excitatory POA to DMH pathway induces torpor (Takahashi et al. 2020). 
The nature of the DMH neurons targeted by this projection is unknown, but they 
appear to have antagonistic effects to the populations of glutamatergic and GABAergic 
neurons implicated in homeostatic thermoregulation (Zhao et al. 2017). That is to say, 
previously identified DMH neurons - be they glutamatergic or GABAergic – are thought 
to drive thermogenesis (Zhao et al. 2017), whereas the population targeted by the 
excitatory Adcyap1 / Qrfp projection from the POA appear to induce hypothermia and 
torpor. One possibility is that these cold-inducing DMH neurons are cholinergic (Jeong 




7.6  Strengths and weaknesses of the approach taken in this thesis 
The TRAP2 mouse provides a powerful tool for neuroscientists to target specific 
populations of neurons defined by their activity during a behaviour of interest. The 
strength of approach is demonstrated by the fact that both this thesis, and the recent 
paper by Hrvatin et al. have been able to use it to identify a torpor ‘master switch’ in 
the preoptic area of the hypothalamus. Just as with any approach that utilises the c-fos 
gene activation as a surrogate for neuronal activity, there are some caveats, including 
low temporal resolution that operates across tens of minutes to hours, inability to 
detect neurons whose activity is suppressed by a behaviour of interest, confounding by 
constitutive c-fos activation, and the existence of neurons that appear to never 
activate the c-fos gene (reviewed in Kovács, 2008).  
The transgenic mouse line used in Chapter 4, had a complicated structure that allowed 
several different recombination events, some of which were non-permanent and could 
be recombined back to a configuration that does not result in DREADD expression. In 
hindsight, the more straightforward transgene structure in the mouse used by Hrvatin 
et al. is preferable. The full complexity of the RC::L-hM3Dq line was not appreciated 
until after the experiments were started.  
Leak was observed in control TRAP2 mice undergoing DMH injection of pAAV2-hSyn-
DIO-hM3Dq-mCherry without 4-OHT delivery (see Chapter 5, section 5.3.3). Also, 
almost 35% of all cells within the region of the DMH analysed for RNA ISH expressed 
mCherry following 4-OHT exposure, indicating that the transgene had been 
recombined.  While it is possible that this high rate of DREADD expression in the DMH 




of the 4-OHT injection, it seems likely that at least some of those DREADD-expressing, 
mCherry positive cells in fact also represent leak. By comparison, Hrvatin et al., 
sequenced a total of 28,103 neurons from the anteroventral preoptic area from five 
mice. Four of these mice had received 4-OHT during torpor. They found a total of 342 
TRAPed neurons in the four torpor-TRAPed mice. Assuming that the number of 
neurons sequenced was equal across the five mice, then they sequenced 
approximately 22,500 neurons from the anterior POA of torpor-TRAPed mice. This 
indicates that they TRAPed just 1.5% of neurons in the POA following 4-OHT, which is a 
surprisingly low value. 
As introduced in chapter five, Cre-dependent AAVs are known to suffer from some 
expression in the absence of Cre exposure, and some of this leak can be mitigated by 
using lower concentrations of vector (Fischer, Collins, and Callaway 2019). The vector 
concentration for the excitatory DREADD vector used by Hrvatin was between 5x1012 
and 1x1013 viral genomes per ml. By comparison, the final excitatory DREADD vector 
concentration used in the experiments presented in Chapter 5 was 3.7x1012 viral 
genomes per ml. These concentrations are similar, but it is possible that the batch 
used in the experiments presented in this thesis had a greater proportion of vectors 
that contain the DREADD gene spontaneously in the sense orientation. Addgene 
indicate that between 0.01 and 0.03% of Cre-dependent vectors will carry the 
transgene in the flipped, readable orientation (www.addgene.org).  
The leak could also have occurred through the TRAP2 mouse, which generates the Cre-
ERT2 fusion protein. As described in Chapter 3, this Cre-ERT2 fusion protein will be 




of 4-OHT, it remains bound to Hsp90 and cannot enter the nucleus to recombine 
floxed genes, instead being broken down by intracellular recycling processes. It is 
possible for the Hsp90 to spontaneously dissociate in the absence of 4-OHT (Kristianto 
et al. 2017). However, the contribution of leak from the TRAP2 mouse is likely to be 
minimal in these experiments. TRAP x Tomato mice not exposed to 4-OHT showed very 
little spontaneous tdTomato fluorescence (see Chapter 3, section 3.3.2).  
The consequences of leak are likely to make the demonstration of synthetic torpor 
more difficult. This is because torpor represents a profound deviation from ‘normal’ 
physiological states. In order to induce torpor, many normal counter-regulatory 
processes are presumably suspended or counteracted. Leaky DREADD expression in 
non-torpor related neurons would be expected to obscure the signal for torpor when 
CNO is administered. In fact, off-target DREADD expression could even contribute to 
promoting a return to a normal physiological state, since the DREADD could be 
expressed in neurons whose role is, for example, to maintain a normal core 
temperature. Despite the observation that the vector leaked at concentrations used, 
torpor promotion and synthetic torpor were observed in Chapters 5 and 6, 
respectively. Similar findings were not observed in control hM3Dq-DMH-homecage-
TRAP mice described in Chapter 5. Hence, despite some leaky expression of the 
DREADD, the approach maintained sufficient specificity to generate meaningful 
results. 
The DREADDs used in these experiments were derived from the human M3 and M4 
muscarinic acetylcholine receptors (see section 4.1). These have been mutated to 




clozapine, and its metabolite clozapine-N-Oxide (CNO) (Armbruster et al. 2007). 
Clozapine is an agonist at several CNS receptors, while CNO is thought to be relatively 
pharmacologically inert. However, there is increasing evidence that CNO at doses used 
in DREADD experiments can be reverse-metabolised to clozapine, which can have 
behavioural effects (Gomez et al. 2017; MacLaren et al. 2016; Manvich et al. 2018). 
One of the issues with CNO is that it does not readily penetrate the blood-brain barrier 
(Gomez et al. 2017), hence doses in the 1-5 mg/kg range are often required to achieve 
CNS levels that can activate DREADDs. Higher doses increase the rate of reverse-
metabolism to clozapine, which does easily cross the blood-brain barrier and can exert 
confounding behavioural effects. 
These off-target effects can be accounted for to an extent by selecting appropriate 
controls, and experiment 4.2 included wild type mice receiving CNO during calorie 
restriction, which showed no effect of CNO on the probability, duration, or depth of 
torpor. Controls such as those used in experiment 4.2 can help to rule out the 
possibility that an observed behavioural effect is due to off-target effects of either CNO 
or the product of its reverse-metabolism, clozapine. However, it is more difficult to 
select controls that can establish whether off-target effects of CNO/clozapine are 
responsible for failure to detect a behavioural response. Hence, if the off-target effect 
of CNO/clozapine interferes with the expression of the behaviour of interest that is 
expected to occur following DREADD activation, this will be much harder to control for. 
Again, despite these potential complications and confounds, the approach was able to 
successfully identify hypothalamic regions that were active during torpor, and 




The range of available agonists for DREADDs is increasing, but many probably retain 
some off-target effects (K. J. Thompson et al. 2018; X. Chen et al. 2015). One in 
particular, deschlorpromazine (DCZ) is a promising alternative to CNO, showing 100-
times greater affinity and higher agonist potency at hM3Dq and hM4Di receptors 
compared to CNO. Doses as low as 1-3µg/kg can be used, it readily crosses the blood-
brain barrier, and it appears to have minimal off-target effects (Nagai et al. 2020). 
Alternatively, optogenetics provides a means to activate specific neurons without the 
need to administer actuators with potentially confounding off-target effects. Finally, 
one could switch to a chemogenetic systems that utilise different actuators, such as 
the PSAM system (Atasoy and Sternson 2018). A different actuator ligand would be 
expected to have a different range of potential off-target effects, and hence allow 
separation of the effects of chemoactivation from off-target confounds.   
7.7  Synthetic torpor in humans 
A step towards attempting synthetic torpor in humans is to induce synthetic torpor in 
an animal that does not naturally enter torpor, such as the rat. The challenge with 
these experiments is distinguishing a synthetic torpor state from a non-specific 
inhibition of thermogenesis or disruption of thermoregulation. For example, 
microinjection of the GABA agonist muscimol into the rostral ventromedial medulla 
(RVMM, an area that includes the raphe pallidus) causes a state in rats that is similar to 
torpor in terms of hypothermia and bradycardia (Cerri et al. 2013). However, since the 
injection site includes the raphe, which provides the sympathetic input to drive BAT 
thermogenesis, it is not clear whether this really is analogous to torpor or simply 




Takahashi et al. (Takahashi et al. 2020) also induced what may be a synthetic torpor 
state in the rat, this time by expressing excitatory DREADD in the AVPe/MPA. Limited 
by the absence of a transgenic rat line that expresses Cre in Qrfp neurons, and the fact 
that there are currently no viral vectors that allow specific targeting of Qrfp neurons, 
Takahashi et al. were obliged to use a less selective approach. Using a CaMKIIα 
promoter, they expressed excitatory DREADDs in excitatory neurons within the 
anteroventral periventricular nucleus and anterior parts of the medial preoptic area. 
Chemoactivation of these neurons, some of which expressed Qrfp, generated a 
prolonged and profound hypothermic state. This is an important observation, 
representing a step towards demonstrating that synthetic torpor might be induced in 
species that do not naturally enter torpor. However, the relatively indiscriminatory 
approach that was taken, whereby a non-selected population of excitatory neurons 
were chemoactivated raises some questions regarding whether this is indeed synthetic 
torpor versus disrupted thermoregulation.  
The distinction between synthetic torpor and disrupted thermoregulation is an 
important one. As discussed in above, and in Chapter 1, torpor includes a range of 
physiological adaptations, including modulation of the cardiovascular system (Swoap 
and Gutilla 2009) and active suppression of mitochondrial metabolism (Staples 2014), 
beyond simply switching off thermogenesis. It remains to be seen whether any 
potential clinical benefits from a synthetic torpor state would also be delivered by 
simply inhibiting thermogenesis. These questions are important, and it is probably 
desirable to employ a coordinated ‘physiological’ means to induce hypothermia, 
alongside controlled metabolic and cardiorespiratory suppression such as that seen in 




This leads to another important consideration. Bradycardia occurs with hypothermia 
and it is not clear to what degree the bradycardia observed in torpor is secondary to 
temperature changes. Examination of the heart rate / core body temperature 
relationship during entry into and arousal from torpor suggests active suppression of 
heart rate during torpor entry, coupled with active acceleration during arousal (Swoap 
and Gutilla 2009). However, the relative contribution of autonomic modulation 
compared to biophysical effects of hypothermia in producing the bradycardia 
associated with torpor is unknown. Now that mechanisms are available to induce 
DREADD-driven torpor, an important experiment will be to drive activation of the 
torpor circuit while maintaining the mouse in a thermoneutral temperature such that 
core temperature does not fall. This will inform the debate regarding active heart rate 
suppression and may help to distinguish synthetic torpor states from non-specific 
interruption of thermogenesis.  
A final and related factor when considering human synthetic torpor has to do with 
what is the predominant state of the thermoregulatory system and the major 
determinant of core temperature and energy expenditure in humans compared to 
small animals such as mice that display torpor. While mice are smaller than humans, 
they possess fur. Hence, the thermoneutral temperature for a mouse is approximately 
30°C (Abreu-Vieira et al. 2015). Which is in fact very similar to the thermoneutral 
temperature of a naked adult human. Clothed humans, on the other hand, are 
thermoneutral at approximately 21°C (Kingma et al. 2014). And so, mice in the wild 
and in the laboratory are generally sub-thermoneutral. While surface area increases in 
proportion to body weight to the power of 0.67, basal metabolic rate rises in 




for larger animals, basal metabolic rate generates proportionally more heat than it 
does for smaller animals. A consequence of this is that for a mouse at ambient 
temperatures around 21°C, approximately 50% of energy expenditure is directed 
towards thermogenesis (Abreu-Vieira et al. 2015). On the other hand, the combination 
of clothing and higher basal metabolic rate per kilogram body mass mean that in an 
ambient temperature of 21°C, much less energy is directed towards thermogenesis in 
humans (Carpentier et al. 2018; Cannon and Nedergaard 2004). 
Hence, while the predominant requirement of the thermoregulatory system in mice is 
to generate heat, and a large portion of that heat is derived from BAT thermogenesis 
(Cannon and Nedergaard 2004), this may not be the case for clothed humans. 
Hypothermia and indeed reduced total metabolic rate in torpid mice could presumably 
be achieved to a significant extent by suspension of BAT thermogenesis. In contrast, 
while humans do engage BAT thermogenesis (Blondin et al. 2020; Carpentier et al. 
2018), being larger animals, this probably contributes relatively less to both baseline 
core temperature and to total metabolic demands (Cannon and Nedergaard 2004).  
Therefore, in humans, simply suspending thermogenesis may have relatively little 
effect on overall metabolic demand. This highlights the importance of mimicking all 
aspects of natural torpor, which includes active suppression of metabolism and 
adjustment of the cardiovascular system. Once again, it is important to be able to 
disentangle the direct effects of torpor induction on basal metabolic rate, from the 




7.8  Future experiments 
The field of torpor research has developed rapidly in the past year, as evidenced by 
two recent Nature publications that focus on the neural basis of torpor induction 
(Hrvatin et al. 2020; Takahashi et al. 2020). These advances pave the way for a number 
of exciting experiments.  
7.8.1  Synthetic torpor as a therapeutic intervention 
Now that there are techniques for inducing a synthetic torpor state in mice, it becomes 
possible to engage this in the context of a model of human illness and determine 
whether it confers a benefit. It may be possible, based on the observation of a 
potentially synthetic torpor state in the rat (Takahashi et al. 2020), to carry out this 
experiment in a species that does not naturally enter torpor. This would not only 
inform whether synthetic torpor is beneficial but also whether it is translatable. 
Potential models of disease include an acute lung injury (Patel, Wilson, and Takata 
2012; Akella et al. 2014); myocardial infarction (Lindsey et al. 2018); stroke (Morancho 
et al. 2012); or sepsis (Lewis, Seymour, and Rosengart 2016).  
7.8.2  Synthetic torpor versus disrupted thermoregulation 
An important future experiment would induce synthetic torpor in mice and measure 
oxygen consumption and heart rate while held in an environment that maintains body 
temperature at a normal level. The crucial question will be, to what extent does 
inducing synthetic torpor under these conditions suppress oxygen consumption and 
heart rate. This might help to distinguish synthetic torpor in which both metabolic and 
cardiorespiratory suppression are to some extent independent of hypothermia, from 
disrupted thermoregulation in which suppressed metabolism and heart rate are 




7.8.3  Exploring the relationship between synthetic torpor and natural 
torpor 
Several experiments follow on from those described in this thesis, and the papers by 
Hrvatin et al., and Takahashi et al. One could explore the role of the Qrfp neurons 
during natural torpor. An initial experiment might express a Cre-dependent calcium 
indicator in transgenic mice that express Cre in Qrfp neurons (Qrfp-Cre mice, Takahashi 
et al., 2020). Placing a fibre photometer into the AVPe/MPA would then allow 
measurement of the activity of these neurons during natural torpor.  
A further experiment might deliver an inhibitory optogenetic vector into the POA of 
Qrfp-Cre mice, followed by inhibition of the DMH terminals during calorie restriction. 
This might indicate whether this projection is necessary for natural torpor. Likewise, 
one could deliver a retrograde vector carrying a Cre-dependent tetanus light chain 
toxin into the DMH of Qrfp-Cre mice. This would block synaptic transmission in those 
Qrfp neurons that project from the POA to the DMH, although it would also block 
transmission in any Qrfp neurons that project both to the DMH and elsewhere from 
the POA.  
Alternatively, one might inject a retrograde Cre-dependent vector coding for a 
fluorescent protein into the DMH of Qrfp-Cre mice, followed by natural torpor 
induction and c-Fos labelling. Double-labelled neurons would represent those that 
express Qrfp, project the DMH, and are active during natural torpor. It is also 
important to establish the nature of the Qrfp POA to DMH projection, including 
whether it is excitatory versus inhibitory, and what is the phenotype of the neurons 




Having generated synthetic torpor, either using the TRAP2 mouse, by targeting Qrfp 
neurons (Takahashi et al. 2020), or by targeting Adcyap1 neurons (Hrvatin et al. 2020), 
it is important to examine a greater range of the physiological characteristics of these 
states. For example, one might ask what are the cardiorespiratory and metabolic 
adjustments associated with synthetic torpor engaged by each of these different 
methods, and how do those adjustments compare to natural torpor? 
7.8.4  Overlap between torpor circuits and other physiological 
functions 
Another important question is whether the torpor-TRAPed preoptic area neurons that 
generate synthetic torpor are also involved in other non-torpor physiological functions, 
particularly those that are seen in species that do not naturally enter torpor, such as 
the suppression of body temperature associated with NREM sleep (Harding et al. 
2018). Demonstration of an overlap between ubiquitous circuits and torpor-inducing 
would support the hypothesis that torpor is induced by shared neural circuits that 
might persist in a wide range of mammals including humans.  
One might use a combined approach in which Cre-dependent vectors for both an 
excitatory DREADD and a calcium indicator are injected into the preotic area of TRAP2 
mice, followed by 4-OHT during natural torpor. Generation of synthetic torpor in 
response to chemoactivation would confirm that the target population of neurons has 
been TRAPed. Placement of a fibre photometer into the preoptic area could then allow 
exploration of whether these neurons are also activated during other behaviours such 
as exposure to a warm environment, or the induction of NREM sleep. Alternatively, 
one might use the TRAP x tomato mouse line to express tdTomato fluorescence in 




by a period of recovery sleep to induce NREM, followed by labelling for c-Fos. This 
would establish whether torpor-TRAPed neurons are also involved in the rebound 
NREM sleep associated with sleep deprivation (Zhe Zhang et al. 2015).  
7.8.5  Synthetic torpor in the rat 
Finally, the observation that chemoactivation of glutamatergic AVPe/MPA neurons in 
the rat induces a prolonged period of hypothermia and hypometabolism demands 
further attention. For example, it is important to further phenotype these neurons. 
Retrograde and intersectional vector approaches could be used to establish to where 
these excitatory POA neurons project, and which projection is responsible for inducing 
this torpor-like state. Again, what are the other physiological characteristics of this 
state, including for example, the cardiovascular adaptations? Does the rat become 
hypothermic because it halts metabolism or is the hypothermia secondary to increased 
thermal losses due to vasodilatation?  
7.9  Conclusion 
This project used activity-dependent transgene expression to explore the neural basis 
of torpor in the mouse. Using this approach, I established that the preoptic area of the 
mouse hypothalamus contains neurons that are active during torpor, and that their 
chemoactivation is sufficient to induce a synthetic torpor state. I also identified 
neurons in the dorsomedial hypothalamus that are active during torpor. The activity of 
these neurons, while not necessary for torpor induction, can both increase the 
likelihood of torpor during calorie restriction, and prolong and deepen subsequent 
torpor bouts. This represents a significant development in the understanding of torpor 
in the mouse. The findings pave the way for future work that could test whether 




attempts to induce synthetic torpor in species that do not naturally engage this 
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During discussion in my viva examination, it was suggested that I examine the rate of 
cooling in mice entering natural torpor, compared to synthetic torpor and dysregulated 
hypothermia induced by administration of DMSO, using the data that was already 
available from the work presented here. The hypothesis was that DMSO-induced 
hypothermia, being an uncontrolled process, might result in a more rapid decline in 
temperature than either natural or synthetic torpor. 




































































Given that only two mice showed synthetic torpor on chemoactivation of torpor-
TRAPed neurons, statistical analysis is not appropriate. However, the data does not 
appear to indicate that the rate of change was significantly different across any groups. 
Further work, with larger numbers of animals in each group is required to fully answer 
this question.  
